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Genome integrity is constantly threatened by several stimuli either of exogenous or 
endogenous origin. Cells have evolved several DNA repair mechanisms to maintain their 
genetic information unaltered and a DNA damage response pathway (DDR) coordinates 
DNA repair with several cellular events including a cell-cycle arrest (checkpoint) until 
damaged DNA is repaired. When cells fail to repair DNA lesions, they undergo either 
apoptosis or cellular senescence, a permanent cell cycle arrest. DNA damage accumulation 
in cells has been linked to several events, such as cancer initiation and progression, 
organismal aging, cellular differentiation and reprogramming. More recently, it was also 
suggested to be a key event in transcriptional activation in response to specific stimuli or 
hormone-sensing.  
Despite a clear role for DNA damage in several cellular processes, direct and sensitive tools 
for DNA damage detection have not been available until very recently, leaving important 
questions unanswered. The most used tools to detect DNA lesions rely on indirect, antibody-
based recognition of DDR markers, either chromatin modifications or proteins accumulating 
at the damaged site. One of the main drawbacks of these tools is their low resolution: in fact, 
DNA damage-induced chromatin modifications spread for several kilobases around the 
lesion, preventing precise localization of the break position. This feature has hampered, in 
particular, studies on the impact of DNA damage on transcription. Here, I show the 
validation and optimization of BLESS and BLISS, two recently developed methods that 
allow genome-wide single-nucleotide resolution mapping of DNA double strand breaks 
(DSBs). Using these techniques, in combination with a multi-layered transcription profiling, 
I studied the impact of DSBs on transcription: in particular, I characterized a DDR-
dependent transcription inhibition around the breaks. Differently, exploiting these same 
methods but in a distinct experimental setup, I observed that following macrophages LPS-
stimulation, a transient wave of DSBs is induced at LPS-specific enhancers and it correlates 
with their transcription activation, thus suggesting a new molecular mechanism for LPS-
induced macrophages activation that involves controlled DNA damage generation. 
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While representing an advancement over the commonly used methods to detect DNA 
damage, the recently developed tools such as BLESS and BLISS do not allow single-cell 
studies. Instead, here I describe a new method that I have developed, named DI-PLA, for the 
detection and imaging of DSBs in fixed cells and tissues. I applied this tool to address a 
long-standing question in the senescence field. Cellular senescence is fuelled by persistent 
DDR activation, however, due to the lack of direct DNA damage detection tools, it could 
not be distinguished whether it is associated with stable chromatin modifications or physical 
DSBs. Here I show that two types of senescent cells and cells in aged tissues retain physical 
DSBs associated with activated DDR markers. This observation is in agreement with data 
available in literature, that I could also recapitulate here, showing that senescent cells 
accumulate DNA damage at telomeres, where DNA repair is impaired.  
Finally, I describe a modification of BLESS to discriminate between DSB bearing telomeres 
and deprotected telomeres; this approach has the potential to address important questions on 
the mechanisms of DDR activation at telomeres. 
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Cells genomes are constantly subjected to a pletora of stimuli that can lead to DNA damage, 
which, in turn, alters the genomic structure and the genetic information encoded within. 
Although in the big scheme of things these modifications drive evolution, genome 
mantainance is needed for individual organisms survival and especially in stem cells, where 
genomic mutations are transferred to daughter, or differentiated cells. Genomic mutations 
emerging in non-dividing somatic cells may have less negative impact on individual survival 
compared to those happening in germ and stem cells, however it is well established that 
DNA mutations including DNA recombination events can drive oncogenesis and cancer 
progression (Hoeijmakers 2009, Jackson & Bartek 2009). 
 
2.1 Types of DNA damage 
It has been estimated that each cell in the human body can undergo up to ten thousands DNA 
lesions per day (Lindhal & Barnes 2000). Sources of genomic instability can be both 
endogenous and exogenous to the cell.  
Exogenous sources can be divided in two main groups: physical and chemical insults. 
Physical genotoxic agents are ionizing radiation (IR) such as X-rays used for medical 
diagnoses, and the ultraviolet (UV) component of sunlight. Genotoxic chemical compounds 
are various, from food components, to cigarette smoke and anti-cancer drugs (Ciccia & 
Elledge 2010). 
Endogenous damage to DNA can be either a random event, caused by by-products of cellular 
metabolism, or a scheduled event, such as that induced by a class of enzymes known as 
topoisomerases, that induce transient DNA breaks to release localized topological stress, or 
during meiosis, where genomic recombination is critical for a correct chromosome 
segregation in daughter cells (Borde & de Massy 2013).  
This heterogenous plethora of stimuli can induce different types of DNA lesions. 
Informational DNA damage can be induced, for example, by oxidation reactions, and results 
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in nitrogen bases loss and mutation of the genetic information, as it is the case for cytosine 
deamination that is converted to uracil. DNA structural damage can be generated by single-
strand breaks (SSBs) which are nicks in the sugar-phosphate backbone of one strand, by 
double-strand breaks (DSBs) which consist of breakages of both strands, and by DNA 
crosslinks, which are covalent links between the two strands. Structural damages are 
generated by UV, IR, programmed enzymatic cleavage and reactive oxygen species (ROS). 
Given the number and the variety of DNA lesions threatening the genome integrity every 
day, cells evolved complex mechanisms to detect, signal and repair damaged DNA. The 
study of these mechanisms, that were first discrovered in the 1960s, has generated an entire 
branch of research in the life sciences and has been highlighted in 2015 with a Nobel Prize 
for work in this field. 
 
2.2 DNA damage repair 
In order to repair different kind of lesions, cells have developed several DNA repair 
mechanisms. 
 
2.2.1 Informational DNA damage repair 
Informational DNA damage, is usually quickly repaired with fairly simple processes, well 
conserved from bacteria to human.  
DNA alkylation damage is repaired by direct reversal, through enzymatic removal of the 
adduct (Mishina et al. 2006). DNA mismatch repair pathway (MMR) is responsible for 
correcting base substitutions, insertions and deletions occurring during DNA replication 
(Kunkel & Erie 2005): dedicated sensors recruit endonucleases, at the site of damage, to 
excise the mismatched region in the newly synthethized strand; then DNA polymerases fill-
in the single strand DNA gap and finally DNA ligases seal the repaired DNA strand. A 
similar mechanism is employed by two other DNA repair mechanisms: nucleotide excision 
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repair (NER) and base excision repair (BER). NER is involved in the repair of bulky DNA 
adducts such as thymidine dimers induced by UV light, through removal of a tract of single 
strand DNA surrounding the lesion, which is then newly synthesized and sealed (Marteijn et 
al. 2014). Differently, BER takes care of single base oxidative damage, such as 7,8-dihydro-
8-oxo-2’-deoxyguanosine (OG), which if not repaired, yields a transversion mutation (G:C 
to T:A) after DNA replication (David et al. 2007). BER acts through DNA glycosylases that 
remove the damaged base generating an abasic site, which is later cleaved by endonucleases, 
that induce a SSB, in turn repaired with the contribution of DNA polymerases and DNA 
ligases. 
Another tool that cells have to deal with single-strand DNA lesions, is translesion synthesis 
(TLS). This is a DNA damage tolerance pathway that allows DNA replication past DNA 
lesions such as thymidine dimers or abasic sites, through the switch between the canonical 
DNA polymerases and specialized translesion polymerases that have low-fidelity on 
undamaged templates, but are particularly efficient at pairing nucleotides to the damaged 
bases (Waters et al. 2009). 
 
2.2.2 Structural DNA damage 
Breaks in the DNA backbone, in particular, DSBs, are particularly deleterious, because if 
unrepaired before cell division, can lead to the loss of critical amounts of genetic information 
and to dramatic chromosomal rearrangements. This type of lesion is repaired either with 
non-homologous end joining (NHEJ) or by homologous recombination (HR). 
NHEJ is highly efficient and acts through a simple mechanism of DNA ends re-ligation, 
however, it is prone to mutations (Chang et al. 2017, Lieber 2010). DNA ends are recognized 
by KU proteins that recruit DNA-PK catalytic subunit (DNA-PKcs) which phosphorylates 
itself and several targets. One of DNA-PKcs targets is Artemis, a 3’-5’ exonuclease that 
contributes to DNA ends blunting, to generate compatible DNA ends; to ensure proper DNA 
blunting, also specialized DNA polymerases (DNA pol X) are active to fill-in protruding 
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DNA ends. Notably, it has been reported that microhomology domains (<4 nucleotides 
protruding ends), may favour DNA ligation of DNA ends. Finally, DNA ligase IV, which is 
phosphorylated by DNA-PKcs, together with its binding partners X-ray repair cross-
complementing protein 4 (XRCC4) and XRCC4-like factor (XLF), ligates DNA ends. NHEJ 
is active throughout the entire cell cycle and it is the most used mechanism to repair DSBs 
in mammals. There is also a redundant pathway, the alternative NHEJ (a-NHEJ), also known 
as backup NHEJ or microhomology-mediated end joining (MMEJ) (Bennardo et al. 2008), 
that is active in the absence of the proteins needed for the classical NHEJ and requires 2-20 
nucleotides protruding DNA ends. This mechanism relies on a different subset of proteins, 
among which DNA ligase 3, XRCC1 and DNA polymerase θ seem to play a major role. 
Differently from NHEJ, HR is an error-free mechanism that uses a sister chromatid as 
template for repair, thus it can occur only during the S and G2 phases of the cell cycle (Heyer 
et al. 2010, San Filippo et al. 2008). The HR process begins with the endonuclease activity 
of the MRE11-RAD50-NBS1 (MRN) complex in cooperation with CtIP (Clerici et al. 2005, 
Sartori et al. 2007). This initial step generates short 3’ protruding ends that are further 
processed by the 5’-3’ exonuclease activity of exonucleases such as BLM and Exo1 
(Mimitou & Symington 2008). Once DNA ends have been resected, ssDNA is immediately 
coated by the RPA complex, which is then displaced by RAD51 which, in cooperation with 
BRCA2, coats the DNA generating a nucleoprotein filament (White & Haber 1990). RAD51 
is able to catalyse the invasion of the intact homologous duplex DNA, which is used as a 
template to repair the DSB: the invading filament generates a structure known as D-loop. 
According to the canonical HR pathway, the free DNA end of the invading DNA is then 
extended by a DNA polymerase and, finally, the invading DNA end is ligated to the other 
end of the DSB generating a structure named Holliday Junction (HJ): this is resolved by 
endonucleases and helicases to obtain two intact and repaired DNA molecules. Alternatively 
to the pathway just described, synthesis-dependent strand annealing (SDSA) and Break-
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induced replication (BIR), are other HR sub-types that lead to the resolution of the D-loop 
but do not require endonuclease activity. 
The repair pathway choice is a fine-tuned mechanism, still not completely understood 
(Gobbini et al. 2013, Symington & Gautier 2011). However, it is clear that the Ku70/Ku80 
heterodimer plays a major role, promoting c-NHEJ and inhibiting the recruitment of HR 
components to the DNA ends. The 5’-3’ resection is also very well regulated and is inhibited 
by RIF1 and 53BP1 in G1 phase (Clerici et al. 2014, Daley & Sung 2013, Panier & Boulton 
2014), while it is promoted by CtIP and BRCA1 in G2 to favour HR (Cruz-García et al. 
2014). Recently, a new protein named CYREN, has been described as negative regulator of 
NHEJ in S/G2 (Arnoult et al. 2017). 
 
2.3 The DNA damage response pathway 
The DNA Damage Response (DDR) pathway is a complex signalling cascade that 
coordinates the DNA repair process with a broad set of events (Figure 1) (Ciccia & Elledge 
2010, Polo & Jackson 2011). In the presence of DNA breaks, the DDR is activated and 
transiently arrests cell-cycle progression to prevent the propagation of altered genomic 
information to the daughter cells. 
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Figure 1 - The DNA damage response pathway. 
DNA breaks are recognized by DNA damage sensors including the MRN complex and the RPA complex. 
These sensors recruit the apical kinases ATM and ATR, which is also bound by ATRIP and the RAD9-RAD1-
HUS1 complex. The apical kinases, in turn, phosphorylate (P) the histone variant H2AX on Ser139 (γH2AX) 
to recruit DNA damage mediators such as MDC1, 53BP1, BRCA1, which boost the signal, providing a positive 
feedback loop on the apical kinases. The diffusible downstream kinases CHK2 (mainly phosphorylated by 
ATM) and CHK1 (mainly phosphorylated by ATR) spread the signal to several effectors including p53 and 
CDC25, which coordinate several cellular events to ensure that the DNA damage is not propagate to daughter 
cells. The first response is a transient cell cycle arrest until DNA is repaired (DNA damage checkpoint); failing 
to repair DNA damage, and prolonged DDR activation leads, instead, to cell death by apoptosis or cellular 
senescence. 
 
 
The DDR is triggered by DNA damage sensors recognizing the lesion, mainly the MRE11-
NBS1-RAD50 (MRN) complex, poly (ADP ribose) polymerase 1 (PARP-1), KU and RPA 
(that coats ssDNA). Once the lesion has been recognized by sensor proteins, these activate 
three key protein kinases of the phosphatidylinositol 3-kinase-like protein kinase (PIKK) 
family: ATM and DNA-PK, mainly in response to DSBs, and ATR, which is activated in 
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response to ssDNA, which might be generated by SSBs, or by resection at DSBs in S/G2 
phase, or under replication fork stalling. In particular, ATM is recruited to DSBs by MRN, 
where it is acetylated by lysine acetyl transferase 5 (KAT 5) (Sun et al. 2005), and then 
undergoes an autophosphorylation reaction on serine 1981, causing its activation and 
monomerization (Shiloh 2006). DNA-PKcs is instead recruited to the break site by KU and 
undergoes an activating autophosphorylation on the five residues within the PQR cluster 
(also known as the S2056 cluster). ATR activation relies on the presence of ATR-interacting 
protein (ATRIP) and ssDNA bound to RPA. In addition to ATR, other protein complexes 
are recruited to ssDNA, including the RAD17 containing complex, which loads the 
heterotrimeric 9-1-1 complex (RAD9, RAD1, HUS1) on the DNA, where it contributes to 
boosting ATR kinase activity (Parrilla-Castellar et al. 2004). 
 
One of the first targets of the three apical kinases is the histone variant H2AX, which is 
locally phosphorylated in cis at serine 139 (named γH2AX): this phosphorylation can spread 
up to 1Mb away from the DNA lesion site (Iacovoni et al. 2010). γH2AX acts as recognition 
mark for the DSBs and promotes the retention of other DDR proteins at the site of damage 
(Martin et al. 2009, Rogakou 1998). This also results in the formation of cytologically 
detectable nuclear foci that contain the DDR proteins recruited to the site of damage (Lukas 
et al. 2011). Thus, immunostaining or chromatin immunoprecipitation (ChIP) with 
antibodies against γH2AX and other DDR proteins are commonly used tools to detect the 
presence of DSBs in cells or at specific genomic loci. However, this indirect way to detect 
DSBs is associated with several drawbacks, as discussed in the section 2.5. 
It is well established that γH2AX plays a key role in the DDR cascade, and it fuels the signal 
amplification by recruiting the DDR mediator MDC1 (mediator of DNA-damage checkpoint 
1). MDC1 directly binds γH2AX through its C-terminal domain and further promotes MRN 
and ATM accumulation at the DSB (Spycher et al. 2008), leading to an increase in the 
concentration of several DDR proteins at the DSB site, thus generating a positive feedback 
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loop that amplifies DDR signalling. MDC1 also recruits chromatin re-modellers which 
favour DDR signal amplification and DNA repair. Really Interesting New Genes (RING) 
domain-containing E3 ubiquitin ligases enzymes, RNF8/RNF168, target H2Ak15 (Mailand 
et al. 2007) and favour the recruitment of methyltransferases, which in turn target the histone 
H4k20 (Mallette et al. 2012). These chromatin modifications promote the recruitment of the 
DNA damage mediators p53 binding protein 1 (53BP1) and BRCA1 to the site of break 
(Bekker-Jensen et al. 2005, Meerang et al. 2011, Panier et al. 2012, Wang & Elledge 2007). 
Moreover, the SWI/SNF histone re-modelling complex has been found to be quickly 
recruited to the DSBs, where it relaxes chromatin and evicts nucleosomes in the immediate 
vicinity of the exposed DNA ends, promoting resection and repair (Dong et al. 2015, 
Morrison et al. 2004). 
Ultimately, the activated apical kinases, phosphorylate CHK2 (the main target of ATM) and 
CHK1 (the main target of ATR), which are downstream protein kinases, that can diffuse in 
the nucleoplasm, where they target their substrates, among which are the cyclin-dependent 
kinases (CDKs), responsible for the so-called DNA damage checkpoints (see next section). 
In case of unrepairable DNA damage, prolonged activation of the DDR checkpoints can 
induce cell death (apoptosis) or a permanent cell cycle arrest known as cellular senescence 
(see section 2.6). 
 
2.3.1 DNA damage checkpoints 
DNA damage checkpoints are transiently activated to arrest cell cycle proliferation until the 
DNA lesion has been repaired. To do so, DDR modulates cyclin-dependent kinases (CDKs) 
that are responsible for transitions between cell cycle phases (Branzei & Foiani 2008, Sancar 
et al. 2004). There are three distinct checkpoints regulating cell cycle progression: the G1/S, 
the intra-S, and the G2/M. 
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2.3.1.1 G1/S checkpoint 
The G1/S checkpoint prevents the transition to S phase in the presence of DNA damage, by 
inhibiting the initiation of DNA replication. In the presence of DNA damage in G1, CHK2 
and CHK1 phosphorylate the phosphatase CDC25A, which is consequently activated and 
inhibits CDK2, preventing, in this way, the CDK2-dependent phosphorylation of CDC45, 
that is necessary to initiate replication. 
Moreover, ATM, ATR, CHK1 and CHK2 target p53 at different phosphorylation sites as 
well as the ubiquitin ligase MDM2: this leads to inhibition of p53 nuclear exportation and 
inhibition of MDM2-dependent p53 degradation (Sancar et al. 2004). The accumulation of 
p53 in the nucleus leads to activation of p53 targets, including p21, which binds to and 
inhibits the S-phase-promoting CDK2-cyclinE complex, thus contributing to the 
maintenance of G1/S arrest. Furthermore, p21 binds to the CDK4-cyclinD complex, thus 
preventing pRB phosphorylation, which is necessary for the activation of E2F, a 
transcription factor which promotes cell cycle progression (Bartek et al. 1996). 
 
2.3.1.2 The intra-S checkpoint 
The intra-S checkpoint is triggered by unrepaired DNA damage that escapes the G1/S 
checkpoint and generates a block in replication or by DNA damage encountered during the 
S phase. 
The intra-S checkpoint acts by slowing down replication forks and by blocking replication 
origin firing. This is obtained by multiple pathways, one being the CDC25-dependent 
CDK2-CyclinE inhibition, as described for the G1/S checkpoint, while another is the ATR-
dependent Cdc7/Dbf4 inhibition: both pathways ultimately lead to the inhibition of Cdc45, 
which is necessary to promote the replication origin firing (Costanzo et al. 2003). 
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2.3.1.3 The G2/M checkpoint 
The G2/M checkpoint prevents the entrance in mitosis in the presence of DNA damage 
encountered during G2 phase or escaped from the previous checkpoints. ATM and ATR, 
through phosphorylation of CHK2 and CHK1, inhibit the entry into mitosis by down-
regulating CDC25A and up-regulating Wee1, which together control CDK1-Cyclin B 
activity, responsible for G2/M transition (Yarden et al. 2002). 
 
2.4 DNA damage and RNA 
Transcription is the cellular function that converts the genetic information of the DNA in 
RNA molecules: protein-coding RNAs are then translated into functional proteins, while 
noncoding-RNA directly exert their functions (Shandilya & Roberts 2012). 
DNA damage and RNA metabolism are intertwined at several levels (Capozzo et al. 2017, 
D’Alessandro & d'Adda di Fagagna, 2016). Transcription has classically been considered an 
endogenous source of genomic instability, however recent reports have suggested a role for 
RNA in DDR signalling and DNA repair and even a role for DDR proteins and DNA damage 
in transcription modulation. 
 
2.4.1 RNA as a source of DNA damage 
Transcription can cause DNA damage in several ways, although, compared to traditional 
sources of DNA damage, transcription-induced damage is less frequent. The transcriptional 
machinery can collide with the DNA replication machinery either when they are moving in 
opposite directions or when they are moving in the same direction (Helmrich et al. 2013). 
To limit the collision events, transcription levels are reduced during the S phase, however, 
genes larger than 800kb require more than one complete cell cycle to be transcribed and 
exhibit DNA damage hotspots known as common fragile sites (CFS) (Helmrich et al. 2011). 
The collision between DNA replication and transcription bubbles results in localized 
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torsional stress, which can cause DNA polymerases to stall or collapse, resulting in a DNA 
lesion. Moreover, as consequence, also RNA polymerases get stalled, favouring the 
formation of so-called R-loops: hybrid duplexes formed between the nascent RNA and the 
template DNA strand, that leave the non-transcribed DNA strand in a single-stranded state, 
which can undergo DNA damage (Reaban et al. 1994). Moreover, single strand DNA can 
form noncanonical structures depending on its sequence and base content, such has single-
stranded hairpins or loops in genes containing stretches of the same trinucleotide repeat 
(Petruska et al. 1996, Zhao & Usdin 2015), and G-quadruplex in GC-rich regions (Duquette 
et al. 2004), which are stable structures that induce RNA polymerase II (RNA POL II) 
pausing and promote the stability of the R-loops, in a positive feedback loop 
(Belotserkovskii et al. 2010). Prevention of R-loops formation is necessary to avoid the 
negative effects of their accumulation. Under physiological conditions, the nascent RNA is 
promptly bound by several proteins that control its nuclear export and splicing, impeding the 
formation of RNA:DNA hybrids. Moreover, prokaryotes and eukaryotes have RNAseH 
enzymes, which are specialized in degrading RNA hybridized to DNA molecules; mutations 
in the RNAseH2 enzymes have been linked, in humans, to the Aicardi-Goutières syndrome 
(AGS), a neurological inflammatory disorder, which resembles a congenital viral infection 
and is associated with accumulation of ribonucleotides in the DNA (Crow et al. 2006). 
 
2.4.2 RNA contribution to DNA repair and DDR signalling 
Besides the detrimental effects of transcription-induced torsional stress and DNA:RNA 
hybrids on genome integrity, several reports show a positive role of transcription in DNA 
repair and genome maintenance. In fact, it has been reported that actively transcribed 
regions, are repaired faster than non-transcribed regions, despite being DNA damage 
hotspots (Aguilera 2002, Mellon et al. 1986). Indeed, transcription-coupled repair, is a 
conserved NER pathway, that actively removes DNA lesions which block RNA POL II 
(Hanawalt & Spivak 2008). Moreover, in mammalian cells, high-resolution mapping of 
 27 
proteins bound to regions surrounding the DSBs showed that RNA POL II is not disengaged 
from the DNA upon damage (Iacovoni et al. 2010). Intriguingly, occupancy peaks of the 
main subunit of RNA POL II, POLR2A, spatially exclude histone occupancy (including 
γH2AX), which could be due to the transcription machinery ability to evict nucleosomes, 
thus favoring DNA repair (Iacovoni et al. 2010). As additional evidence for a role of 
transcription machinery in DNA repair, it has been reported that DSBs falling in actively 
transcribed regions are preferably repaired by homologous recombination, possibly because 
the chromatin modifications normally associated with transcription favor DNA end resection 
(Aymard et al. 2014). 
Several transcription factors and RNA binding proteins (RBPs) have also been reported to 
localize at DNA damage sites, where they are phosphorylated by ATM or ATR (Izhar et al. 
2015). One example, is the splicing regulator FUS, that is recruited to DSBs, where it seems 
to play a role in promoting DNA repair by both HR and NHEJ (Mastrocola et al. 2013). This 
hypothesis is supported by the observation that amyotrophic lateral sclerosis patients 
harboring familial mutations in FUS genes have increased genomic instability (Wang et al. 
2013). 
 
Recently, a role for RNA itself, has been integrated into the canonical model of DDR 
signaling. 
Upon DNA damage, small non-coding RNAs (sncRNAs), named DNA-damage response 
RNAs (DDRNAs) and DSB-induced RNA (diRNA), have been reported to accumulate at 
DSBs in humans, drosophila, plants and mice (Sharma & Misteli 2013). DDRNAs are 
generated by DROSHA and DICER cleavage of a longer precursor RNA, and together with 
the RNA precursor participate in DDR signaling (Francia et al. 2012), favoring 53BP1 and 
MDC1 recruitment (Francia et al. 2016). Recent evidence shows that the long precursor 
RNA is produced at the site of damage by RNA POLII, that is recruited to the DSB through 
the interaction with MRN complex (Michelini et al, in press).  Another group, independently 
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identified a role for diRNAs in promoting DNA repair by HR (Gao et al. 2014, Wei et al. 
2012).  
  
2.4.3 The impact of DNA damage on transcription 
Despite the recent observations reporting that noncoding RNAs are produced at site of break, 
it has also been known for a while an overall inhibitory effect of DSBs on pre-existing 
transcription. This mechanism prevents aberrant transcripts to be produced at DNA damaged 
loci, which could alter cell homeostasis (Adam & Polo 2014, Svejstrup 2010).  
Recent reports have shown some apparently contrasting data on the mechanism of DSBs-
dependent transcription inhibition. In particular, it has been reported that generation of a 
DSB within a gene body, results in transcription inhibition of the damaged gene, in a DNA-
PK dependent manner, through the exclusion of RNA POLII from the gene body and 
promoter (Pankotai et al. 2012). However, the transcription inhibition affects only the 
damaged locus and not the neighboring genes, and this observation was also recapitulated in 
vivo, in mice, through the genome-wide analysis of transcriptome alterations induced by the 
endonuclease I-PpoI (Kim et al. 2015). Differently, a cluster of DSBs induced in an 
exogenous sequence, repressed the activity of a distal promoter in cis, in an ATM-dependent 
manner, through chromatin condensation, for several kilobases (Shanbhag et al. 2010). ATM 
was reported to promote H2A ubiquitination, which in turn promotes PRC1 recruitment at 
DSBs, which is a well-known repressor of gene expression. The contrasting views of these 
two reports might be explained by the peculiar features of DNA loci where DNA damage 
was induced: in fact, while Shanbag and colleagues induced several breaks close to an 
exogenous sequence, Kim and colleagues, generated single DSBs at endogenous loci mainly 
within ribosomal genes. As it is also described in the Results section, in collaboration with 
Dr. Iannelli and colleagues, I have contributed to show that DSBs induced at endogenous 
sites promote an ATM-dependent transcription inhibition of the gene bearing the DSB and 
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of the neighbouring genes, although the transcription inhibition is progressively weaker at 
increasing distance from the DSB (Iannelli et al. 2017). 
ATM-dependent transcription inhibition has also been reported for RNA polymerase I upon 
DNA damage induced in rDNA (Harding et al. 2015, Kruhlak et al. 2007). 
 
Although the effect of DNA damage on transcription inhibition is in apparent contrast with 
the observation of RBPs recruitment at DSBs and de novo transcription involved in DDR 
signaling and DNA repair, it has been proposed that a first PARP-dependent chromatin 
relaxation, required for the accessibility of DDR proteins at the DSBs sites, might lead to 
the recruitment of RNA POLII and transcription factors at DNA damage sites (D’Alessandro 
& d’Adda di Fagagna 2016). This event may precede the ATM-dependent chromatin 
condensation required for further amplification of DDR signalling and transcription 
silencing. 
 
In support of a role for DSBs in chromatin relaxation and consequent transcription 
activation, several observations emerged in the last few years showing stimuli-dependent, 
scheduled, transient DNA damage in several physiological processes, leading to 
transcription of specific promoters or enhancer. 
One of the first observations connecting DNA damage to transcription activation was 
topoisomerase IIβ (TOP2B) accumulation in β-estradiol-sensitive pS2 promoter following 
hormone stimulation, along with proteins associated with DDR such as PARP1, KU, and 
DNA-PK (Glass & Rosenfeld 2006). Here, TOP2B induces transient DNA breaks that are 
necessary for transcriptional activation of the genes activated by the hormone. 
DNA damage-mediated transcription activation has also been reported in cultured primary 
neurons stimulated by various molecules that induce synapses-like signals, such as N-
methyl-D-aspartate (NMDA), potassium chloride, and bicuculline (Madabhushi et al. 2015). 
Also in this case, transcription activation depends on transient DSBs induced by TOP2B 
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activity at gene promoters and enhancers, that leads to RNA POLII releasing from a paused 
state.  
Another report showed TOP1-induced SSBs at androgen-receptor binding sites, in prostate 
cancer cells activated by dihydrotestosterone to activate enhancers and promoters (Puc et al. 
2015b). Here, TOP1 induces nicks that are readily recognized and repaired by the DDR and 
DNA repair pathways. Indeed, knockout of the DDR or DNA repair pathways abolishes 
androgen-induced transcription activation. Similarly, in estrogen-sensitive breast cancer 
cells, hormone-induced gene activation is mediated by APOBEC3B. This enzyme, is part of 
the AID/APOBEC family and catalyzes the cytidine to uracil conversion on DNA, which is 
recognized by the BER pathway: a transient DSB is generated to remove the lesion and this 
is required to recruit RNA POL II at promoters (Periyasamy et al. 2015). 
 
Several models could explain the role of DNA damage-mediated transcription activation 
(Vitelli et al. 2017). The simplest explanation is that DSBs are needed to release topological 
stress that accumulates in actively transcribed genes, in order to promote RNA polymerase 
processivity: this is in agreement with the observations that TOP1 and TOP2B are involved 
in most of the cases described here. Another hypothesis is that DSBs are needed to induce 
chromatin reorganization and modifications that favour transcription, as it has been observed 
in the case of APOBEC3 (Periyasamy et al. 2015). Nevertheless, while the appearance of 
transient breaks, leading to nucleosome-free zones and chromatin modifications may favour 
transcription initiation, prolonged and unrepairable DNA damage is detrimental and can lead 
to transcription inhibition. In collaboration with Dr. Vitelli, as described in the Result 
section, I have contributed to find a new molecular basis for LPS-induced macrophage 
activation through transient DSB induction at specific enhancers. 
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2.5 DNA damage detecting methods 
The most commonly used methods to detect DNA damage rely on antibody recognition of 
chromatin modifications associated with DNA damage or proteins involved in DDR 
signalling. With this strategy, it is possible to detect, by immunostaining, the accumulation 
of DDR foci or map, by ChIP, the genomic regions enriched with the DDR marker of choice. 
However, an increasing amount of evidence suggests that H2AX is not uniformly distributed 
in the genome, and heterochromatin is, to an extent, resistant to H2AX phosphorylation 
(Cowell et al. 2007, Kim et al. 2007, Lafon-Hughes et al. 2013). These observations, suggest 
the existence of genomic regions where DNA damage is repaired with low efficiency, which 
might bear “invisible” DNA damage. Moreover, in a particular cell type, astrocyte, our group 
has observed the lack of a full DDR response upon IR-induced DNA damage generation 
(Schneider et al. 2012). On the other hand, other labs reported the accumulation of γH2AX 
in the absence of DSBs (de Feraudy et al. 2010) and some groups have suggested DNA 
damage-independent functions for γH2AX (Fernandez-Capetillo et al. 2003, Rybak et al. 
2016a, Tu et al. 2013). Thus, the use of DDR markers as a proxy for DSB marker might be 
biased or misleading. As an additional drawback, ChIP against DDR markers provide low 
resolution in DNA damage mapping, since DNA damage markers spread away from the 
lesions for up to 1 Mb, preventing precise identification of the DNA breaks positions. This 
feature has negatively impacted the studies on the correlation between DSBs and 
transcription events. In fact, differently from DNA damage mapping methods, several tools 
widely used by the scientific community to study transcription alterations, such as 
differential expression of genes with RNA sequencing (RNA-seq) (Wang et al. 2009), 
different genome-wide transcription start activities with cap analysis gene expression 
(CAGE) (Shiraki et al. 2003), bromouridine labeling and sequencing (Bru-seq) (Paulsen et 
al. 2014), and native elongating transcript sequencing (NET-seq), generate high sensitivity, 
single-nucleotide resolution maps of the transcriptome.  
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To circumvent the problem of DNA damage mapping, several studies exploited the 
generation of controlled DSBs at known loci. This approach was pioneered in the budding 
yeast Saccharomyces cerevisiae by inducing DNA cleavage in the MAT gene locus with the 
endogenous endonuclease HO (Kramer et al. 1994) and was subsequently implemented in 
mammalian cells through the use of restriction enzymes (Massip et al. 2010, Monnat Jr et 
al. 1999) or engineered nucleases (such as zinc-finger nucleases (ZFNs), transcription 
activator–like effector nucleases (TALENs), or clustered regulatory interspaced short 
palindromic repeats/CRISPR-associated protein 9 (CRISPR/Cas9) (Ghezraoui et al. 2014)) 
to introduce DSBs at specific sites in the genome. Although these studies have provided 
valuable insights into DDR mechanisms, they had the great disadvantage of being limited to 
individual loci—often within an ectopic DNA sequence, limiting their impact on 
transcriptomic studies. 
However, in the last five years, prompted by the limitations of DNA damage detection 
methods mentioned above, by an increasing interesting in DSB mapping associated with 
gene editing methods, and by the reduced costs of next-generation sequencing (NGS), 
several groups have independently developed techniques to map different types of DNA 
lesions at genome-wide level (Table 1). All of these methods provide high-resolution 
information about the genomic locations of the lesions (most of them at a single-nucleotide 
level), making them particularly suitable for use in conjunction with established methods of 
transcriptomic analysis. The recently developed DSB-mapping methods have been used to 
profile genome-wide CRISPR/Cas9-induced DSBs (Kim et al. 2015a, Shi et al. 2016, Wang 
et al. 2015), to generate genome-wide maps of DNA lesions induced by genotoxic drugs 
such as etoposide (Baranello et al. 2014) and aphidicolin (Crosetto et al. 2013a) and to map 
DSBs that occur during physiological processes such as B cell development (Chiarle et al. 
2011), or transcription-associated DSBs in neural stem/progenitor cells (Schwer et al. 2016).  
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Although each method has its own peculiarities, they can be divided into two main categories 
based on their main purposes: those used to map unrepaired (and thus exposed) DNA ends, 
and those used to track repaired DSBs (either in situ or by translocation). 
 
2.5.1 Genome-Wide Mapping of exposed DNA Ends 
Several methods have been developed to map exposed DNA in a population of fixed cells, 
thus generating a snapshot of any DNA breaks at a given moment. 
The general strategy adopted by these methods is to enzymatically tag DNA ends in fixed 
cells, either by adding biotinylated dNTPs by terminal deoxynucleotidyl transferase (TdT)  
(Baranello et al. 2014, Grégoire et al. 2016, Hoffman et al. 2015, Leduc et al. 2011) or by 
DNA ends blunting and ligation to a biotinylated DNA oligonucleotide (Canela et al. 2016, 
Crosetto et al. 2013b, Lensing et al. 2016). Once DNA ends have been tagged, genomic 
DNA is recovered, fragmented and enriched with streptavidin beads that bind the 
biotinylated tags ligated to DSBs. The enriched material is then suitable for NGS sequencing. 
All these methods, are affected by general drawbacks, being prone to background signals 
(which may also be artificially induced while performing cell manipulations), and are limited 
by the efficiency of DNA ends tagging. Few experimental data are available to compare the 
different methods, although, as described in the Results section, I have contributed to 
compare the BLESS method with other published tools. Moreover, I developed a strategy to 
analyze the DNA captured by BLESS, by quantitative PCR (qPCR), which was neither 
implemented in the originally published protocol (Crosetto et al. 2013a), nor in any of the 
other published methods so far. 
Among these methods, a special mention goes to BLISS (Iannelli et al. 2017, Yan et al. 
2017), which is a development of the original BLESS protocols, and allows DSB mapping 
starting with a few thousand cells, 1.000 times less than the number of cells required by all 
the other methods developed so far: this is a great advancement since it allows DSB mapping 
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on precious samples and reduces the background signals generated by random DNA breaks 
in a population of cells. 
 
2.5.2 Genome-Wide Mapping of Repaired DNA Double-Strand Breaks 
The other approach to map DSBs at high resolution is to track their repair. The simplest 
strategy is to perform whole-genome sequencing at high coverage, assuming that a repaired 
DSB will result in a mutation (Veres et al. 2014). However, this is a very indirect strategy, 
that cannot distinguish bewteen SSBs and DSBsm and it is expensive due to the requirement 
of very high sequencing coverage. Two other methods (Tsai et al. 2014, Wang et al. 2015), 
instead, track in-situ the rejoining of two broken ends: cells are transfected with short double-
stranded oligonucleotides that can be ligated by the endogenous DNA repair machineries at 
the DSBs sites. The genomic DNA is then recovered and sequenced and the exogenous DNA 
sequence marks the position of the DNA breaks. A third strategy to track the repair of DSBs 
has been developed by Dr. Frederick Alt lab, at Harvard, that applied it to study DSB 
generation and repair in a number of biological problems including transcription-associated 
breaks and development of mature lymphoid cells (Dong et al. 2015, Hu et al. 2015, Meng 
et al. 2014, Schwer et al. 2016). It requires cells transfection with an engineered nuclease 
that induces “prey” DSBs which can recombine with “bait” endogenous DSBs. Then, 
genomic DNA is recovered and sequenced: junction points between the prey sequence and 
other genomic regions mark the DSBs (Chiarle et al. 2011, Hu et al. 2016). 
These techniques, while having lower sensitivity compared with methods mapping exposed 
DNA ends, are less prone to background signals and are unlikely to detect low-frequency 
random DNA breaks, since they can only map DNA repaired regions. Clearly, the drawback 
of these techniques is that they cannot be used for precise time-course experiments (for 
example to monitor the DSBs induced by a stimulus) or to study unrepairable DSBs. 
Moreover, these methods require cell transfection, thus limiting their application to a subset 
of experimental setups. 
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The techniques mentioned here will certainly be applied in the future to further characterize 
the links between DNA damage and transcription, due to the possibility to map at single 
nucleotide resolution both DSBs and transcription events. As described in the result section, 
I have applied BLESS and BLISS to study the inhibitory role of DSBs in transcription 
(Iannelli et al. 2017) and a positive role of transient DSBs in the LPS-induced enhancer 
activation in macrophages (Vitelli et al., in preparation).  
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Method 
Applied to map 
breaks induced by: 
Strategy Key steps Advantages Disadvantages 
dDIP/DBrIC Restriction enzyme 
Map unrepaired 
DSBs 
Fixing/embedding 
of cells in agarose 
plugs 
Have the highest 
sensitivity among 
methods for 
mapping DNA 
breaks 
Are prone to background 
signals 
Break-seq Hydroxyurea 
Enzymatic tagging 
of DNA ends 
Require efficient tagging 
of DSBs 
DSB-seq (SSB-seq) Etoposide 
Purification of 
DNA 
Provide snapshots of 
unrepaired DSBs 
(possibility to 
perform time-course 
experiments) 
May induce DSBs by 
cell manipulation 
End-seq Endonucleases, RAG 
Enrichment and 
PCR amplification 
(or in vitro 
transcription) of 
tagged DNA 
fragments 
  
BLESS 
Aphidicolin, 
endonucleases 
  
DSBCapture Endonucleases, RAG   
BLISS 
Etoposide, 
CRISPR/Cas9 
Sequencing 
  
Digenome-seq CRISPR/Cas9 
Map unrepaired 
DSBs in vitro 
Digestion of 
genomic DNA in 
vitro with the 
endonuclease of 
interest 
Endonuclease cut 
sites are not masked 
by the epigenomic 
context 
Has high sequencing 
costs 
Sequencing 
Whole-genome 
sequencing 
Endonucleases 
Map the 
repaired DNA 
lesion that 
produced a 
mutation 
Sequencing at high 
coverage 
Maps any DNA 
lesion that produces 
a mutation 
Has high sequencing 
costs 
GUIDE-seq CRISPR/Cas9 Map repaired 
DSBs in situ 
Cell transfection 
with DNA 
oligonucleotides 
Has the highest 
sensitivity among 
methods for 
mapping DNA 
breaks 
Require cell transfection 
Purification of 
genomic DNA 
Has less background 
signal than other 
methods  
dsODN/IDLV sequence 
and length are critical for 
efficient insertion 
PCR amplification 
of insertion points 
  Require cells proficient 
in DNA repair 
IDLV CRISPR/Cas9 Sequencing     
HTGTS/LAM-
HTGTS 
Endonucleases, RAG, 
AID, transcription- 
associated breaks 
Map repaired 
DSBs that 
produced 
rearrangements 
Transfection with 
endonucleases to 
generate bait DSBs 
HTGTS is the 
method applied in 
most studies 
Are biased by bait DSB 
position 
Purification of 
genomic DNA Have high 
sensitivity in 
proximity to the bait 
DSB 
Require cell transfection 
or a highly recurrent 
DSB 
PCR amplification 
of translocated bait 
DSBs 
TC-seq AID Sequencing     
  
Table 1 - Methods for high-resolution mapping of DNA damage.  
Techniques are grouped on the basis of the strategy used. Because of space limitations, when one method was 
used to map DSBs induced by different types of exogenous nucleases (such as restriction enzymes, ZFNs, 
TALENs, and CRISPR/Cas9), we did not list all of them. Abbreviations: AID, Activation-induced deaminase; 
BLESS, breaks labeling, enrichment on streptavidin, and next-generation sequencing; BLISS, breaks labeling 
in situ and sequencing,  CRISPR/Cas9, clustered regulatory interspaced short palindromic repeats/CRISPR-
associated protein 9; DBrIC, DNA break immunocapture; dDIP, damaged DNA immunoprecipitation; DSB, 
double-strand break; dsODN, double-stranded DNA oligodeoxynucleotide; GUIDE-seq, genome-wide 
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unbiased identification of DSBs enabled by sequencing; HTGTS, high-throughput genome-wide translocation 
sequencing; IDLV, integrase-defective lentiviral vector capture; LAM-HTGTS, linear amplified-mediated 
high-throughput genome-wide translocation sequencing; PCR, polymerase chain reaction; RAG, 
recombination-activating gene; SSB, single-strand break; TALEN, transcription activator–like effector 
nuclease; TC-seq, translocation capture sequencing; ZFN, zinc-finger nuclease. 
 
2.5.3 DNA damage detection in single cells 
The general drawback of the methods described above to map DSBs position on the genome 
is their sensitivity limit, and the impossibility to apply them to single-cells studies, as in the 
case of DNA repair kinetics after random DNA damage induction. 
For long time, the only alternatives to immunofluorescence for DNA damage detection have 
been terminal deoxynucleotidyl transferase dUTP nick end labeling (TUNEL), which allows 
DNA ends labeling with fluorescent nucleotides and detection (Shmuel 1992), and COMET 
assays (Olive et al. 1991).  
TUNEL relies on the enzymatic modification of DNA exposed ends, with the addition of 
biotinylated dNTPs: this allows physical detection of DSBs, by imaging, with fluorophore-
conjugated anti-biotin antibodies. 
In the COMET assay, a suspension of single cells is mixed with agarose and spread onto a 
microscope glass slide. Cells are then lysed and DNA unwinding by electrophoresis is 
carried out at a specific pH. When subjected to an electric field, the DNA fragments migrate 
out of the cell, towards the anode, appearing like a 'comet'. The size and shape of the comet 
and the distribution of DNA within the comet correlate with the extent of DNA damage. 
However, heterogenous types of DNA lesions migrate differently, confounding the results 
and resulting in unreliable comparisons between comets induced from different DNA 
damaging stimuli (Olive & Banath 2006). 
Since, both methods have low sensitivity and are prone to artifacts, their application is 
usually limited to study massive DNA damage, such as that induced by apoptosis. Here, I 
will describe a method that I have developed to detect physical DNA breaks in single-cells 
(see Results section) (Galbiati et al. 2017). 
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2.6 Cellular senescence 
Cellular senescence was first formally described more than half a century ago, by Hayflick 
and colleagues, as the progressive and permanent loss of proliferative potential of human 
somatic cells (Haflick & Moorhead 1961). Cellular senescence has been connected since 
long ago to cancer suppressor and aging (Campisi 2013, Deursen 2014), and more recently, 
it has implicated in cellular reprogramming (Mosteiro et al. 2016), embryonic development 
(Muñoz-Espìn et al. 2013), wound healing (Demaria et al. 2015), and a wide range of 
diseases, often associated with aging (Erusalimsky & Kurz 2005, Martin & Buckwalter 
2003, Noureddine et al. 2011, Schafer et al. 2017). In addition to the permanent growth 
arrest, several features and molecular markers are used to identify senescent cells. However, 
no single characteristic is uniquely associated to the senescent state. Vice versa, not all 
senescent cells display the whole array of markers that have been identified so far. Thus, 
senescent cells are generally identified by a constellation of characteristics. 
 
2.6.1 Senescent-associated features 
2.6.1.1 Growth arrest 
The senescent growth arrest is the first feature that identifies cellular senescence. The 
senescent arrest is sustained and maintained by at least two major tumor suppressor 
pathways: the p53/p21 and p16INK4a/pRB pathways. It is indeed distinct from quiescence, 
because it cannot be reverted by appropriate mitogenic stimuli and changes in culturing 
conditions. However, senescent cells that do not express p16INK4A can resume growth after 
inactivation of p53 (Beauséjour et al. 2003). Cellular growth arrest can be detected by 
measuring the incorporation rate of 5-bromodeoxyuridine (BrdU) in replicating DNA (see 
section 3.10), or by monitoring the expression levels of proliferation markers, such as Ki-
67. 
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2.6.1.2 Morphology 
The morphology is altered when cells undergo senescence: cells are flattened and the size is 
increased, sometimes enlarging more than two-fold compared to non-senescent cells 
(Hayflick 1965). 
 
2.6.1.3 Senescent-associated β-galactosidase 
Lysosomal β-galactosidase, encoded by the GLB1 gene, is normally active at acidic pH 4.5. 
Its expression level increases during senescence, so its activity can be detected also in 
suboptimal conditions, at pH 6 (Dimri et al. 1995). Senescence-associated-β-galactosidase 
(SA-β-gal) was the first marker to permit the detection of senescent cells in tissues, and it is 
still one of the most used to markers for senescent cells (see section 3.11). 
 
2.6.1.4 Senescent-associated DNA damage foci 
The DDR activation can be detected in the form of persistent DNA damage foci, which 
contain proteins that are associated with the DDR, like γH2AX, the MRN complex, 53BP1, 
ATM pS1981 and MDC1 (Di Micco et al. 2006, Fagagna et al. 2003, Rodier et al. 2011, 
Sedelnikova et al. 2004). These foci lack ssDNA and DNA repair proteins associated with 
HR, such as RPA and RAD51 (Rodier et al. 2011). It has been hypothesized that these 
structures might not be sites of damaged DNA per se, rather stable chromatin alterations 
resulting from damage (without an underlying lesion), which are necessary to reinforce 
senescence, termed DNA-SCARS (Rodier et al. 2011). This hypothesis could not be verified 
due to the lack of tools to detect physical DNA breaks, however with the method that I 
developed, and here described (DI-PLA), I could prove that these persistent DDR foci 
correspond to physical DNA breaks (Galbiati et al. 2017). This is consistent with the 
observation that DNA damage in senescent cells preferentially accumulates at telomeres 
(Fumagalli et al. 2012, Hewitt et al. 2012), where DNA repair is inhibited (see section 2.7). 
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DDR plays an essential role in both senescence initiation and maintenance (d'Adda di 
Fagagna et al., 2003; Herbig et al., 2004; Sedelnikova et al., 2004; von Zglinicki et al., 2005). 
Indeed, transient inactivation of ATM, alone or together with ATR, and combined CHK1 
and CHK2 inactivation, leads to escape from senescence and re-entry into the S-phase of the 
cell cycle. Several stimuli that induce senescence also induce DDR activation (see section 
2.6.2), such as ROS, produced by mitochondria (Correia-Melo & Passos 2015, Correia‐Melo 
et al. 2016). Moreover, long term activation of the checkpoint gene p21 induces 
mitochondrial dysfunction and production of highly reactive ROS, which are well known 
inducers of DNA lesions (Passos et al. 2010). In particular, telomeric DNA, being rich in 
guanine is be particularly susceptible to oxidative modifications, and, being resistant to DNA 
repair, leads to a persistent activation of the DDR checkpoint, enforcing cell senescence 
through a positive feedback loop. 
2.6.1.5 Senescent-associated secretory phenotype 
Senescent cells undergo widespread changes in protein expression and secretion, developing 
what is known as secretory phenotype of senescent cells (SASP) (Coppé et al. 2010). SASP 
signature can vary depending on stimuli and tissue type, however it includes cytokines (such 
as IL-1, IL-6), chemokines (IL-8), growth factors (such as TGFβ and VEGF) and 
extracellular proteases (such as matrix metalloproteinases). These components can bind 
receptors on the same cell that secreted them (autocrine effect) or on the surrounding cells 
(paracrine effect), fuelling the senescence state (Acosta et al. 2013).  
Cytokines that are part of the SASP facilitate the removal of senescent cells by attraction of 
phagocytic immune cells. This function proved to be particularly important for tissue repair: 
wounding induces senescence in resident fibroblasts and endothelial cells; consequently 
senescent cells secret PDGF, which promotes myofibroblasts differentiation and favour the 
kinetics of wound closure (Demaria et al. 2015). Senescent induction and subsequent 
macrophage-dependent clearance also elicits tissue remodelling, explaining the role of 
senescence-induction during embryonic development (Muñoz-Espìn et al. 2013).  
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However, when senescent cells accumulate, such as during aging or in age-associated 
diseases, the chronic pro-inflammatory environment induced by SASP appears to be 
detrimental. This model is strongly supported by the observation that organisms that do not 
display a typical aging phenotype, are highly efficient in the clearance of senescent cells, 
such as salamander (Yun et al. 2015). Moreover, genetically engineered mice where it is 
possible to selectively induce clearance of senescent cells, display a delay in the onset of 
age-associated disorders (Baker et al. 2011), extended median lifespan (Baker et al. 2016) 
and show reduced chemotherapy side effects (Baar et al. 2017, Demaria et al. 2016).  
Despite a growing interest in modulating the SASP to uncouple the tumour-suppressor role 
of senescent-associated growth arrest from the detrimental pro-inflammatory response 
induced by the senescent-associated secretory phenotype (Birch & Passos 2017), it is not yet 
clear what are the key regulators involved in SASP modulation. DDR is certainly involved 
in SASP regulation: in particular ATM signalling has been linked to NFkB activation, one 
of the major transcription factors regulating SASP-associated components (Fumagalli & 
d’Adda di Fagagna 2009, McCool & Miyamoto 2012, Rodier et al. 2009). mTOR activity 
has also been connected to SASP production (Laberge et al. 2015). Furthermore, recent 
evidence suggests that cytosolic chromatin fragments (CCF) that are extruded from the 
nucleus in senescent cells (Ivanov et al. 2013), induce the activation of the cGAS-STING 
pathway, an innate immune response pathway which senses double-stranded DNA in the 
cytosol, and leads to secretion of SASP components (Glück et al. 2017). 
 
2.6.1.6 Senescent-associated heterochromatin foci (SAHF) 
In some types of senescent cells, the heterochromatin is reorganized into discrete foci, that 
are proposed to enforce cellular senescence by suppressing the transcription of genes 
involved in proliferation (Narita et al. 2003, Zhang et al. 2007). SAHFs are detected by the 
preferential binding of DNA dyes, such as 4',6-diamidino-2-phenylindole (DAPI), and the 
presence of heterochromatin-associated histone modifications like H3K9me3 and 
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H3K27me3, and proteins, like heterochromatin protein-1 (HP1). SAHFs are mainly 
generated as a consequence of spatial reorganization of the existing heterochromatin, rather 
than expansion of heterochromatin domains (Chandra et al. 2012). Chromatin reorganization 
is facilitated by the senescent-associated reduction in nuclear lamin B1 that is normally 
associated with heterochromatin domains (Sadaie et al. 2013). 
 
2.6.2 Cellular senescence inducers 
There are several stimuli that are known to induce cellular senescence, most of them leading 
to DNA damage, although with different mechanisms. Interestingly, it has been recently 
reported that most of the genes that are transcriptionally altered when cells undergo 
senescence, are specific for cell type and the senescence inducer (Hernandez-Segura et al. 
2017).  
Mechanism leading to cellular senescence activation in the embryo, and involved in tissue 
repair and cell reprogramming will need further investigation, although it is known that they 
rely on p21 (Muñoz-Espìn et al. 2013) or p16 (Demaria et al. 2015, Mosteiro et al. 2016) to 
enforce the senescence phenotype. Differently, much more studies are available on other 
types of cellular senescence. 
 
2.6.2.1 Replicative senescence 
Replicative senescence was the first cell senescent phenotype described as the result of in 
vitro replicative exhaustion of human fibroblasts (Hayflick 1965). During DNA replication, 
telomeres are incompletely replicated, losing between 50 and 200 bp during each S phase 
(see section 2.7.4). Therefore, in the absence of specialized telomere maintenance 
mechanisms (which, indeed, are normally absent in somatic cells), each DNA replication 
cycle, reduces the number of telomeric repeats (see further discussion in section 2.7.4). 
Telomere attrition limits the proliferative lifespan of many human cells types and causes 
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cells to undergo replicative senescence with short telomeres (Harley et al. 1990). In fact, 
progressive telomere shortening ultimately leads to the recognition of the DNA ends by 
ATM and ATR, with the consequent appearance of DDR foci. Interestingly, it is not the 
average length of telomeres, rather the presence of a single (or few) critically short telomere 
that triggers senescence (Hemann et al. 2001, Joice et al. 2014). Indeed, ectopic expression 
of the enzyme telomerase, which is capable of elongating telomeres, bypasses the replicative 
senescence arrest (Bodnar et al. 1998). 
 
2.6.2.2 Stress-induced premature senescence 
The Stress-induced premature senescence (SIPS) is a response to an external stress coming 
from the cell environment (Toussaint et al. 2000). Repeated or acute non-lethal doses of 
these stresses are required to efficiently induce accumulation of stress-induced senescent 
cells. However, cells undergoing SIPS share many cellular and molecular features with 
replicative senescent cells. 
UV and IR-induced senescence. UV light, and in particular UVB (280-320 nm), is 
known to provoke oxidative stress through the generation of highly reactive ROS that could 
be the cause of UV-induced SIPS (De Magalhães et al. 2002). Indeed, free radical scavengers 
were shown to remove ROS and reduce the harmful effects of UVB irradiation, resulting in 
a significant delay in senescence establishment (Ho et al. 2005). IRs are also inducers of 
SIPS: IR-treatment creates DSBs resulting in the activation of the ATM-p53-p21 pathway 
within few hours from treatment (Fumagalli et al. 2012). Differently from replicative 
senescence, SIPS is not associated with telomeric shortening and IR does not appear to 
accelerate telomere erosion. Moreover, telomerase expression in different types of normal 
diploid cells exposed either to high doses of IR, UV or hydrogen peroxide, did not prevent 
senescence induction. Cumulatively, these data indicate that DNA lesions can induce 
senescence and that telomere dysfunction can occur irrespectively of length (Gorbunova et 
al. 2002). Additional support to this hypothesis comes from length-independent telomere 
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damage observed in post-mitotic tissues such as neurons of aged baboon (Fumagalli et al. 
2012) and mice (Chow & Herrup 2015, Jurk et al. 2012). 
Culture shock-induced senescence. Another interesting example of SIPS comes from 
the biological behaviour of primary mouse embryonic fibroblasts (MEFs). Explanted MEFs 
stop dividing after only 15-30 cell divisions when placed in culture: this observation is not 
consistent with the replicative senescent onset, since MEF telomeres are too long to become 
critically short in so few replication cycles. However, it has been shown that oxygen 
sensitivity can trigger SIPS: in fact MEFs do not senesce in physiological (3%) oxygen 
levels, but do so in 20% oxygen (Parrinello et al. 2003). Moreover, mild hyperoxia has been 
correlated with enhanced telomere shortening, likely due to accumulation of ROS-induced 
DNA damage at telomeres (Saretzki et al. 2003, von Zglinicki et al. 1995). 
DNA damaging drug-induced senescence. Several chemiotherapic drugs used to treat 
cancer, can induce SIPS, without affecting telomere length (Schmitt 2003). Notable 
examples are the DNA-intercalating doxorubicin, the topoisomerase I inhibitor 
camptothecin, the topoisomerase II inhibitors Adriamycin and etoposide, the cross-linking 
agent cisplatin and the anti-metabolite cytarabin. Recent observations connected 
chemotherapic drugs-induced senescence to chemotherapy side-effects such as fatigue and 
cancer relapse (Demaria et al. 2016). 
 
2.6.2.3 Oncogene-induced senescence 
Oncogenes are particular genes that have the potential to transform cells when they 
accumulate mutations or their expression level is altered. Normal cells respond to many 
oncogenes by triggering the so-called oncogene-induced senescence (OIS). This results in 
the generation of a biphasic response: activated oncogenes prompt an initial burst of cellular 
hyperproliferation, that is followed by senescence (Di Micco et al. 2007). Indeed, OIS has 
been shown to prevent cancer development in vivo both in humans and in mouse models 
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(Dankort et al. 2007, Grandori et al. 2003, Lazzerini Denchi et al. 2005, Michaloglou et al. 
2005) 
OIS was first described in cells expressing the constitutively activated form of RAS, which 
is responsible for transducing mitogenic signals and promoting cell growth, proliferation and 
survival (Serrano et al., 1997). Similarly, activation or upregulation of other components of 
the RAS signalling cascade, such as RAC1, RAF, MOS, MEK or the loss of the inhibitor of 
the RAS pathway, PTEN, can induce cellular senescence (Evan & d’Adda di Fagagna 2009). 
At the molecular level, upregulated expression of oncogenes leads to aberrant DNA 
replication, which in turn generates DNA lesions due to discontinuous replicative fork 
progression and altered single-stranded DNA generation, which eventually triggers DDR 
activation (Bartkova et al. 2006). Moreover, RAS activation induces re-replication, an event 
known to cause DNA damage and DDR activation, and to increase the number of active 
origins (Di Micco et al., 2006). Similarly, upregulation of MYC oncogene boosts the number 
of contemporary active DNA replication origins leading to DNA replication-associated 
DNA damage (Dominguez-Sola et al. 2007). Oncogene activation in proliferating cells, also 
induces formation of SAHFs, dependent on p16 upregulation and DNA replication-stress 
associated ATR activation (Di Micco et al. 2011, Narita et al. 2003, Serrano et al. 1997, Sulli 
et al. 2012).  
 
Despite a clear role for OIS senescence in tumour suppression, by preventing the 
proliferation of cells bearing an activated oncogene, more and more reports show a role for 
cellular senescence in favouring tumour onset and progression (Campisi 2013). This “dark 
side of senescence”, is fuelled by some, but not all (Wang et al. 2011), components of the 
SASP, such as VEGF (Coppé et al. 2006) which promotes tumor-driven angiogenesis, or IL-
6 and IL-8 that promote epithelial-to-mesenchymal transition in pre-malignant epithelial 
cells and nonaggressive cancer epithelial cells (Laberge et al. 2012).  
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Thus, as already discussed above, cellular senescence has a dual role in preventing 
uncontrolled proliferation leading to cancer, but also in favouring tumour growth of 
surrounding cells. 
 
2.6.3 Cellular senescence and aging 
Cellular senescence is considered a major hallmark of organismal aging in vivo (López-Otín 
et al. 2013, Rossiello et al. 2014). Senescent cells have been reported in vivo in human skin 
fibroblasts (Dimri et al. 1995), in mouse stem and somatic cells (Hewitt et al. 2012, 
Sedelnikova et al. 2004) and in baboons skin, brain and liver (Fumagalli et al. 2012, Herbig 
et al. 2006). Moreover, cells that express senescence markers are also found in age-related 
pathologies, including osteoarthritis, atherosclerosis and chronic lung diseases (Birch et al. 
2015, Erusalimsky & Kurz 2005, Martin & Buckwalter 2003, Noureddine et al. 2011, Price 
et al. 2002, Schafer et al. 2017). 
At a molecular level, telomere shortening is certainly involved in tissue aging in various 
tissues (Tümpel & Rudolph 2012). Consistently, loss of telomerase function, in mice, causes 
senescence and aging in various tissues (Ferrón et al. 2004, Rudolph et al. 1999, 
Satyanarayana et al. 2004). Moreover, elongation of telomeres by reactivation of telomerase 
is sufficient to eliminate the degenerative phenotypes in multiple organs observed in 
telomerase knockout mice (Jaskelioff et al. 2011). 
However, as discussed above, dysfunctional telomeres can induce senescence irrespectively 
of their length: in support of this, accumulation of chronic DNA damage has been shown to 
mimic tissue aging by White and colleagues (White et al. 2015). 
The causative effect of senescence on ageing is supported by different observations. In fact, 
p16 expression increases with age in the stem and progenitor cells of the mouse brain, bone 
marrow and pancreas, where it suppresses stem-cell proliferation and tissue regeneration. 
Consistently, the age-related tissue regeneration decline can be prevented by the lack of p16 
expression (Janzen et al. 2006, Molofsky et al. 2006). Similarly, a genetically engineered 
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mouse model in which p16-expressing cells are specifically cleared, shows a delay in age-
related pathologies,  delayed tumorigenesis and preserved organ function, leading to a longer 
median lifespan (Baker et al. 2011, 2016). The role of senescence in aging is believed to be 
related to the chronic inflammation induced by the SASP.  
These observations have led the scientific community to identify new interventions to target 
senescence as a therapy against ageing and age-related diseases (Chang et al. 2016, Soto-
Gamez & Demaria 2017, Zhu et al. 2015). Effort has been put by both companies and 
academics to identify anti-ageing drugs, also called senolytics: 14 compounds have been 
described so far, including small molecules, antibodies and peptides, and have been 
successfully applied in mouse models of physiological ageing (Baar et al. 2017), 
osteoarthritis (Jeon et al. 2017), fibrotic pulmonary disease (Schafer et al. 2017), and more. 
However, caution is necessary since, while these senolytic drugs selectively kill senescent 
cells, they are not effective against all types of senescent cells. Moreover, the long-term 
effects on young tissues have not yet been adequately investigated. 
 
2.7 Telomeres 
2.7.1 Telomere structure 
Telomeres are nucleoprotein structures at the end of the linear chromosomes (Figure 2). 
They are made of three main components: long stretches of DNA tandem repeats (TTAGGG 
in vertebrates), telomere-associated proteins (known as the shelterin, a six-subunits 
complex) and non-coding RNA (Telomeric repeat-containing RNA, TERRA).  The length 
of human telomeres is typically 9-15 Kb, whereas laboratory mice strains chromosomes have 
longer telomeres, ranging from 10 to 60 Kb. Chromosome ends have a 3'-protruding single-
stranded G-rich overhang, typically 50-300 nucleotides long, also named G-tail or G-
overhang (O’Sullivan & Karlseder 2010). The overhang is generated through post-
replicative 5’-3’ resection of the C-rich strand by APOLLO and EXO1 nucleases (Wu et al. 
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2012) and it has a key role in telomere maintenance. In fact, it functions as a primer for the 
telomerase complex, which adds newly synthesized repeats to the telomere end (Greider & 
Blackburn 1987, see section 2.7.4).  Moreover, the G-tail can invade the preceding double-
stranded DNA region in a lasso-like structure, known as the T-loop. The formation of T-
loop is mediated by the DNA binding protein TRF2, and it contributes to telomere protection 
as a cap that masks the telomeric DNA ends to the DDR machinery (Griffith et al. 1999). T-
loops were first detected by electron microscopy (EM) analysis in vitro (Griffith et al. 1999), 
however, in vivo detection of T-loops has been hampered by technical challenges. Only 
recently, super-resolution microscopy allowed imaging of T-loops in cells (Doksani et al. 
2013), although with steep requirements in the imaging machinery required for the 
experiments. In the Result section, I will describe how DI-PLA can be adapted to easily 
assess T-loop formation in situ. Moreover, with a complementary approach based on 
BLESS, I will suggest an unprecedented strategy to distinguish between intact telomeres, 
DNA damage bearing telomeres, and uncapped telomeres (see Results section 4.4.2). 
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Figure 2 - Structure of the human telomeres. Structure of the human telomeres.  
Human telomeres are nucleoprotein complexes consisting of kilobases of TTAGGG repeats, with a 3’ G-rich 
overhang, an RNA component called TERRA and the shelterin proteins TRF1, TRF2, RAP1, TIN2, TPP1 and 
POT1. These factors help the formation of a protective structure at chromosome ends, the T-loop. Activation 
of ATM is inhibited by TRF2, while ATR is inhibited by POT1. Telomerase (TERT-DKC1-TR) is probably 
inhibited by the shelterin proteins.  
 
 
2.7.2 Telomeric binding proteins 
Telomeres are associated to a protein complex named shelterin (Palm & de Lange 2008), 
consisting of six components: TRF1 and TRF2 (telomeric-repeat-binding factor 1 and 2), 
POT1 (protection of telomeres 1), RAP1 (also known as TERF2IP, telomeric repeat binding 
factor 2 interacting protein), TIN2 (TRF1-interacting nuclear factor 2) and TPP1 (POT1 and 
TIN2 organizing protein). However, besides the shelterin complex, which represents the core 
of key proteins involved in telomere maintenance, almost 200 proteins have been associated 
with different aspects of telomere biology (Déjardin & Kingston 2009, Grolimund et al. 
2013) 
TRF1 and TRF2 directly associate as homodimers with the double-stranded telomeric DNA, 
through their MYB domain. TRF1, has been proposed to allow efficient replication of 
telomeres (Sfeir et al. 2009). In fact, the G-rich telomere strand is a substrate prone to fold 
into four-stranded G-quadruplex structures, that interfere with DNA replication. In the 
absence of TRF1, replication stress induced by G-quadruplex activate an ATR dependent 
checkpoint. TRF1 prevents ATR signalling and in cooperation with the helicases BLM and 
RTEL1 allows DNA replication at telomeres. Moreover, TRF1 acts as a negative regulator 
of the telomere length, probably by controlling the access of telomerase, together with 
several partners including Tankyrase I, TIN2 and TRF2 (Ancelin et al. 2002, Kim et al. 1999, 
Smith & de Lange 2000, Smogorzewska et al. 2000, van Steensel & de Lange 1997). 
Recently, another protein associated with telomeres, but not part of the shelterin complex, 
named TZAP has been discovered as a new regulator of telomere length, independent from 
TRF1 functions (Li et al. 2017). 
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TRF2 maintains the T-loop structure and is mainly implicated in chromosome end 
protection, by preventing DNA repair activity at telomere ends, which would result in ATM 
activation and end-to-end fusions (Doksani et al. 2013, Griffith et al. 1999, van Steensel et 
al. 1998). However, it has been proposed that telomeres may adopt an intermediate state 
where the T-loop is lost and DDR is activated without leading to end-to-end fusions due to 
the presence of sufficient shelterin proteins (Cesare et al. 2009) 
POT1 coats the single-stranded overhang using two oligonucleotide/oligosaccharide binding 
folds and inhibits the ssDNA recognition by the ATR-dependent DDR. Moreover, it acts as 
a regulator of telomere length, switching between an inhibitory and a promoting role in 
telomerase recruitment at DNA ends (Baumann & Cech 2001, Baumann & Price 2011, 
Colgin et al. 2003). 
RAP1 binds to TRF2 and is involved in the silencing of subtelomeric genes and telomere-
length regulation (Lustig et al. 1990, Martinez et al. 2010).  
TIN2 is essential to the overall integrity of the shelterin complex as it links TPP1/POT1 
heterodimer to TRF1 and TRF2, and stabilizes TRF1 and TRF2 association to telomeric 
DNA (Frescas & De Lange 2014; Ye et al. 2004a,b).  
 
Telomeres and subtelomeres are enriched for heterochromatic markers, such as H3K9me3, 
H4K20me3 (Benetti et al. 2007). In addition, human and mouse subtelomeres are heavily 
methylated through the activity of DNA methyltransferases (Schoeftner and Blasco, 2009). 
This chromatin context has an inhibitory role on telomerase activity, and contributes to 
subtelomeric gene silencing. However, in contrast with these observations, recent evidence 
has shown that telomeres are transcribed by RNA POL II, giving rise to a class of long 
noncoding RNAs containing telomeric repeats called TERRA. 
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2.7.3 Telomeric transcripts 
TERRAs molecules are transcribed from the subtelomeric regions toward the chromosome 
ends and consist of subtelomeric-derived sequences and G-rich telomeric repeats (Azzalin 
& Lingner 2008, Schoeftner & Blasco 2008). TERRAs are transcribed by RNA Polymerase 
II starting from promoters located in the subtelomeric regions through the telomeric repeats 
(Nergadze et al. 2009), although it has also been suggested that TERRAs are mainly 
produced at a single promoter on chromosome 18 (de Silanes et al. 2014). TERRAs are 
polyadenylated and very heterogenous in size (Porro et al. 2010). Their expression level is 
cell cycle regulated, with a decrease in S phase to allow DNA replication, it is positively 
regulated by TRF1, which interacts with RNA POL II, and negatively regulated by 
heterochromatin and telomere length (Schoeftner and Blasco, 2008).  
A physiological role for TERRAs has been described in regulating telomere length, by 
functioning as a telomerase inhibitor (Redon et al. 2010), and in promoting 
heterochromatinization (Deng et al. 2010). It has also been proposed that TERRA promotes 
telomere protein composition changes during cell cycle: TERRA regulates the RPA-to-
POT1 switch during S phase to allow DNA replication and subsequently telomere protection 
(Flynn et al. 2011). TERRAs are also involved in favouring DNA ends processing: at 
deprotected telomeres RNA promotes the physical interaction between the lysine 
demethylase LSD1 and MRE11, thus favouring MRE11 nucleolytic processing of uncapped 
telomeres (Porro et al. 2010). Furthermore, TERRAs transcripts are upregulated in the 
absence of TRF2 (Porro et al. 2014) 
Recently, it has been reported that dysfunctional telomeres are transcribed to generate 
telomeric DDRNAs (tDDRNAs) and their precursors, that are necessary for DDR activation 
at deprotected telomeres (Rossiello et al. 2017). 
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2.7.4 Mechanisms of telomere maintenance 
DNA replication of linear chromosomes suffers from the end-replication problem: at the end 
of the chromosome, on the lagging strand the DNA replication machinery is unable to copy 
the last bit of DNA sequence. Thus, at each cell division telomeres are shortened by 100-
300bp due to the so-called end-replication problem, combined with the exonucleolytic 
processing needed to generate the G-rich overhang (Harley et al. 1990). This progressive 
telomere shortening leads to critically short telomeres that lose their protective structure and 
induce replicative senescence (see section 2.6.2.1), although it is not yet clear what is the 
critically short length necessary to activate the DDR signalling (O’Sullivan & Karlseder 
2010).  
In most cases, the telomere shortening is counteracted by the telomerase complex, which 
consists of the reverse transcriptase catalytic subunit (TERT), the RNA component (TERC) 
that is used as a template to elongate the G-rich telomeric DNA strand, dyskerin that helps 
the assembly of the complex and TCAB1, involved in the localization of telomerase to the 
Cajal Bodies, where the telomerase complex is assembled (Cohen et al. 2007, Greider & 
Blackburn 1987, Mitchell et al. 1999, Venteicher et al. 2009). In humans, telomerase is not 
active, with the exception of activated lymphocytes, adult stem cells, germ line, and 
embryonic cells (Wright et al. 1996). Telomerase inactivation, despite possibly reducing the 
organism longevity (Tomás-Loba et al. 2008), is an important tumour suppressor 
mechanism: indeed, most cancer need to activate telomerase to survive. 
Recently, non-telomeric functions for mammalian TERT have been suggested, which 
include the regulation of global chromatin dynamics, stem cell proliferation and transcription 
of developmentally regulated genes (Masutomi et al. 2005, Park et al. 2009). Moreover, 
telomerase is excluded from the nucleus upon oxidative stress and it has been proposed a 
role for telomerase in mitochondria protection under mild oxidative stress (Ahmed et al. 
2008). 
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Approximately 10–20% of human cancers maintain their telomeres by a telomerase 
independent pathway known as the alternative lengthening of telomeres, or ALT (Cesare & 
Reddel 2010, Lovejoy et al. 2012). ALT is essentially dependent on HR: when the 3′ 
overhang is recognized by the HR machinery, it can invade other telomeric DNA, which can 
be used as a template for DNA replication. Telomeres in ALT cells are heterogeneous in 
length; some of them are very short, but they can reach up to 100 kb. A particular feature of 
ALT cells, is the presence of extrachromosomal telomeric DNA, predominantly in the form 
of partially single stranded circles (C-circles) (Henson et al. 2009). 
 
2.7.5 Telomeres and the DDR 
Telomeres resemble, at their essence, a single DSB end, however they are not recognized by 
the DDR machinery. This is mostly due to the shelterin complex, since the activation of the 
DDR apical kinases ATM and ATR is inhibited by TRF2 and POT1, respectively (Denchi 
& de Lange 2007, Karlseder et al. 2004). TRF2 knockout leads to DDR activation, including 
H2AX phosphorylation, ATM activation, 53BP1 recruitment at telomeres and activation of 
downstream kinases CHK2 and p53 (Bae & Baumann 2007, Benarroch-Popivker et al. 2016, 
Takai et al. 2003) and results in dramatic end-to-end fusions by c-NHEJ (van Steensel et al. 
1998). Paradoxically, a component of the c-NHEJ pathway, the Ku70–Ku80 complex, is 
constitutively present at telomeres (d’Adda di Fagagna et al. 2001), where its main function 
is to inhibit both a-NHEJ and HR events (Sfeir & de Lange 2012). However, POT1 plays 
the main role in preventing ATR activation at telomeres, by coating the ssDNA and 
excluding RPA binding (Gong & de Lange 2010), apparently with the help of TERRA and 
heterogeneous nuclear ribonucleoprotein A (hnRNPA) (Flynn et al. 2011). 
This view of irreparable DNA damage at telomeres has been recently challenged by a HR-
dependent and an a-NHEJ-dependent mechanisms for DSB repair at telomeres (Doksani & 
de Lange 2016, Mao et al. 2016). Internal telomeric DSBs generated by engineered nucleases 
were reported to activate DDR signaling in mice and human cells, and undergo DSB repair. 
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However, repair was observed only in proliferating cells, while senescent cells with 
persistent DDR activation failed to repair the endonuclease-induced damage (Mao et al. 
2016), possibly as a consequence of senescence-associated heterochromatinization which 
inhibits DNA repair. 
  
 55 
 
 
 
 
 
 
 
 
 
 
3 Materials and Methods 
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3.1 Cell culture 
All cell lines used here were grown under standard tissue culture conditions (5% CO2, 37°C). 
BJ cells (human diploid fibroblasts, The American Type Culture Collection, ATC) were 
grown in MEM supplemented with 10% foetal bovine serum (FBS), 1% L-glutamine, 1% 
non-essential amino acids, 1% sodium pyruvate. BJ hTERT cells, are a BJ-derived cell line 
that stably expresses human telomerase reverse transcriptase (Fumagalli et al. 2012). 
MEFs CRE-ER TRF2flox/flox GFP-TRF1 (Rossiello et al. 2017), were grown in DMEM 
supplemented with 10% foetal bovine serum and 1% glutamine; they are MEF-derived cell 
line which stably express the fusion protein TRF1-eGFP, both TRF2 alleles are loxP-
flanked, and that stably expresses the CRE recombinase fused to the oestrogen receptor 
(ER); for induction, cells were grown in the presence of 4-hydroxytamoxifen (600 nM, 4-
OHT Sigma cat. no. H7904) for 48 hours, to allow CRE-ER to translocate into the nucleus 
and to generate the TRF2-/- cells.  
DIvA (AsiSI-ER-U20S) cells were cultured in Dulbecco’s modified Eagle’s medium 
(DMEM, Gibco) without phenol red, supplemented with glutamine, pyruvate, HEPES and 
10% foetal bovine serum (FBS). Cells were selected on a semi regular basis with puromycin 
at a final concentration of 1 μg/ml. For AsiSI-dependent DSB induction, cells were treated 
with 300 nM 4-OHT for 4h. 
Hela111, a kind gift of Dr. Evi Soutoglou were cultured in DMEM without phenol red, 
supplemented with 10% Fetal Calf Serum TET system, 1% Glutamine, 0.1mM sodium 
pyruvate. These cells contain an I-SceI site stably integrated in the genome, flanked on one 
side by on array of 256 repeats of the LacO sequence, and on the other side by a unique 
sequence. 
Raw 264.7 were grown in DMEM supplemented with 10% FBS, 1% glutamine. To induce 
the inflammation response Lipopolysaccharides from E. coli (100ng/mL LPS, Sigma L2654) 
was added to the cell culture medium. 
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U2OS NBS1-GFP (Lukas et al. 2004), a kind gift from Jiri Bartek, were cultured in DMEM 
supplemented with 10% FBS, 1% Glutamine. Cells were selected with puromycin at a final 
concentration of 1 μg/ml. 
  
3.2 Animal and treatments 
Mice used to generate Figures 37-38 were bred and maintained under pathogen-free 
condition at the Scripps Research Institute and were handled according to Institutional 
Animal Care and Use Committee guidelines. After exposure to ionizing radiation, tissues 
were collected and freshly frozen in dry ice, embedded in OCT (Sakura), a cryprotective 
embedding medium. Tissues were then sectioned, mounted on glass slides and stored at -80 
°C until use.  
Mice used to generate Figures 48-49 (C57BL/6J) were purchased from Charles River 
Laboratories (Saint-Constant, Quebec), by Christian Beausèjour at Canadian Institute of 
Health Research, Montreal; in vivo manipulations were approved by the Comité 
Institutionnel des Bonnes Pratiques Animales en Recherche (CIBPAR) of CHU-Ste-Justine. 
Immediately after sacrificed, mouse tissues were freshly frozen on dry ice and embedded in 
OCT compound. Cryosections of 10µm thickness were mounted on glass slides previously 
treated with 1% gelatin and 0.05% chromo alum, dried at ambient temperature and then 
stored at −80 °C until use. 
 
3.3  Ionizing radiation 
Ionizing radiation (IR) was used to generate DNA damage exogenously in several 
experiments. IR refers to highly energetic particles or waves that can detach (ionize) at least 
one electron from an atom or molecule. This event leads to DNA damage in the form of base 
damage, single strand breaks (SSB), double strand breaks (DSB) and DNA crosslinks. Here, 
to induce DNA damage with IR in cells, an X-ray generating machine (Faxitron, X-Ray 
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Corporation) was used. The Gray (Gy) is the International System of Units of absorbed 
radiation dose, where 1 Gy is the absorption of 1 joule of radiation energy by 1 kilogram of 
matter.  
Mice used to generate Figures 37-38 were subjected to 5Gy total body irradiation at the 
Scripps Reasearch Institute, San Diego. 
 
3.4 Laser-induced DNA damage 
Laser micro-irradiation is an alternative tool to ionizing irradiation used to induce DNA 
damage, that allows sub-nuclear resolution of DNA damage distribution. It has been broadly 
exploited to study the dynamics of protein recruitment at the site of DNA damage (Lukas et 
al. 2003). Cells were cultured in glass-bottom dishes (Mattek P35G-1.5-14-C) and pre-
sensitized to DNA damage induction by incubation for 72 h in 10 µM BrdU. Laser micro-
irradiation was carried out using a 50 mW 405 nm diode laser with a 100% power output. 
At 2× digital magnification, multiple regions of interest (ROI) of the same size were selected 
in each nucleus and the 405nm laser was used to scan the ROIs for 50 iterations (total dwell 
time per pixel 490μs). 
Live-cell imaging was carried out with a Leica TCS SP5 point scanning confocal microscope 
equipped with a Leica HCX PL APO 63×/1.4NA oil immersion objective and an 
environmental microscope incubator (OKOLab) set to 37°C and 5% CO2 perfusion. The 
Leica TCS SP5 confocal microscope was driven by Leica LAS AF software. 
 
3.5 Neocarzinostatin treatment 
Neocarzinostatin (NCS) is a macromolecular chromoprotein antibiotic, which can bind and 
react with the DNA, inducing DNA damage. Here, cells were incubated NCS 50ng/mL in 
cell culture medium for 20 minutes at 37°C, to induce an amount of DNA damage 
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comparable to that generated by 2-3Gy. Cells were immediately fixed after 20 minutes of 
incubation with the drug.  
 
3.6 Transfection of plasmid DNA in Hela cells and Mouse 
Embryonic Fibroblasts 
Cell transfection was used to obtain transient expression of particular DNA sequences in 
target cells. Hela111 were transfected with the plasmid pCMV5 or pCMV5-ISceI-HA, to 
induce a single cut at a specific locus. MEFs were transfected with the plasmid pLPC-TRF1-
FokI, to induced DSBs at telomeres or with the nuclease dead version pLPC-TRF1-
FokID405A, as control. Cells were plated in 10 cm dishes and transfected at 70% 
confluency. For each transfection reaction 1.5mL of serum-free medium (Opti-MEM) were 
mixed with 12µg of plasmid DNA and 1.5mL of Opti-MEM with 36μl Lipofectamine 2000 
transfection reagent (Life technologies). The two solutions were incubated 5 minutes at RT, 
then mixed and incubated for 20 minutes at RT to allow the formation of lipid complexes. 
The growth medium was removed from the cells and substituted with the transfection mix. 
After 6h incubation, the transfection reaction was removed, and fresh culture medium was 
added to the cells. 
 
3.7 Immunofluorescence in cultured cells 
One of the techniques used in this work to study protein sub-cellular localization (mostly 
DDR foci formation) at single-cell level is immunofluorescence (IF). This technique allows 
visualization by fluorescent microscopy of target proteins that are recognized by antibodies. 
Cells were grown on coverslips, washed twice for 5 minutes with PBS and fixed with 4% 
paraformaldehyde (PFA) for 10 minutes at RT. To allow accessibility of the target epitopes 
to the antibodies, cells were permeabilized with 0.2% Triton X-100 for 10 minutes at RT. 
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Cells were incubated for 1 hour in blocking solution (PBG, 0.5% BSA, 0.2% cold water fish 
gelatin, Sigma) and then incubated with primary antibodies diluted in PBG for 1 hour at RT 
or overnight at +4°C, in a dark humidified chamber. Cells were washed twice for 5 minutes 
with PBG and incubated with fluorophore-conjugated secondary antibodies diluted in PBG 
for 1 hour at RT in a dark humidified chamber. The incubation with secondary antibodies 
was followed by 3 minutes incubation with 4'-6-Diamidino-2-phenylindole (DAPI, 1μg/ml, 
Sigma-Aldrich, excitation wavelength 358nm, emission wavelength 461nm). DAPI binds 
preferentially to AT clusters of DNA minor groove and it was used to visualize nuclei. Cells 
were briefly washed with PBS and water. Finally, coverslips were mounted with mowiol 
mounting medium (Calbiochem), which is a polyvinyl alcohol solution containing an "anti-
fade" agent, capable of reducing photobleaching of the fluorophores conjugated to the 
secondary antibodies. Coverslips were air dried before microscope analyses.  
 
3.8 Immunofluorescence in mouse tissue sections 
In this work, immunofluorescence was also used to detect sub-cellular protein localization 
in tissue sections. Tissue sections mounted on glass slides were fixed with 4% PFA in PBS 
for 20 minutes. Slides were washed twice for 5 minutes at RT in washing buffer (0.1% 
Tween in PBS for 5 minutes). Tissues were blocked in 2% BSA, 0.1% Tween in PBS for 1 
hour at RT and incubated with primary antibodies diluted in blocking buffer, overnight at 
+4°C in a dark humidified chamber. Tissues were then washed twice for 5 minutes at RT 
with the blocking buffer and incubated for 1 hour at RT with fluorophore-conjugated 
secondary antibodies in a dark humidified chamber.  Nuclei were stained with DAPI (1 
μg/ml, Sigma-Aldrich). Samples were mounted with glycerol mounting medium 
(50%glycerol, 50mM Tris, pH 8), which provides an “anti-fading” function similar to 
mowiol, but also allows better conservation of the 3D-structure of the sample. Finally, the 
coverslips were sealed with nail-polish and air-dried before imaging. 
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3.9 BrdU incorporation assay 
The BrdU incorporation assay was used as a tool to monitor cell proliferation. 5- 
bromodeoxyuridine (BrdU) is a synthetic analogue of thymidine, which is incorporated into 
DNA during replication. Cells were plated on coverslips, incubated with cell culture medium 
in the presence of BrdU (Sigma-Aldrich, 10 µg/ml) for 6 hours, then washed twice and fixed 
with 4% PFA. Incorporation can be evaluated by immunofluorescence after DNA 
denaturation. Denaturation was achieved by a mild treatment with a DNA nuclease that 
digests DNA to allow antibody access, simultaneously with antibody incubation. Cells were 
permeabilized with 0.2% Triton X-100 for 10 minutes at RT. After blocking with PBG for 
1 hour, cells were incubated with a 50uL reaction mix containing primary antibody (anti-
BrdU, 1:20), DNaseI (Promega, 0.1 U/μl,), DNase buffer and MgCl2 (3 mM) for 45 minutes 
at RT in a dark humidified chamber. Cells were washed twice in PBG and the 
immunofluorescence was continued following the protocol previously described. 
 
3.10 Senescence-associated-β-galactosidase assay 
The activity of β-galactosidase enzyme is a widely used biomarker for cellular senescence, 
because β-gal is overexpressed in lysosomes of senescent cells and it is specifically active at 
pH 6.0 in senescent cells (Lee et. Al, 2006), while its activity at this pH is poorly detectable 
in pre-senescent, quiescent or immortal and transformed cells (Dimri et al., 1995). Cells were 
grown on coverslips, washed in PBS, fixed in 4% PFA for 10 minutes at RT, washed again 
and incubated at 37°C in the dark with fresh SA-β-gal stain solution (1 mg/ml 5-bromo-4-
chloro-3-indolyl beta-D-galactopyranoside, 0.5 M phosphate buffer at pH 6.0, 5 mM 
potassium ferrocyanide, 5 mM potassium ferricyanide, 150 mM NaCl, 2 mM MgCl2). After 
16h of incubation, cells were washed with PBS, fixed with 4% PFA for 10 minutes at RT, 
permeabilized with 0.2% Triton X-100 for 10 minutes at RT, washed with PBS, incubated 
with DAPI for 2 minutes, washed with PBS and mounted with mowiol. Cells were imaged 
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with a brightfield microscope. β-gal staining led to the formation of detectable blue 
perinuclear precipitates, specifically in senescent human fibroblasts.  
 
3.11 PLA 
Proximity Ligation Assay is a tool commonly used to detect with high sensitivity proximity 
interactions between two proteins of interest at single-cell level (Söderberg et al. 2006, 
Jarvius et al. 2007). Briefly, the proteins of interest are recognized by two primary antibodies 
raised in two different species, then cells are incubated with a pair of different secondary 
antibodies, each conjugated to a DNA oligo (also called probe, in the commercially available 
Duolink In Situ PLA kit, Sigma). In a subsequent reaction two connector oligo are ligated 
forming a DNA circle which can hybridize with the probes; however, the hybridization with 
the probes can take place only if the two target proteins are in close proximity (< 40nm). In 
the final reaction, the DNA circle works as the template and one of the probes as the primer 
for a rolling circle amplification reaction (RCA); the amplified product is recognized by 
fluorescent oligonucleotides, leading to the formation of a signal detectable by fluorescent 
microscopy. Here, PLA was performed using Duolink In Situ PLA reagents from Sigma, 
according to manufacturer’s instructions, with minor modifications. Cells grown on 
coverslips were fixed, permeabilized, blocked with PBG and incubated with primary 
antibodies as described for immunofluorescence. Then coverslips were washed twice for 5 
minutes at RT in PBG and incubated with 35µL of probes (typically 1:5 Duolink In Situ 
PLA Probe Anti-Mouse Plus and Anti-Rabbit Minus, diluted in Duolink Antibody Solution 
1x) for 1 hour at 37°C in a sealed humidified chamber. After two 5 minutes washes with 
Duolink Wash buffer A (Sigma) at RT, coverslips were incubated with 35µL of Ligation 
reaction (1:5 Duolink Ligation Buffer, 1:40 Duolink Ligase, diluted in pure water), for 30 
minutes at 37°C in a sealed humidified chamber. Afterwards, coverslips were washed twice 
for 2 minutes and then incubated with 35uL of Amplification reaction (1:5 Duolink Orange 
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buffer, 1:80 Duolink polymerase, diluted in pure water). Finally, coverslips were washed 
twice with Duolink Wash buffer B for 10 minutes at RT, then incubated for 3 minutes with 
DAPI and finally mounted with mowiol.  
To perform PLA on tissue sections, the samples mounted on glass slides were fixed, 
permeabilized, blocked and incubated with primary antibodies as described for 
immunofluorescence on tissue sections (section 3.8). The volumes used for PLA reactions 
were scaled up to completely cover the tissue sections. 
 
3.12 DI-PLA 
The development of this method, to study physical DSBs in proximity to a DDR marker, has 
been one of the main points of my thesis work and it is extensively described in the Result 
section. 
Adherent cells grown on coverslips were fixed in 4% PFA for 10 minutes at RT and 
permeabilized in 0.2% Triton X-100 for 10 minutes at RT, as described for 
immunofluorescence. Then, coverslips were washed twice for 5 minutes in NEB 2 buffer 
(NEB) 1x and once in blunting buffer 1X (Quick Blunting kit, NEB) at RT. Afterwards, 
exposed DNA ends were blunted, the reaction was performed at RT for 60 minutes, in a final 
volume of 50 µL for each coverslip using: 38.5 µL H2O, 5 µL Blunting Buffer 10x (NEB), 
5 µL dNTP 1mM (NEB), 0.5 µL BSA, Molecular Biology Grade 20mg/mL (NEB), 1 µL 
Blunting Enzyme Mix (NEB), in sealed humidified chamber. Coverslips were then washed 
twice in NEB 2 buffer 1X and twice in T4 Ligase buffer 1X (NEB). Then, in situ ligation 
was performed overnight at 16°C in a sealed humidified chamber, in 100 µL final volume 
per coverslip using: 2 µL T4 Ligase (NEB), 5 µL 10 uM biotinylated linker (Table S1), 10 
µL T4 Ligase Buffer 10X (NEB), 1 µL ATP solution 100mM (NEB), 1 µL BSA, Molecular 
Biology Grade 20mg/mL (NEB), 81 µL H2O. Coverslips were washed twice in PBS, and 
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then blocked for 1 hour in PBG, before incubation with primary antibodies. This step was 
followed by the standard PLA, described above. 
To perform DI-PLA on tissue slides, fixation, permeabilization, blocking and primary 
antibody incubations were performed as described for immunofluorescence on tissues 
(section 3.8). Moreover, reaction volumes were scaled up, in order to completely cover the 
tissue section and the concentration of biotinylated linker was doubled. 
 
3.13 Imaging 
Immunofluorescence, PLA and DI-PLA were acquired using a wide field Olympus 
Biosystems Microscope BX61 or a Leica TCS SP2 confocal laser microscope. To allow 
accurate signals discrimination, confocal images were obtained by sequential scanning of 
several planes along the z-axis. Comparative immunofluorescence analyses were performed 
in parallel, with identical acquisition parameters. Number of foci per cell were analysed by 
the imaging software CellProfiler (Carpenter et al. 2006), using the same pipeline for each 
sample in the same experiment. To identify foci or dots, I used as template the “Speckle 
counting” pipeline that can be found at http://cellprofiler.org/examples/#Tracking. In 
particular, I set an allowed diameter for foci and dots, in order to help the program exclude 
image artifacts and I used a global thresholding strategy with the RobustBackground method. 
Percentages of PLA-positive and DI-PLA-positive nuclei were scored manually. For cells 
experiments I defined: %positive cells = 100* fraction of nuclei with ≥ 2 foci/dots, 
%negative nuclei = 100* fraction of nuclei with < 2 foci/dots. For tissue experiments I scored 
nuclei as positive if they had at least 1 focus/dot. 
 
3.14 Quantitative PCR 
The Real Time PCR (RT-PCR) instrument allows real time detection of PCR products as 
they are generated at the end of each elongating step of the PCR cycles. In qPCR experiments 
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Sybr Green based- reaction mix were used. Sybr Green is an intercalating agent that has the 
property to emit fluorescent signal only when bound to dsDNA. With this strategy, the Real 
time qPCR instrument (Roche LightCycler 480) measures the fluorescence of each reaction, 
which is directly correlated to the quantity of dsDNA PCR products in each sample. In the 
first cycles of PCR, the low fluorescence defines the baseline for the plot of fluorescence 
signal vs cycle number. A fixed fluorescence threshold can be set above the baseline: when 
the fluorescence in a sample exceeds the set threshold, the threshold cycle (Ct) is called. 
Thus, the Ct is defined as the cycle number at which the fluorescence becomes higher than 
the fixed threshold: the higher the initial amount of the sample, the sooner the accumulated 
product is detected in the PCR process as a significant increase in fluorescence, and the lower 
the Ct value.  
Ct values are reproducible in technical replicates because the Ct are detected in the 
exponential phase of the PCR (in the first 35 cycles), where there is a linear relation between 
the log change in fluorescence and the cycle number. When the Ct values were higher than 
35, PCR results were classified as undetermined. Here, Real time qPCR was mainly used to 
quantify the amount of specific genomic DNA regions enriched in BLESS and BLISS 
experiments. 
 
3.15 Antibodies 
Anti-γH2AX (mouse, Millipore, 05-636, 1:2000), Anti-γH2AX (rabbit, Cell Signaling, 
9718, 1:2000), Anti-53BP1 (rabbit, Novus Biological, NB100-304, 1:2000). Anti-biotin 
(mouse, Sigma, B7653, 1:2000), anti-biotin (rabbit, Abcam, AB53494, 1:2000), anti-BrdU 
(Becton Dickinson, 347580, 1:20), Anti-GFP (rabbit, Abcam, ab290, 1:2000), Anti-TRF2 
(mouse, Millipore, 05-521, 1:1000), anti-cyclinA (1:800, BD transduction laboratories). 
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3.16 Statistical analyses 
Results are shown as mean ± standard error of the mean (s.e.m) where the number of 
biological replicates was ≥ 3, if nothing else is specified. Results are shown as mean ± 95% 
confidence interval where the number of biological replicates was ≥ 3, if nothing else is 
specified.   P-values were calculated by Student’s two-tailed t-test or chi-squared test, 
respectively, using Prism software. 
 
3.17 BLESS 
BLESS (direct in situ breaks labeling, enrichment on streptavidin and next-generation 
sequencing) is a technique to detect and map DSBs at genome-wide level in a population of 
cells  (Crosetto et al. 2013). BLESS testing and development has been one of the main point 
of this work, thus extensive discussion on the method can be found in the Results section. 
Here, the version used for most experiments is reported: a modified version of the protocol 
published by Crosetto and colleagues in 2013. For a typical BLESS experiment 5-10 million 
cells, for each condition, were crosslinked with 2% formaldehyde for 30 minutes at RT. The 
crosslinking reaction was then quenched with the addition of 125mM Glycine. Fixed cells 
were rinsed twice in 1X cold PBS, collected by scraping and centrifuged at 2000 rpm for 5 
min at 4°C. Cells were washed twice in cold PBS and the pellet was flash-freezed at -80°C 
and stored until use.  Pellets were resuspended in 1mL of Lysis buffer (Tris HCl pH 8 
10mM, NaCl 10mM, EDTA 1mM, EGTA 1mM, NP-40 0.2%, DTT 1mM, Proteases 
inhibitors (Roche)), and incubated for 90 minutes on a rotating wheel at 4°C. Cells were 
then collected by centrifugation (2000rpm for 5 minutes at 4°C) and resuspended in 1mL 
Nucleus break buffer (Tris HCl pH 8 10mM, NaCl 150mM, EDTA 1mM, EGTA 1mM, 
SDS 0.3%, DTT 1mM) and incubated in a thermomixer at 37°C shaking at 800 rpm for 45 
minutes. Cells were then collected by centrifugation (2000rpm for 5 minutes at RT) and 
resuspended in 500µL NEB Buffer 2 (Tris HCl pH 8 10mM, NaCl 50mM, MgCl2 10mM, 
 67 
DTT 1mM, 0.1% Triton) + 10µg/mL Proteinase K (Roche) and incubated in a thermomixer 
at 37°C shaking at 800 rpm for 45 minutes. Samples were quickly transferred to ice and 
500uL NEB Buffer 2 + Protease Inhibitor was added to each sample. Isolated nuclei were 
centrifuged (3000rpm for 10 minutes at 4°C) and washed twice in NEB buffer 2 and once 
in Blunting buffer (Tris HCl pH 7.5 100mM, NaCl 50mM, MgCl2 10mM, DTT 5mM, 
0.025% Triton X-100). The pellet of isolated nuclei was then subjected to a blunting reaction 
(42µL Blunting buffer 1X, 5µL dNTP 1mM, 2µL Blunting enzyme mix (Quick blunting kit, 
NEB) for 45 minutes at RT. After blunting, nuclei were resuspended in 1mL NEB Buffer 2, 
centrifuged (3000rpm for 10 minutes at 4°C) and washed twice. Then the pellet was washed 
twice in T4 Ligase buffer and finally the nuclei were subjected to the Ligation step with the 
biotinylated proximal linker which would tag each exposed DSB in the nuclei (18.5µL T4 
Ligase buffer 1x, 5µL of 10µM Linker P1B in T4 Ligase buffer 1x, 1.5 Ligase 400.000 
U/µL (NEB)). In situ ligation was performed overnight as described in the published BLESS 
protocol, followed by DNA de-crosslinking and extraction. After ligation, the pellets were 
washed twice in 1mL Wash&Bind buffer (W&B, 5mM Tris HCl pH 7.5, 1mM EDTA, 1M 
NaCl, 0.1% Triton X-100); after each wash, the samples were centrifuged 10 minutes at 
3000rpm, at RT). Then, the pellets were resuspended in 500uL of NEB Buffer 2 + 
200µg/mL Proteinase K and incubated for 45 minutes in a thermomixer set at 55°C, shaking 
800rpm. Afterwards the incubation was continued for 45 minutes at 65°C. 
The samples were spinned for 1 minute and transferred in ice. Potassium Acetate (0.3 M), 
Glycogen and 0.7 volumes of ice-cold Isopropanol. After mixing the solution, samples were 
incubated for 1 hour at -20°C and later centrifuged 13000rpm for 20 minutes at 4°C. Pellets 
were washed twice with 70% ethanol and finally resuspended in 130 µL of pure water. 
Purified genomic DNA was fragmented with Covaris S220 (10% duty factor, 175W peak 
incident power, 200 Cycles/burst, 150s) to obtain a pool of 250 bp fragments. Covaris 
machines utilize the Adaptive Focused Acoustics™ (AFA) process to shear DNA, 
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exploiting bursts of ultrasonic acoustic energy at very high frequency that lead to a strictly 
regulated fragment size distribution. 
Next, the sheared DNA fragments were diluted with 180 µL of pure water: 10µL of this 
solution was stored and used as Input for further analyses. The remaining sheared DNA 
fragments were captured on streptavidin beads (Dynabeads MyOne Strepdavidin C1, 
ThermoFisher Scientific): the samples were incubated for 30minutes with 10µL of beads on 
a rotating wheel at 4°C in W&B buffer. 
Magnetic beads were then washed twice in W&B buffer and resuspended in 37.5µL pure 
water. The sheared fragments underwent a blunting reaction (5 µL Blunting buffer, 5 µL 
dNTP 1mM, 2 µL Quick blunting enzyme mix, 0.5 BSA 20mg/mL) for 45 minutes at RT, 
shaking at 1200rpm for 15 seconds every 15 minutes.  
Afterwards, the sheared DNA fragments were washed twice in W&B buffer and 
resuspended in 33 µL pure water. Next, they were ligated to the distal linker (LinkerD3): 
they were incubated overnight in 5µL Ligase buffer 10X, 10µL Linker D3 100mM, 2 µL 
T4 Ligase (400.000 U/µL, NEB), in a thermomixer set at 16°C, shaking for 45 seconds at 
1200rpm every 45 minutes. 
The ligation product was washed twice in W&B buffer and resuspended in 21 µL pure 
water. BLESS linkers have a hairpin-like structure: the stem is composed of a barcode 
sequence, the I-SceI target site then there is the loop containing the biotinylated nucleotide. 
Digestion of the ligation product with I-SceI allowed linearization of the linkers, thus 
recovery of the fragments from the magnetic beads, followed library preparation. The 
digestion was performed by adding 2.5 µL Cut Smart Buffer 10x, 0.5 µL BSA 20mg/mL, 1 
µL I-SceI (NEB): the samples were incubated at 37°C for 4 hours. In parallel, also input 
samples were digested with I-SceI using the same reaction mix. Finally, the supernatants 
were recovered and subjected to PCR amplification. Each sample was split in 5 PCR 
reactions: 5 µL I-SceI digested DNA, 1 µL PCR primer 1, 1 µL PCR primer 2, 1 µL dNTP 
1mM, 5 µL 10x Q5 buffer, 0.5 µL Q5 polymerase (NEB). Each reaction was subjected to 
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18 cycles of PCR reaction. PCR products were recovered and the ones coming from the 
same sample were pooled together. Finally, both input samples and PCR products were 
purified with Wizard SV gel and PCR clean-up system (Promega) and resuspended in 35 
µL pure water. 
The purified samples were either subjected to Next Generation Sequencing (NGS) library 
preparation with Truseq Nano LT kit (Illumina) or analyzed with BLESS-quantitative PCR 
(BLESS-qPCR). 
  
3.18 BLESS-qPCR 
To quantify the enrichment of DNA sequences at specific genomic regions, captured by 
BLESS, I developed an approach inspired by ChIP-qPCR analyses. I performed BLESS as 
described above, but I stopped before preparing the Truseq DNA library for Next Generation 
Sequencing. 
qPCR primers were typically designed in the 500bp surroundings of the site of interested. 
qPCR with the selected primers was performed on the final BLESS product and on the 
genomic Input, that corresponds to 1:30 of the material recovered after sonication. 
The enrichment was expressed as % of input: 
% 𝑜𝑓 𝑖𝑛𝑝𝑢𝑡 =  
𝐿𝐵
𝐼𝑁
 × 100  
LB = 2-Ct Library, corresponding to the BLESS product obtained after the PCR step 
IN = 2-Ct Input 
In this way, the DNA enrichment for each sample is normalized on the amount of starting 
material. Note that this calculation does not take into account the input dilution and the PCR 
cycles used to amplify the material in the final step of BLESS protocol. However, since I 
always used the same input dilution and number of PCR cycles, different BLESS 
experiments are comparable. 
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3.19 BLISS linker preparation 
The single-strand oligonucleotides for BLISS, listed in 3.25, were annealed in 100µL of 
purified water, at a final concentration of 10 µM. The oligonucleotides mix was heated to 95 
°C for 5 minutes. Tubes were removed from the heat source and slowly allowed to cool to 
room temperature. 
 
3.20 BLISS 
Breaks Labelling In Situ and Sequencing (BLISS) is an evolution of BLESS method, to map 
DSBs at genome-wide level, that allows low-input samples and higher sensitivity (Yan et al, 
2017). Here, I used the same protocol available in Protocol Exchange 
doi:10.1038/protex.2017.018. 
For the experiments presented in this work a range of 1 to 3 coverslips per sample were 
fixed, with 10.000 to 50.000 cells attached. Briefly, cells were fixed with 4% PFA for 10 
minutes, washed with PBS and incubated for 1 hour at 4°C in Lysis buffer (the same 
described above for BLESS, but with 0.2% Triton X-100). Then, coverslips were washed 
and incubated with Nucleus break buffer (the same described above for BLESS), for 1 hour 
at 37°C. Permeabilized nuclei were washed twice with PBS, and twice with Cut Smart Buffer 
1x (NEB). Afterwards, DNA ends were blunted by incubating coverslips with 50µL of the 
blunting mix used for BLESS, for 1 hour at RT. After blunting, coverslips were washed 
twice with Cut Smart Buffer 1x (NEB) and subjected to ligation with the BLISS adapter (2 
µL). The ligation reaction was performed overnight at 16°C in a sealed humidified reaction, 
with the same ligation reaction described for DI-PLA. 
The excess of linkers was removed by washing twice in W&B buffer (as for BLESS) 1 hour 
at RT. Finally, genomic DNA was extracted by scraping cells in DNA extraction buffer 
(100mM NaCl, 50mM EDTA, 10mM Tris HCl pH 8, 1% SDS) and Proteinase K 
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(10mg/mL). The scraped samples were transferred to tubes and incubated overnight at 55°C, 
shaking at 800 rpm.  
DNA was the purified by standard phenol-chloroform protocol and EtOH precipitation: 
briefly phenol:chloroform:isoamyl alcohol was added 1:1 to the extracted DNA sample, then 
the mix was centrifuged at 13000rpm for 10 minutes at RT, and the upper phase (containing 
the DNA) was transferred to a new Eppendorf. Sodium Acetate was added to obtain 0.3M 
solution, then glycogen and 2.5x volumes of 100% EtOH were added and the mix was 
incubated at -20°C for 1 hour. The DNA was centrifuged at 13000rpm for 20 minutes at 
+4°C and washed twice with 70% EtOH. 
Finally, the pellet is air dried and resuspend in 130µL pure water and sonicated with Covaris 
as described for BLESS. The sheared DNA fragments were then concentrated with vacuum 
to obtain a 16µL solution in pure water: half of the material was saved as Input for further 
analyses, while 7.5µL were subjected to in vitro transcription using Ambion T7 Megascript 
kit, with the following reaction mix: 7.5µL Sonicated genomic DNA, 8 µL rNTP mix, 2µL 
T7 polymerase buffer 10×, 2 µL T7 Polymerase, 0.5 Ribosafe RNase Inhibitor). The reaction 
was incubated for 14 hours at 37°C and was followed by 15minutes at 37°C DNAseI 
treatment. 
Afterwards, the RNA product of the IVT reaction was purified using Agencourt RNA XP 
beads, following manufacturer’s instruction, and resuspended in 8uL pure water. 
Afterwards, the library for NGS is prepared using components from Truseq SmallRNA seq 
kit (Illumina), performing reaction as advised by manufacturer’s instruction. Firstly, the RA3 
(3’ adapter) is ligated, then the RNA is reverse transcribed using SuperScript III, and finally 
the library is indexed and amplified for 8-10 cycles of PCR. Agencourt Ampure XP beads 
were used to purify the PCR product, resuspending the library product in a final volume of 
20µL pure water. Library product was then either subjected to NGS or analysed by BLISS-
qPCR. 
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3.21 BLISS-qPCR 
Similarly to the approach developed for BLESS, qPCR was used to analyze BLISS libraries, 
to study whether specific genomic regions were represented in the library.  
Differently from the experiments performed for sequencing, the starting material was 
doubled (2 coverslips per condition). After in situ blunting, ligation with linkers and genomic 
purification, the DNA was fragmented by sonication, according to BLISS standard 
procedure. Then, the fragmented DNA of each condition was concentrated to 16µL, of which 
8µL were used for in vitro transcription (IVT), while the remaining 8µL were stored at -
20°C. This aliquot was used as Input of genomic DNA, to allow normalization of the 
genomic material represented in BLISS libraries, on the amount of starting material for each 
sample. IVT and library preparation were performed according to BLISS workflow. 
Primers designed to amplify the regions of interest were used for qPCR analysis of the 
BLISS libraries, normalized over the input. Following the same formula shown in BLESS-
qPCR section. 
Fold induction of DSBs for each couple of primers was calculated with this formula: 
𝐹𝑜𝑙𝑑 𝑖𝑛𝑑𝑢𝑐𝑡𝑖𝑜𝑛 =  
𝐿𝐵𝐼𝑛𝑑𝑢𝑐𝑒𝑑
𝐼𝑁𝐼𝑛𝑑𝑢𝑐𝑒𝑑
𝐿𝐵𝑈𝑛𝑖𝑛𝑑𝑢𝑐𝑒𝑑
𝐼𝑁𝑈𝑛𝑖𝑛𝑑𝑢𝑐𝑒𝑑
   
LB = 2-Ct Library, corresponding to the final BLISS product  
IN = 2-Ct Input 
 
3.22 BLESS and BLISS sequencing, alignment and data 
analysis 
Library quality and quantity was assessed on the 2100 Bioanalyzer (Agilent) using the High 
Sensitivity DNA kit (Agilent). Clusters were generated on the Illumina flow cell using the 
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automatic cBot station and the TruSeq PE Cluster Kit v3-cBot-HS. Sequencing was carried 
out on Illumina HiSeq 2000 using the TruSeq SBS Kit v3-HS chemistry. 
For DSB detection in U2OS AsiSI cells, paired-end sequencing reads from each sample were 
mapped to the human genome (GRCh37/hg19) using BWA. At most one mismatch per read 
was allowed and duplicated reads were removed using rmdup of SAMtools (Li et al. 2009). 
All reads uniquely mapping were scanned for the presence of the proximal linker barcode 
with ad-hoc scripts written in bash and R languages. Finally, all reads within ±100 bp of the 
AsiSI sites identified by BEDtools intersect, were considered on target and retained for 
further analysis (Quinlan & Hall 2010). The same approach was used for DSB detection in 
LPS-induced macrophages, with the only difference that only the reads falling in the 
enhancers (as listed in (Ostuni et al. 2013)), were considered on target and retained for the 
analysis. 
Differently, for DSB detection in IR exposed cells, a different pipeline was developed, in 
order to do a de novo detection of genome-wide DSBs, without a focus on any particular 
region. 
The algorithm involves several steps, briefly summarized as follows. The first stage of 
analysis consists in filtering the raw sequencing data in order to remove reads with low 
mapping-quality score. The second step is the normalization of BLISS reads due to the huge 
discrepancy of their depth of coverage. In the third step, a Discrete Wavelet Transform 
algorithm, followed by a statistical evaluation according to a Poisson distribution, were used 
to obtain, for each time point, a list of significant peaks having p-values lower than an 
arbitrarily-defined threshold of significance, representing DSBs more enriched for reads in 
treated sample than in normalized control. 
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3.23 DSBCapture 
DSBCapture is a technique to detect and map DSBs at genome-wide level in a population of 
cells (Lensing et al. 2016). DSBCapture protocol was adapted from the published protocol 
to make it most comparable with BLESS. All buffers and all steps in the protocol are the 
same as described for BLESS, however, DSBCapture linkers were used. Since the linkers 
are T-tailed, a A-tailing step was introduced after in situ DNA ends blunting with the 
following reaction mix: 0.5µL 10mM dATP, 3µL Klenow Fragment exo- (NEB, cat. no. 
M0212), 46.5µL pure water. 
Each sample was incubated for 45 minutes at 37°C, then washed twice with NEB2 buffer 
and submitted to linker ligation as described for BLESS. 
DSBCapture linkers do not have a hairpin structure, thus enzymatic linearization after the 
second linker ligation was not performed, and the final PCR amplification of the captured 
DSBs sequences was performed directly on the beads, with the same reaction mix and PCR 
program described for BLESS: here, in each PCR reaction were used 5µL of DNA bound to 
beads (instead of 5µL of digested DNA), and primers matching DNACapture linkers were 
used instead of BLESS PCR primer (see Primers table). 
qPCR detection of DSBs sequences detected by DSBCapture was performed with the same 
strategy described in BLESS-qPCR. 
 
3.24 Primers 
ID Sequence Figure 
PCRP1 CCCTAGCGTAACTCTCGAGGTAGTA 3,4,,57,58 
PCRD3 CTAGCGTAACTCTCGAGACGACG 3,4 
507_prox_FW GGATTGACTCTGGGGTTTGC 4,6 
507_prox_rev TCACACTCCACAGCCAATCC 4,6 
203up_prox_fw CCAGTTGATTTGAGTAGGAGACG 4,5,6,10 
203up_prox_rev TCTAGAATTAAGGGACGAGGCC 4,5,6,10 
uncut_FW ACCTGGGATGGGACATATC 4,5,6,10 
uncut_rev TACCAAGCCTGTCCCTGAAC 4,5,6,10 
245down_prox_fw AGAAGGATGGTGGTGTCTGC 4,5,6,10 
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245down_prox_rev AATCAGAACTCTCGCTCCCC 4,5,6,10 
453_prox_fw GCCTATGGAACTGACGGTGG 4,5,6,10 
453_prox_rev GCTCCTCCCCTCCTTTCC 4,5,6,10 
985_down_Fw CACCAAACCAAGGAAGCAGC 4,5,6,10 
985_down_rev GGTTCTCTGCCTTCCAAAGC 4,5,6,10 
I-sceI_near_F TTGGGTAACGCCAGGGTTTT 7 
I-sceI_near_R TTCCTCAGCGTGGCCAATTC 7 
483_F TTCTGACAGTGGGGAAAGCA 15 
483_R CTGAGATCTTCGGCAAGCC 15 
554_F GGCACTCACGTAGGCTAGAT 15 
554_R GGGGACTGGCTAGATCTGTG 15 
961_F GATCCATGCCCGCTGAATTT 15 
961_R GCTTGGGGTCGTTGAATCTG 15 
1072_F TGTCACAGACCCACACACC 15 
1072_R GTCAGCAAACCACAGAGAGG 15 
E1_F AGTTCACAGGCTGGCTGTCCAT 17,18 
E1_R CCACACTCAAGCTGCATGCTG 17,18 
E2_F CCACACTCAAGCTGCATGCTG 17,18 
E2_R TTACTGGGCTGTTACAAATGGG 17,18 
E3_F GCCATTACACTTGAAGTTCCTC 17,18 
E3_R CTAAGCAAGCACAGGGACAT 17,18 
E7_F CAGAGTTCAGAAATGAGGGA 17,18 
E7_R CACCCAGCAGTCTAATGCTA 17,18 
H3.1 FW ACCACAATTTCAGGCCCTCT 51 
H3.1 REV CACCACGCCCAGCTAATTTT 51 
H3.2 FW GGGTGACGGAGCATGACT 51 
H3.2 REV AGGATTAGGATGGTGGTGGC 51 
H6.1 FW AAGGCAAGAAAGGAAAGGGC 51 
H6.1 REV ACAAAATGGTATCTGGAGCAAGA 51 
No_DSB_F AGCATCTCCACCACCTCAAA 51 
No_DSB_R CACCACTGCACTTTAGCCTG 51 
H9.1 FW TGCAGAGGAGGTTCTTTGGT 51 
H9.1 REV TGGAAGGAAGGGAGGAAGGA 51 
H11.1 FW TCCTGGGCAAGTCACTTCAG 51 
H11.1 REV CTTTAGCCAATCCTGCCTGC 51 
H11.2 FW GGACGTCATTGAACTGCAGG 51 
H11.2 REV TAGCTTGCACACCTGACTCT 51 
H12.1 FW GTCCCCGACTTAAGATGGTT 51 
H12.1 REV CGTAGCCTTCCTTAAACATGCT 51 
H12.2 FW GTAATGGGGTGGACGAGACA 51 
H12.2 REV TCTGCCTCATTGCCCAACTA 51 
H22.1 FW ATCCACCTAAGTTGGGCTCC 51 
H22.1 REV GTACATCACTGGTGGGAATGT 51 
TELO_FW TAGGGTTAGGGTTAGGGT 52,56,57,58 
TELO_REV CCCTAACCCTAACCCTAA 52,56,57,58 
PCR-DSBC_FW AATGATACGGCGACCACCGAGATCTACACTCTTTCCCTACACGA 10 
PCR-DSBC-REV CAAGCAGAAGACGGCATACGAGATATTGGCGTGACTGGAGTTCAGACGTGT 10 
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3.25 Linkers 
 
 
 
 
 
 
 
  
ID Sequence Notes
Linker P1B
TACTACCTCGAGAGTTACGCTAGGGATAACAGGGTAATATAGTTT[BtndT]TTTCTATATTACCCTGTTATCCC
TAGCGTAACTCTCGAGGTAGTA
Biotinylated linker used for 
BLESS and DI-PLA
Linker P1
TACTACCTCGAGAGTTACGCTAGGGATAACAGGGTAATATAGTTTTTTCTATATTACCCTGTTATCCCTAGC
GTAACTCTCGAGGTAGTA
Non-biotinylated linker used 
for DI-PLA controls
Linker D3
CGTCGTCTCGAGAGTTACGCTAGGGATAACAGGGTAATATAGTTTTTTTCTATATTACCCTGTTATCCCTAG
CGTAACTCTCGAGACGACG
Distal linker used for BLESS
BLISS_FW
GCGTGATGNNNNNNNNGATCGTCGGACTGTAGAACTCTGAACCCCTATAGTGAGTCGTATTACCGGCCTCA
ATCGAA
Linker FW for BLISS
BLISS_REV
CGATTGAGGCCGGTAATACGACTCACTATAGGGGTTCAGAGTTCTACAGTCCGACGATCNNNNNNNNCATC
ACGC
Linker Rev for BLISS
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4 Results 
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In this section, I will first describe the optimization of a genome-wide method to map DNA 
double strand breaks (BLESS) and its comparison with other recently published tools. I will 
describe the application of one of these tools (BLISS) to map at genome-wide level DSBs 
induced by a restriction enzyme (Iannelli et al. 2017). Genome-wide data have been analyzed 
in collaboration with Dr. Fabio Iannelli, a bioinformatician in the lab where I have worked. 
I will also describe the application of BLESS and BLISS to map DSBs induced in response 
to LPS activation of macrophages, which is part of a project in collaboration with Dr. Valerio 
Vitelli, a post-doc in the lab where I carried out my thesis.  
In the second part, I will describe a new tool that I developed for DNA doubles strand breaks 
imaging in fixed cells and its application to study persistent DNA damage in senescent cells 
and tissues from aged animals (Galbiati et al. 2017). 
In the last part, I will describe how DI-PLA and BLESS can be applied to study the integrity 
of telomeres. 
 
4.1 DSB Mapping 
The most commonly used method to map DNA double strand breaks (DSB) is Chromatin 
Immunoprecipitation (ChIP) using antibodies against chromatin modifications (γH2AX) or 
their interacting proteins (such as 53BP1), which are used as a proxy for DNA damage. 
However, these DNA damage markers spread away from the lesions for up to 1 Mb, thus 
not allowing a precise location of DSBs (see Introduction, section 2.5). Recently, an 
increasing interest in genome editing, together with the decreasing cost of high-throughput 
sequencing techniques, prompted the development of several new techniques to map DSBs 
at genome-wide level, as I recently reviewed in collaboration with other colleagues from our 
group (Vitelli et al. 2017). At the beginning of my PhD, I started working on the optimization 
of a recently published protocol, BLESS (Crosetto et al. 2013b, Figure 3),  that could be 
applied to several biological problems.  
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Figure 3 - BLESS workflow. 
a. Highlight of the key steps in BLESS workflow. b. Scheme of a typical BLESS product: DNA fragment in 
black, linkers in green (distal) and blue (proximal). 
 
As described in detail in the Material and methods section 3.17, this technique can be applied 
to fixed cells to map DSBs. It relies on in situ DSB blunting and ligation to a biotinylated 
double-stranded DNA linker which labels the DSB positions. Thus, after DNA extraction 
and fragmentation, it is possible to pull-down the biotinylated sequences with streptavidin 
beads. Following a distal linker ligation, it is possible to amplify the enriched sequences 
using primers matching the linkers and submit the amplified library to sequencing.  
 
To test and optimize BLESS, I first applied it to map DSBs in a human osteosarcoma (U2OS) 
cell line, stably expressing the fusion protein AsiSI-ER (Iacovoni et al. 2010, Massip et al. 
2010), where the restriction enzyme AsiSI is fused to a modified oestrogen receptor (ER) 
binding domain. The addition of tamoxifen (4-OHT) to cell culture medium induces nuclear 
translocation of AsiSI-ER, where the restriction enzyme cleaves its target sequences. This 
cell line has been recently used in several studies on DDR, and published results suggest that 
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although more than 1.000 genomic loci contain AsiSI target sequence, the endonuclease, in 
vivo, cleaves only a fraction of these, probably due to the varying degrees of accessibility of 
the genomic regions containing the target sequence. Given the possibility to induce DSBs 
with varying efficiency at known location in the genome, I thought that this cell line would 
be an ideal model to test BLESS efficacy in mapping DSBs. 
 
4.1.1 BLESS-PCR 
For my own reference, in collaboration with the bioinformatician of our group, Dr. Fabio 
Iannelli, we generated a map of all putative AsiSI target sequences in the human genome 
and we assigned an ordered number to each AsiSI site (AsiSI ID) starting from the closest 
to the start of chromosome 1. 
The published BLESS paper lacked any tool to analyze BLESS-captured sequences, besides 
Next Generation Sequencing (NGS). Thus, I decided to develop a strategy to quickly test by 
PCR or quantitative PCR (qPCR) whether specific genomic regions were enriched in BLESS 
libraries. This strategy is also valuable to perform controls on the library preparation steps, 
prior submitting it to NGS. 
To do this, one possible approach was to design one PCR primer in proximity of the putative 
DSB site to test and another matching the proximal linker (the one that marks the DSB 
position in BLESS) – Figure 4a. Alternatively, I designed a couple of primers, both matching 
genomic DNA, in the proximity of the putative DSB sites – Figure 4c. For this experiments 
I chose arbitrarily 4 AsiSI sites that, according to literature, were enriched in γH2AX 
(measured by ChIP - (Iacovoni et al. 2010) and 1 site as negative control (uncut), that was 
not in proximity to an AsiSI target site. 
I performed BLESS on U2OS AsiSI cells either uninduced, induced for 4 hours with 4OHT 
and on parental U2OS cells, that did not contain the construct coding for the fusion protein, 
to exclude the contribution of a background level of AsiSI cleavage in cells containing the 
fusion protein. 
 81 
 
Figure 4 – BLESS-PCR on U2OS AsiSI cells.  
Detection of captured DSB sequences by BLESS-PCR in U2OS AsiSI cells either induced (+4OHT), 
uninduced (-4OHT) and in U2OS cells (Parental) a. Forward primer specific for the genomic region, reverse 
primer specific for BLESS proximal linker b. PCR products run on agarose gel. Lane IDs 1: AsiSI_507, 2: 
Uncut, 3: AsiSI_203, 4: AsiSI_453, 5: AsiSI_985. c. Forward and reverse primers are designed on genomic 
DNA to amplify a specific region. d. PCR products run on agarose gel. Lane IDs 1: Uncut, 2: AsiSI_507, 3: 
AsiSI_203, 4: AsiSI_453, 5: AsiSI_985. 
 
 
As shown in Figure 4b, d I found that using two primers matching the genomic DNA gave 
the best specificity in PCR detection, producing a single band, and showing the expected 
higher amount of captured DSBs, for at least 3 of the 4 AsiSI sites tested, in the induced 
sample compared to the uninduced, and no enrichment at the uncut site and in parental cells. 
On the other hand, PCR using one primer matching the genomic DNA and one matching the 
linker, were less efficient, often producing multiple bands; although I could still observe an 
enrichment for 3 of the 4 AsiSI sites tested. In Figure 4, as in any other Figure, the AsiSI 
IDs are the ones that we assigned to each putative AsiSI cleavage site in the genome, when 
we generated the in silico AsiSI cleavage map. 
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To further confirm that the PCR approach to detect BLESS-enriched DSB was reliable, I 
repeated the experiment, adding a normalization step on the Input (before streptavidin 
enrichment, see Material and Methods), to take into account the amount of starting material 
for each sample, in a similar fashion to the commonly used ChIP-qPCR approach. 
 
Figure 5 - BLESS-PCR normalized on input in U2OS AsiSI cells.  
PCR detection of captured DSB sequences in U2OS AsiSI cells either induced (+4OHT), uninduced (-4OHT) 
and in U2OS cells (Parental). a. PCR products on BLESS libraries and PCR product on Input fragments were 
run on an agarose gel. Lane IDs 1: AsiSI_985; 2: AsiSI_453; 3: uncut. The ratios of band intensities quantified 
with (ImageJ Gel Analysis tool) of BLESS products over input, for each primer couple, are plotted in panel b. 
 
 
As shown in Figure 5, I observed that, indeed, even after normalization of the BLESS 
products on the inputs, I could detect a specific enrichment of genomic material at the AsiSI 
cut sites in induced cells compared to uninduced cells or parental U2OS, but not at the uncut 
site, indicating that the approach that I developed was working reliably. 
Since PCR is a semi-quantitative technique, and band intensity quantification by digital 
acquisition, followed by automatic quantification with imaging software (such as ImageJ, 
here) may not be particularly precise, I decided to use qPCR to have more accurate 
quantification of BLESS-captured DSBs. As shown in Figure 6, I observed that, using the 
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strategy validated by semi-quantitative PCR, I could reproducibly detect an enrichment of 
genomic material at several AsiSI-cleaved sites, specifically in induced cells. 
 
 
 
 
 
 
 
 
 
Figure 6 - BLESS-qPCR at several genomic regions in U2OS AsiSI cells either Induced or Uninduced. 
Bars represent % of input (n=3). 
 
 
As further confirmation that BLESS-qPCR was working, I performed BLESS on Hela111, 
a cell line carrying an exogenous sequence containing the target site for the I-SceI 
endonuclease (Figure 7a) and transfected the cells with a plasmid coding for I-SceI, to induce 
one DSB per cell, or with the empty vector as control. As shown in Figure 7b, I could 
specifically detect the cut at the I-SceI cleavage site only in cells that were transfected with 
the endonuclease.  
 
Figure 7 - BLESS in Hela 111. 
a. Scheme of the genomic region containing the I-SceI target site and qPCR primer design. b. BLESS-qPCR 
in Hela111 transfected with an empty vector (EV) or a plasmid coding for the endonuclease I-SceI. Bars 
represent % of input (n=3). 
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In summary, I assessed that BLESS-qPCR is a reliable strategy to analyze BLESS captured 
DSBs. 
 
4.1.2 Improvement of BLESS fragmentation step 
I was interested in using BLESS to draw a precise genome-wide map of AsiSI cleavage sites 
in U2OS AsiSI-ER cells, something that was missing when I started this project, and would 
have been a useful resource for other studies in the laboratory and in the DNA damage field, 
given the broad application of this cell line. 
While I was preparing the library for NGS, I realized that the mean size of library fragments, 
obtained by HaeIII enzymatic digestion, as reported in the original BLESS protocol 
(Crosetto et al. 2013a), was between 1000-2000bp (Figure 8a). This fragment size 
distribution is suboptimal for Illumina sequencing and it is known to yield low efficiency in 
cluster formation, a key step in Illumina sequencing-by-synthesis: in fact, long fragments 
have a low chance to stably hybridize to the probes attached to the Illumina flow cells, thus, 
yielding low efficiency of library sequencing.  Instead, the optimal library fragment size 
distribution should be in the 200bp-600bp range (Bronner et al. 2013). 
I was able to solve this problem by substituting the enzymatic fragmentation with a 
mechanical fragmentation step, using the Covaris sonicator (see Materials and Methods, 
section 3.17), which yielded smaller mean library fragments size, sharper fragment size 
distribution (Figure 8b), with the added advantage of being a faster and cheaper step than 
enzymatic digestion.  
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Figure 8 - Bioanalyzer profiles of BLESS on U2OS AsiSI cells. 
U2OS AsiSI cells were either induced (I), uninduced (U) on U2OS cells (P). a. Fragmentation step performed 
with enzymatic digestion. b. Fragmentation step performed with Covaris. 
 
 
To confirm the effectiveness of the change that I made to the original protocol I sequenced 
the BLESS libraries. In collaboration with Dr. Iannelli, we aligned the reads around the AsiSI 
cleavage sites that we found with the in silico AsiSI genome restriction. Figure 9 shows the 
normalized read counts in proximity (at different window sizes) of the detected AsiSI sites 
obtained with the two protocols. Strikingly, I found that the Covaris fragmentation yielded 
more than 10-times higher mean read counts in proximity of cut sites compared with the 
library prepared with enzymatic fragmentation. 
 
Figure 9 - Normalized read counts in the proximity (500bp or 1000bp windows) of AsiSI cut sites in 
U2OS AsiSI induced cells. 
I        U     P  
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From this point onward, I always performed BLESS with the Covaris fragmentation step, 
unless otherwise specified. Notably, the latest methods developed to map DSBs, that use 
strategies similar to BLESS to capture DNA breaks, such as DSBCapture (Lensing et al. 
2016) and End-seq (Canela et al. 2016), also include a mechanical fragmentation step, 
instead of an enzymatic fragmentation step. 
 
4.1.3 Comparison between BLESS, DSBCapture and BLISS 
4.1.3.1 DSBCapture 
Following BLESS, a number of DSBs mapping methods have been published, as also 
discussed in the introduction (section 2.5), some with a whole different strategy, while others 
are improvements of the original BLESS protocol. 
I decided to compare BLESS with DSBCapture (Lensing et al. 2016), which shares most of 
the protocol with BLESS, but uses T-tailed linkers to improve the efficiency of ligation of 
linkers to the DSBs, thus leading to a more efficient DSB labeling. This modification also 
requires the introduction of an A-tailing step after the DSBs blunting, to allow the ligation 
of the T-tailed linker.  Another minor modification to the linker design, to include Illumina 
adapters in the sequence, allows the DSBCapture users to skip some steps in the library 
preparation for sequencing; however, this improvement is not relevant for the PCR detection 
of DSBs at specific loci. Lensing and colleagues, reported that DSBCapture mapped 
genome-wide more endogenous breaks than BLESS in normal human epidermal 
keratinocytes (NHEK), however they did not provide any control for false positive or 
background noise. 
Thus, I decided to compare DSBCapture and BLESS efficiency in detecting AsiSI-induced 
DSBs and measure the enrichment of the captured sequences by qPCR. 
As shown in Figure 10, and in agreement with the results published by Lensing and 
colleagues, I observed higher enrichment of DSB detection with DSBCapture compared to 
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BLESS in induced U2OS AsiSI cells. However, I also observed a higher level of background 
in uninduced cells and at an uncut sequence (lacking the AsiSI target site): this is particularly 
obvious when plotting the ratio of induced over uninduced at each AsiSI site (Figure 10b), 
where BLESS outperformed DSBCapture for most of the sites analysed. 
 
Figure 10 - qPCR comparison of DSBs detected by BLESS and DSBCapture. 
a. Bars represent the % of input at each AsiSI site (n=2). b. Bars represent the ratio of % of input of Induced 
over Uninduced for each method of DSB detection. 
 
 
Although, with this experiment, I could not infer any conclusion on genome-wide DSB 
detection by NGS with DSBCapture, the results indicate that this method does not 
significantly outperform BLESS when using a PCR method to detect captured sequences 
and suggest that DSBCapture might be more prone than BLESS to pick up background 
signals. 
I also tried to repeat the same comparison between BLESS and End-Seq (Canela et al. 2016), 
but I failed to retrieve any DNA sequence at the end of End-seq process, possibly because 
the published protocol lacked some key details. 
 
4.1.3.2 BLISS 
BLISS technique (Yan et al. 2017) works with a strategy similar to BLESS, producing 
nucleotide-resolution genome-wide maps of DSBs in fixed cells, however a different linker 
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design and a different strategy for the enrichment of labeled sequences allows the technique 
to work on few thousand cells, differently from BLESS and most other DSB mapping 
methods that require a few million cells as starting material. I was also directly involved 
with BLISS testing in its unpublished version by spending a short period in Dr. Nicola 
Crosetto’s lab in Karolinska Institutet, Stockholm. 
The different strategies for DSB labeling and amplification does not allow a side-by-side 
comparison between BLESS and BLISS by qPCR, thus I compared the two techniques by 
NGS. 
I used the well-tested U2OS AsiSI system and I compared the performance in mapping DSBs 
genome-wide of BLESS (with either enzymatic fragmentation – Dig, or Covaris 
fragmentation – Cov) and BLISS. I performed the analysis of sequencing data in 
collaboration with Dr. Fabio Iannelli. We focused on 100bp windows around AsiSI putative 
cut sites, we applied a normalization procedure to account for the number of reads 
surrounding these windows in induced and uninduced samples and, finally, we called DSBs 
only when we mapped more reads in the AsiSI window in the induced sample compared to 
the uninduced one, after normalization (see Materials and Methods – section 3.22). 
We compared the sites that we detected as cut with a list of AsiSI sites validated in literature 
by Ligation Mediated-PCR (LM-PCR) (Aymard et al. 2014b, Chailleux et al. 2014): 15 
AsiSI cleaved sites (Positive controls) and 3 AsiSI uncut sites (negative controls). We also 
compared this list of AsiSI sites with the AsiSI-induced DSBs detected by DSBCapture, as 
reported in literature (Lensing et al. 2016). 
Strikingly, I found that all 15 positive controls were detected by BLISS and all 3 negative 
controls were not detected as cut (Figure 11). Differently, none of the other methods 
performed as well, with BLESS Dig clearly setting the lowest efficiency in detecting DSBs. 
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Figure 11 - Comparison between different DSB mapping techniques in mapping breaks at subset of 
validated AsiSI sites. 
Each column represents one AsiSI site, as indicated by the genomic coordinates on top. Yellow sites are cut, 
Black sites are not. BLESS Dig: fragmentation with restriction enzymes. BLESS Cov: fragmentation with 
Covaris. 
 
 
4.1.4 Genome-wide characterization of AsiSI-induced breaks 
Next, we characterized the entire set of the 214 cut sites detected by BLISS and we observed 
that these sites were homogenously distributed along the genome and the coverage of BLISS 
reads was fairly uniform, as it can be inferred by the fact that most of the detected sites had 
similar read coverage (Figure 12). 
These observations suggest that there were no obvious regions in the genome under- or over- 
represented due to sequencing errors or sequence-dependent coverage bias. 
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Figure 12 - Circos plot (http://circos.ca/) showing the AsiSI-induced DSBs detected by BLISS, for each 
chromosome. 
Each dot represents an AsiSI site detected by BLISS, and the circles with different shades of red represent the 
read coverage of BLISS reads in a 200bp window centered around each AsiSI site (bins of read density from 
inner to outer circle: 0-0.25, 0.25-0.5, 0.5-0.75, 0.75-1). 
 
 
To further validate the genome-wide map of AsiSI-induced breaks obtained with BLISS, we 
compared the detected sites with γH2AX ChIP-seq (Iannelli et al. 2017) performed under 
the same experimental conditions. We established a subset of the 100 AsiSI cut sites with 
the highest γH2AX enrichment around the DSB, and we found that 74 of 100 sites were also 
detected by BLISS (Figure 13).  
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Figure 13 - AsiSI cut sites detection by different DSB mapping techniques. 
Bars on the left represent the number of AsiSI sites detected by different techniques: metadata from γH2AX 
ChIP-seq (Aymard et al. 2014a), γH2AX ChIP-seq (Iannelli et al. 2017), DSBCapture (Lensing et al. 2016) 
and BLISS. Vertical bars indicate the number of AsiSI cut sites exclusively detected in each intersection among 
experiments. 
 
 
Analyses of the 26 sites that were not detected by BLISS, but detected by ChIP-seq, showed 
that they might be cut with low efficiency, possibly with little reproducibility among 
biological replicates. In fact, only 4 out of 26 (15%) γH2AX ChIP-seq specific sites were 
detected consistently in literature (Figure 13), while a strikingly higher number of sites 
detected by both BLISS and γH2AX ChIP-seq were confirmed also by other reports (56 out 
of 74, 76%, Figure 13). Extending this analysis to all the 214 sites detected by BLISS, we 
found that 178 sites were next to genes. Active transcription requires an open chromatin state 
that could make AsiSI sites particularly accessible to enzyme, thus cut with higher 
efficiency. Consistently, we noticed that sites detected by both BLISS and γH2AX ChIP-seq 
were the ones next to genes with significantly higher levels of transcription, compared to the 
genes in proximity of a AsiSI site that were detected only by one of the two techniques 
(Figure 14).  
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Figure 14 - Transcripts expression in proximity of AsiSI cut sites detected by BLISS and/or γH2AX 
Chip-seq. 
Boxplot representing the relative expression of transcripts in uninduced overlapping or adjacent (± 2 Kb) to 
the 140 BLISS only sites (blue), to the 74 sites detected by both BLISS and γH2AX ChIP-seq (purple), and to 
the 26 γH2AX ChIP-seq only sites (red).  (* = P<0.05, Wilcoxon test; ** = P<0.01, Wilcoxon test). 
 
 
As an additional control of BLISS reliability in detecting DSBs, I tested whether a subset of 
the sites exclusively detected by BLISS, were reproducibly detected in a biological replicate. 
Indeed, by BLISS-qPCR I found that 4 out of 4 sites that I tested were reproducibly cut, 
albeit with a low fold induction over uninduced samples (Figure 15).  
 
 
 
 
 
 
Figure 15 - BLISS-qPCR on U2OS AsiSI either uninduced or induced at a selected subset of AsiSI sites, 
detected by BLISS sequencing experiment, but not by other techniques. 
Bars represent the normalized ratio of % of input for each site in the Induced sample over the uninduced (n=1). 
 
 
In summary, our analyses indicate that the map of AsiSI-induced breaks generated by BLISS 
is reliable, it can be used as a resource for other research labs for other studies, and it is likely 
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to be the most precise map generated so far for this cell line. The fact that not all genomic 
sequences containing AsiSI sites are not cut according to BLISS is expected, due to different 
degree of accessibility among different genomic regions, and it is in general agreement with 
data available in literature. 
 
4.1.4.1 Multi-layered expression profiling around DSBs mapped by BLISS  
It is well established that DDR activation leads to global transcription alterations, thus 
impacting on multiple pathways, including cell cycle arrest, DNA repair, senescence and 
apoptosis (Riley et al. 2008). More recently, DDR activation has been linked to the local 
regulation of transcription at the damaged regions (Capozzo et al. 2017). As discussed at 
length in the introduction, contrasting observations on the impact of DSBs on transcription 
have been reported.  In particular, a cluster of DSBs has been shown to repress the activity 
of a distal promoter in cis, in an ATM-dependent manner (Shanbhag et al. 2010), while 
another group showed that a single DSBs induces transcription inhibition only at the gene 
bearing the lesion and not at neighboring regions (Pankotai et al. 2012), in a DNA-PKcs 
dependent manner. 
To address the contrasting views on the impact of DNA damage on transcription, in 
collaboration with Dr. Fabio Iannelli, we thought to exploit the precise map of AsiSI 
cleavage sites that we generated by BLISS. We correlated the DSB map with data obtained 
in our lab and in collaboration with other labs, from four different RNA sequencing 
technologies: RNA-seq to study steady-state RNA levels, Bru-seq (Paulsen et al. 2014) to 
study rates of RNA synthesis, Cap analysis gene expression (CAGE, (Shiraki et al. 2003)) 
to study transcription initiation and RNA POLII ChIP-seq to study levels of total and 
elongating polymerase (Iannelli et al. 2017). By monitoring transcriptions at genes with 
AsiSI cut or uncut sites we could observe transcription repression, specifically around AsiSI-
cleavage sites (Figure 16).  
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Figure 16 - Impact of AsiSI cleavage on transcription. 
a. Distribution of the rlog fold change for transcription at genes with AsiSI cut sites (blue) compared to the rest 
of the genes (grey). Genes in proximity to AsiSI cut sites show significant shift towards downregulation 
(P<0.05, Wilcoxon test). b. Distribution of the rlog fold change for transcription at genes with uncut AsiSI 
sites (green) compared to the rest of the genes (grey). Genes in proximity to uncut AsiSI cut sites do not show 
significant shift towards downregulation (P=0.9996, Wilcoxon test).   
 
 
This result was further supported by correlating the data obtained with the other 
transcriptomic analyses, mentioned above, with DSBs position. With this approach, we 
could study, for the first time at genome-wide level and single-nucleotide resolution, the 
impact of DSBs on transcription of endogenous sequences. We could robustly conclude that 
transcription is inhibited around AsiSI-induced DSBs, but not around AsiSI uncut target 
sites, in an ATM-dependent manner, and that transcriptional repression is stronger in 
proximity of the DSBs (Iannelli et al. 2017). 
 
4.1.5 Transient DSBs correlate with LPS-induced macrophages 
activation 
Despite the observation that DSBs induce a local transcriptional repression as reported by 
our lab and others, there is a growing amount of evidence of functional, transient, site-
specific DSBs controlling the activation of transcription programs after exogenous and 
endogenous stimuli, such as hormone stimulation and neuronal activity, as discussed in the 
introduction (2.4.3). Here, scheduled, transient DNA breaks may appear at enhancer or 
promoter regions, possibly inducing chromatin changes, as the accumulation of histone 
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marks favouring transcription (Hartung et al. 2015, Madabhushi et al. 2015, Periyasamy et 
al. 2015, Puc et al. 2015b). 
Macrophages are one of the best studied models for activation of transcriptional programs 
upon environmental stimuli. Indeed, comparative analysis of the transcriptional signature of 
ex vivo macrophages derived from different tissues, revealed a striking diversity among 
them, which is shaped by the presence of different stimuli from the environment of the tissue 
of origin (Lavin et al. 2014). Here, in collaboration with Dr. Valerio Vitelli, a post-doc in our 
lab, we asked whether DSBs could be involved in the activation of macrophages 
proinflammatory response to the recognition of pathogen-produced lipopolysaccharide 
(LPS). The possibility to apply genome-wide high-resolution DSBs mapping techniques was 
key to draw a correlation between DSBs generation and transcription activation.   
We selected a subset of enhancers, which are silent in normal conditions, but trigger the  
production of long non-coding enhancer RNAs (eRNAs) upon LPS stimulation (Ostuni et 
al. 2013). Indeed, all the enhancers tested and their target genes showed a clear induction in 
transcription starting 20 minutes following LPS stimulation (Figure 17a, b).  
 
Figure 17 - Transcription activation following LPS stimulation. 
RAW264.7 macrophages were either untreated or treated with LPS and harvested 5, 20 or 60 minutes after 
induction a. qRT-PCR of RNA with primer pairs against 4 different enhancer regions (indicated on the x-axis 
as E1, E2, E3 and E7) (n≥3). The y-axis represents the fold change over the untreated sample which was set at 
1. b. qRT-PCR performed on the mRNA of the genes under the control of the enhancer analyzed in a BLESS 
signal determined by qPCR on the same region analyzed in a. On the x-axis, the name of the gene is indicated 
and the name of the controlling enhancer is indicated in parenthesis. The y-axis represents the fold change over 
the untreated sample which was set at 1 (n=3). 
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Strikingly, I observed a clear transient DSB formation by BLESS-qPCR, at each of the tested 
enhancers, as early as 5 minutes after LPS stimulation, which were rapidly resolved and 
disappeared after 60 minutes (Figure 18). 
 
Figure 18 - BLESS-qPCR detection of DSBs at the enhancers analyzed in Figure 17. 
RAW264.7 macrophages were either untreated or treated with LPS and fixed 5, 20 or 60 minutes after induction 
(n≥3). 
 
 
The observation that I made in a subset of enhancer was later extended by genome-wide 
mapping of DSBs by BLISS followed by NGS. In collaboration with Dr. Iannelli, we focused 
on the analysis of  BLISS reads in DSBs proximal to the enhancers activated upon LPS 
treatment, as published by Ostuni and colleagues (Ostuni et al. 2013). We observed that upon 
LPS stimulation, there is a 2-fold increase in the number of enhancers containing at least one 
DSBs, as detected by BLISS (Figure 19), showing a significant correlation between LPS 
administration and DSB formation. 
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Figure 19 - BLISS genome-wide detection of DSBs induced at enhancers by LPS 
Bars show the number of enhancer regions containing BLISS reads. BLISS followed by NGS was performed 
on RAW264.7 macrophages either untreated or treated with LPS for 5 minutes. 
 
Thus, these results suggest a new role for DSBs in LPS-induced enhancer activation. In 
particular, LPS might trigger the formation of a transient DSB, which, in turn, can favor 
transcription activation, similarly to what was already observed in other cell types (Hartung 
et al. 2015, Madabhushi et al. 2015, Periyasamy et al. 2015, Puc et al. 2015a). These results 
have set the bases for further investigations to dissect how the DNA damage sensing and 
resolution are linked to the transcriptional activation of enhancer RNAs (Vitelli et al., in 
preparation). 
 
 
4.2 DSB detection by imaging 
While the most commonly used method to map DSBs in a population of cells is ChIP, 
immunofluorescence is commonly applied to detect DSBs in individual cells. Both methods, 
also immunofluorescence relies on antibodies recognizing chromatin modifications 
(γH2AX) or DNA damage markers (such as 53BP1) accumulating in so-called DDR foci. 
As discussed in the introduction section 2.5.3 this may represent a considerable source of 
bias since, since several groups showed or suggested DNA damage accumulation in the 
absence of DDR or, on the opposite, DDR activation in the absence of DNA damage. Despite 
the development of several new tools to detect DSBs genome-wide, at high-resolution, there 
are still some limitations. One is the amount of starting material required by these methods 
(thousands of cells at least) and another, is their relatively low sensitivity: a DSB has to be 
generated in the same position in hundreds of cells to be detectable. This implies that they 
cannot be used to detect randomly distributed DNA damage or with high cell-to-cell 
variability, or to obtain single-cell resolution of damaged genomes. On the other hand, the 
only alternatives to immunofluorescence for DNA damage detection in single-cells are 
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TUNEL, which allows DNA ends labeling with fluorescent nucleotides and detection 
(Shmuel 1992), and COMET assay (Olive et al. 1991). However, both methods have low 
sensitivity and are mostly used to detect massive DNA damage, such as that induced by 
apoptosis.  
Inspired by BLESS strategy to label DSBs, I thought to use the same approach to detect 
DSBs in situ. First, I fixed cells with paraformaldehyde and permeabilized them in order to 
allow enzymes and reagents to enter the cell; then, I performed in situ DNA ends blunting 
by T4 DNA Polymerase (which has both a 3’ overhang resection activity and a 5’ overhang 
fill-in activity), followed by ligation to a biotinylated linker (see Material and Methods, 
section 3.12). Notably, these steps are very similar to the initial steps of BLISS, which was 
independently developed at later time. Having cells with DSBs labeled by biotin on 
coverslips, I thought to use an antibody against biotin to detect DSBs in the cells, by 
canonical immunostaining followed by microscopy. Unluckily, I have not been able to 
obtain a detectable signal (Figure 20), despite inducing several DSBs in the cells (with the 
inducible version of AsiSI, already used for DNA damage mapping experiments), probably 
because the single biotin molecule per DSB is too little abundant to have a robustly 
detectable signal by immunofluorescence. 
 
 
Figure 20 - Immunofluorescence with antibodies against biotin and γH2AX in DNA damaged cells. 
U2OS AsiSI-ER cells, DNA damage is induced by the translocation of AsiSI in the nucleus upon 4-OHT 
treatment. DNA is stained by DAPI. The biotinylated linker has been ligated to exposed DNA ends. 
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To solve this problem of detection, I first thought to amplify the signal using a chain of 
secondary antibodies. After DNA end blunting, ligation and blocking with BSA and cold 
fish gelatin (PBG, see materials and methods, section 3.7), I sequentially incubated cells 
with a primary antibody against biotin (raised in rabbit), a secondary antibody against rabbit 
IgG (raised in donkey) conjugated with Cy5, then an antibody against Cy5 (raised in mouse) 
and finally an antibody against mouse IgG, conjugated with Cy5. However, with this 
strategy, I was only able to detect, by microscopy, a pan-nuclear background in both 
damaged and undamaged cells, even in the absence of the biotinylated linkers, probably due 
to the sum of unspecific binding of the various antibodies (Figure 21). 
 
Figure 21 - Multistep immunofluorescence on U2OS AsiSI-ER cells either uninduced or induced with 
300nM 4-OHT. 
Primary antibody against biotin (raised in rabbit), secondary antibody against rabbit IgG, conjugated with Cy5, 
tertiary antibody against Cy5 (raised in mouse), quaternary antibody against mouse IgG, conjugated with Cy5. 
DNA stained by DAPI. 
 
As an alternative way to enhance the signal, I thought to exploit the Proximity Ligation 
Assay (PLA, see Material and Methods, 3.11) which, through rolling circle amplification 
(RCA), allows high signal amplification (up to 1000-fold) and high sensitivity (Baner et al. 
1998, Larsson et al. 2004, 2010, Ke et al. 2013). By Proximity Ligation Assay, whenever 
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two proteins of interested come in close proximity (~ 40 nm) and are recognized by two 
different primary antibodies, an in situ RCA reaction can take place, producing a fluorescent 
signal, dot shaped, detectable by microscopy. PLA reagents are commercialized as kit by 
Sigma, and this technique has been applied in several studies to study protein-protein 
interaction both in fixed cells and tissues (Söderberg et al. 2006, Jarvius et al. 2007, Gomez 
et al. 2013, Leuchowius et al. 2013, Rassoolzadeh et al. 2015). Moreover, it has been 
modified to work in combination with FISH, to study RNA-protein interaction (Roussis et 
al. 2016) and it has also been used to study DNA:RNA hybrids formation (Petruk et al. 
2016). 
I thought to perform PLA, after the ligation of the biotinylated linker to exposed DNA ends, 
using a primary antibody against biotin and a partner antibody against a marker of DDR 
activation such as γH2AX or 53BP1. With this strategy, that I named “DNA damage in situ 
ligation followed by Proximity Ligation Assay” (DI-PLA), each signal corresponds to at 
least one exposed DNA end of a DSB, in close proximity to a DDR factor (53BP1 or γH2AX 
in most of the following experiments). Importantly, with this strategy, DDR accumulation 
in the absence of an exposed DNA end is not sufficient to generate a signal by DI-PLA. A 
flowchart of DI-PLA is shown in Figure 22. 
Figure 22 - DI-PLA workflow. 
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4.2.1 DI-PLA validation 
4.2.1.1 DI-PLA detection of DSBs induced different DNA damaging sources. 
To validate the efficiency of DSBs detection by DI-PLA, I first tested it on U2OS AsiSI cells 
either uninduced or induced with tamoxifen as I did for DSB mapping experiments by 
BLESS. 
First, I performed immunofluorescence against the DDR factors 53BP1 and γH2AX (Figure 
23) to use as reference for DI-PLA experiment. 
 
Figure 23 - Immunofluorescence for DNA damage markers in U2OS AsiSI cells. 
a. Immunofluorescence for γH2AX and 53BP1 in uninduced (Unind) or induced (Ind) U2OS AsiSI-ER cells. 
DNA stained by DAPI. Scale bars: 10 µm. Quantification are shown in panels b (n=3). 
 
Next, in the same experimental conditions, I performed PLA between γH2AX and 53BP1 
and DI-PLA between biotin and either 53BP1 or γH2AX. As shown in Figure 24, both by 
PLA and DI-PLA, nuclear signals were robustly detected only in induced cells and not in 
control cells. Importantly, the number of dots measured by DI-PLA was very similar 
between the two sets of antibodies and comparable to those obtained by PLA between 53BP1 
and γH2AX. Additionally, PLA and DI-PLA signals were similar in number to those 
obtained by immunofluorescence for the individual DDR markers. 
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Figure 24 - DSBs generated by AsiSI are detected by DI-PLA in fixed cells. 
a. PLA between ɣH2AX and 53BP1 or DI-PLA between 53BP1 and biotin or ɣH2AX and biotin, in uninduced 
(Unind) or induced (Ind) U2OS AsiSI-ER cells (DNA stained by DAPI). Scale bars: 10µm. Quantifications 
are shown in panel b (n≥3).  
 
I reasoned that AsiSI-induced DSBs are particularly “clean”, having all the same structure, 
with 2 protruding nucleotides, thus they are a very suitable substrate to DNA ends blunting 
and ligation reactions. However, most of the DSBs induced by endogenous stimuli or 
exogenous genotoxic agents are likely to have complex and heterogenous structures. Thus, 
I tested the robustness of DI-PLA in detecting DSBs generated by different genotoxic 
treatments, producing a plethora of different DNA breaks, including DSBs, likely to have 
heterogenous end structures. For this test, I used human BJ fibroblasts untreated or fixed 1 
hour after exposure to ionizing radiations (IR), and I first performed immunofluorescence 
(Figure 25) for γH2AX and 53BP1, that I later compared with PLA performed between 
53BP1 and γH2AX, and DI-PLA using antibodies against biotin and either 53BP1 or γH2AX 
(Figure 26).  
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Figure 25 - Immunofluorescence for DDR markers in Irradiated cells. 
a. Immunofluorescence for 53BP1 and ɣH2AX in BJ cells either untreated or irradiated with IR 2Gy and fixed 
1 hour after treatment. DNA stained by DAPI. Scale bars: 10 µm. Quantifications are shown in panels b, c 
(n=3). 
 
 
Figure 26 - DI-PLA detects IR-induced DSBs. 
a. PLA between ɣH2AX and 53BP1 or DI-PLA between 53BP1 and biotin or ɣH2AX and biotin, in not 
irradiated (No IR) or irradiated (IR) BJ fibroblasts. DNA stained by DAPI. Scale bars: 10µm. Quantifications 
are shown in panel b (n=3). 
 
 
As expected, I observed DDR foci formation specifically in irradiated cells by 
immunofluorescence, which were recapitulated by PLA signals detectable only in the 
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damaged cells. Strikingly, also by DI-PLA I detected signals specifically in the nucleus of 
irradiated cells, with an efficiency comparable to PLA between 53BP1 and γH2AX and 
quantitatively similar to the number of foci measured by IF for 53BP1 or γH2AX. 
 
As an additional proof of the robustness of DI-PLA in efficiently detecting heterogenous 
DSBs, I performed a similar experiment to the one described above, using BJ cells either 
untreated or treated for 20 minutes with the radiomimetic drug neocarzinostatin (NCS). 
Also in this case, I observed similar efficiency in DSB detection between 
immunofluorescence (Figure 27), PLA between γH2AX and 53BP1 and DI-PLA between 
biotin and 53BP1 (Figure 28). 
 
Figure 27 - Immunofluorescence for DDR marker in NCS treated cells. 
a. Immunofluorescence for 53BP1 in BJ cells either untreated or treated for 20 minutes with neocarzinostatin 
(NCS, 50ng/mL). DNA stained by DAPI. Scale bars: 10 µm. Quantifications are shown in panel b (n=2). 
 
 
Figure 28 - DI-PLA detects NCS-induced DSBs. 
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a. PLA between ɣH2AX and 53BP1 or DI-PLA between 53BP1 and biotin on untreated or NCS treated BJ 
fibroblasts. DNA stained by DAPI. Scale bars: 10µm. Quantifications are shown in panel b (n=3). 
 
Although ionizing radiations and radiomimetic drugs are known to induce DSBs with 
complex end structures, which might lower the efficiency of DNA ends blunting by T4 DNA 
polymerase, thus reducing DI-PLA signals, in practice I consistently observed similar results 
with IF, PLA and DI-PLA in all the conditions I tested. Taken together, these results indicate 
that DI-PLA reliably detects DSBs generated by different sources, in proximity to an 
activated DDR marker. 
 
4.2.1.2 DI-PLA signals specificity 
To exclude the contribution of antibody binding to unspecific targets that could lead to false 
positive DI-PLA signals, I repeated DI-PLA on BJ cells fixed 1 hour after irradiation, using 
linkers not bearing the biotin. As shown in Figure 27, I could clearly observe the lack of any 
detectable signal by microscopy. 
 
Figure 29 - In the absence of the biotinylated linker DI-PLA does not generate any signal. 
a. DI-PLA between ɣH2AX and biotin in BJ cells either not irradiated (No IR) or irradiated (IR) as in Figure 
24, in the presence of a non-biotinylated linker. DNA stained by DAPI. Scale bars: 20µm. Quantifications are 
shown in panel b (n=2). 
 
 
Another variability that could lead to misinterpretation of DI-PLA data is due to the biotin 
partner antibodies recognizing DDR factors that are not detectable in the absence of DNA 
damage. In other words, I asked whether DI-PLA signals increased in DNA damaged cells, 
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only because they reflect an increase in the DDR markers used as a partner for biotin, rather 
than the presence of DDR markers in physical proximity of biotin-labeled DSBs. To address 
this point, I used an antibody against a chromatin component that is unchanged upon DNA 
damage induction. Thus, I first performed immunofluorescence for the histone H4 on fixed 
BJ cells either untreated or irradiated (Figure 30). 
 
Figure 30 - H4 levels do not change upon IR. 
Immunofluorescence for histone H4 in BJ fibroblasts, untreated (-IR) or irradiated (IR) with ionizing radiation 
(2Gy). DNA stained by DAPI. Scale bars: 10µm. 
 
As expected, the antibody against H4 produced a pan-nuclear staining, that was unchanged 
upon irradiation. Next, I performed DI-PLA between H4 and biotin, under the same 
experimental conditions. I observed a low background in untreated cells, and a clear increase 
of nuclear signals in irradiated cells, similarly to PLA between H4 and γH2AX (Figure 31). 
 
Figure 31 - DI-PLA signals are dependent on biotin-labeled DSBs in proximity to a partner target 
protein. 
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a. PLA between γH2AX and H4, and DI-PLA between H4 and biotin, Not Irradiated (-IR) or irradiated (IR) 
BJ fibroblasts. DNA stained by DAPI. Scale bars: 10µm. Quantifications are shown in panel b (n=2). 
 
 
This result indicates that DI-PLA signals are dependent on biotin-labeled DSBs in proximity 
to a partner target protein. It also suggests the possibility to use DI-PLA to probe for the 
presence of DSBs in particular genomic regions that could be characterized by specific 
chromatin components, such as centromeres or telomeres. 
 
As additional technical control, I asked whether DI-PLA is specific for the distance between 
biotin and its partner target: I wanted to prove that biotin and the partner protein must be 
physically close to produce a signal. To answer this question, I performed DI-PLA on 
irradiated U2OS cells using antibodies against biotin and cyclin A, a protein commonly used 
as marker of cell cycle phase, which is not recruited at DSBs. To avoid any cell cycle 
variation (that would result in altered level of Cyclin A), I irradiated BJ fibroblasts (in 
exponential growth phase) and fixed cells only 15 minutes after IR. As shown in figure 30, 
I could only observe a low background by DI-PLA between biotin and Cyclin A in both 
untreated and irradiated cells (Figure 32). 
 
 
 
 
 
 
Figure 32 - The partner target protein must be in close proximity to biotin to generate a signal by DI-
PLA. 
Quantifications of dots per nucleus detected by DI-PLA using antibodies against biotin and Cyclin A on BJ 
not irradiated or irradiated with 2Gy and fixed 15 minutes after IR (n=2). 
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This result is an additional proof that the antibody that is paired with the anti-biotin one must 
be specific for a protein present at the DSBs.  
To further test DI-PLA specificity I asked whether the number of signals could be correlated 
to the dose of DSBs generated in the cell. To investigate this matter, I irradiated BJ cells 
with different doses of ionizing radiation, fixed and stained them for immunofluorescence 
for DDR markers (Figure 33) or PLA between γH2AX and DI-PLA between biotin and 
γH2AX (Figure 34). 
 
 
 
 
 
 
 
 
Figure 33 - Immunofluorescence for DDR marker in cells exposed to various doses of IR. 
Quantifications of foci per nucleus detected by immunofluorescence using antibodies against γH2AX and 
53BP1 on BJ not irradiated or irradiated at different doses and fixed at the indicated time points after irradiation 
(n=2). 
 
 
 
 
 
 
 
 
 
 
Figure 34 - DIPLA signals depend on the amount of DSBs in the cell. 
Quantifications of dots per nucleus generated by PLA using antibodies against γH2AX and 53BP1 or DI-PLA 
using antibodies against biotin and γH2AX on BJ not irradiated or irradiated at different doses and fixed at the 
indicated time points after irradiation (n=2). 
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By DI-PLA I observed a higher number of nuclear signals 15 minutes after IR (Figure 34), 
compared to 1 hour after IR, while, increasing IR dose from 2.5 Gy to 5 Gy resulted in a 1.5-
fold increase in DI-PLA signals, consistently to what I observed by PLA and IF for DDR 
markers (Figure 33).  
 
To further test DI-PLA sensitivity to the number of DSBs present in the cell, I performed an 
in vitro ligation experiment. I induced U2OS AsiSI cells with tamoxifen, then I fixed with 
PFA, permeabilized the cells and performed DNA ends blunting and ligation (as the 
described for DI-PLA), in the absence of any linker: this step should lead to in vitro ligation 
of the available DNA ends. Next, I performed DI-PLA (blunting, ligation with biotinylated 
linkers and PLA between γH2AX and biotin) and compared with canonical DI-PLA on 
uninduced U2OS AsiSI cells and induced U2OS AsiSI cells (Figure 35). 
Figure 35 - DI-PLA signals depend on the presence of physical DSBs. 
a. DI-PLA between γH2AX and biotin on Uninduced, Induced or Induced in vitro Ligated U2OS AsiSI cells. 
DNA stained by DAPI. Quantifications are shown in panel b (n=1). 
 
 
I could clearly observe, that in vitro ligated - induced AsiSI displayed nearly the same very 
low number of DI-PLA signals as uninduced cells. 
This result, together with the experiments with different IR doses, indicates that the number 
of DI-PLA signals per nucleus directly depends on the amount of DSBs in the cell.  Next, I 
asked whether DI-PLA signals were also spatially specific for DSBs positions. 
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The easiest way to address this question would be to analyze the co-localization of DI-PLA 
signals with a DDR marker; this could be achieved using an antibody against a DDR factor, 
different from the one used as the partner of biotin, which could be detected by 
immunofluorescence, and then analyze the co-colocalization between the IF signal and DI-
PLA. However, this experiment is not simple to perform due to the requirement of having 3 
different antibodies raised in 3 different species, with good specificity against their target 
proteins. Instead, I took advantage of a cell line expressing the DDR marker NBS1 fused to 
GFP, to achieve direct visualization of the sites of NBS1 recruitment. I induced DNA 
damage by laser micro-irradiation, then I fixed cells and performed DI-PLA between biotin 
and γH2AX. As expected, I could clearly observe the sub-cellular recruitment of NBS1 at 
the site of damage, resulting in bright stripes. As it is shown in Figure 36, I observed almost 
80% of DI-PLA signals colocalizing with the NBS1-GFP stripes, clearly indicating a good 
specificity of DI-PLA signals. 
 
  
 
 
 
 
Figure 36 - DI-PLA signals co-localize with DDR marker. 
a. DI-PLA for γH2AX and biotin in U2OS NBS1-GFP laser irradiated. GFP is in yellow, DI-PLA signal is 
magenta. DNA stained by DAPI. Quantifications are shown in panel b (250 cells scored). 
 
 
Collectively, these experiments show that DI-PLA produces detectable signals only in the 
presence of labeled DSBs in close proximity to the partner factor. Moreover, DI-PLA signals 
are dependent on the amount of DSBs in the cell and specific for the sub-cellular localization 
of the DSBs. 
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4.2.1.3 DI-PLA is suitable to detect DSBs in tissue sections 
Having validated the specificity of DI-PLA in detecting DSBs in fixed cells, I asked whether 
this technique could also be used to investigate DSBs presence in fixed tissue sections. PLA 
had already been applied in studies on both formalin fixed paraffin embedded (FFPE) and 
fixed frozen tissues, with minimal modifications to the standard protocol (Leuchowius et al. 
2013b, Spears et al. 2012). I used fixed frozen kidney sections from not irradiated and 
irradiated mice, which I first stained with an antibody against γH2AX by 
immunofluorescence (Figure 37), and later compared with PLA between γH2AX and 53BP1 
and DI-PLA between biotin and γH2AX (Figure 38), without selecting for the cell types. 
 
 
 
 
 
 
 
 
Figure 37 - Immunofluorescence for γH2AX in mouse tissue sections. 
a. Immunofluorescence for ɣH2AX in kidney sections from not irradiated (No IR) or irradiated (IR) with 5Gy 
TBI and sacrificed 6h after IR. DNA stained by DAPI. Scale bars: 5µm. Quantifications are shown in panel b 
(n=2). 
 
Figure 38 - DIPLA detects DSBs in irradiated mouse tissue sections. 
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a. DSBs generated by IR are detected by DI-PLA in tissue sections derived from mice. PLA between ɣH2AX 
and 53BP1 or DI-PLA between ɣH2AX and biotin, in kidney sections from not irradiated (No IR) or irradiated 
(IR) mice (DNA stained by DAPI). Scale bars: 5µm. Quantifications are shown in panel b (n=3). 
 
 
I detected nuclear signals by DI-PLA between biotin and γH2AX only in tissue sections 
from the irradiated mice, with an efficiency similar to both PLA between 53BP1 and γH2AX 
and IF for γH2AX, although I occasionally observed unequal staining of the tissue sections, 
possibly due to the critical thickness of the sections or partial drying of the reaction mixes. 
Moreover, using the non-biotinylated version of the linker, DI-PLA between biotin and 
γH2AX did not generate any detectable signal (Figure 39), proving the specificity of DI-
PLA signal. 
 
Figure 39 - DSBs are detectable by DI-PLA in tissue sections only in the presence of the biotinylated 
linker. 
a. DI-PLA between ɣH2AX and biotin, in kidney sections from not irradiated (No IR) or irradiated (IR) mice, 
using a non-biotinylated linker. DNA stained by DAPI. Quantifications are shown in panel b (n=2). 
 
 
In summary, these results show the feasibility of DI-PLA on fixed frozen tissue sections; 
instead, I was not able to obtain an efficient staining by DI-PLA of FFPE tissue sections 
(data not shown). 
 
4.3 Senescent cells accumulate persistent DSBs 
When cells are unable to repair DSBs, the unrepaired DNA damage can lead to persistent 
DDR activation, enforcing a permanent cell-cycle arrest termed cellular senescence (d’Adda 
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di Fagagna 2008). As discussed in the introduction (section 2.6), senescent cells display 
persistent DDR foci that are necessary to fuel damage-induced senescence (Rodier et al. 
2011). Previously, our lab and others, have proposed that these are persistent DNA lesions 
in the form of DSBs that resist cell repair activities (Fumagalli et al. 2012, Hewitt et al. 
2012). However, others have proposed that such structures might not be sites of damaged 
DNA per se, but instead stable chromatin alterations resulting from damage (without an 
underlying lesion), which are necessary to reinforce senescence (DNA-SCARS) (Rodier et 
al. 2011). So far, whether the persistent DDR foci present in senescent cells correspond to 
physical DSBs or not has been an open question. However, having previously demonstrated 
the possibility to detect DSBs in the proximity of an activated DDR marker by DI-PLA, I 
could finally try to address this matter. Thus, I generated two types of senescent cells and 
studied them with DI-PLA. 
 
4.3.1.1 Replicative senescent cells display persistent DSBs 
First, I compared early with late passage BJ cells: it is well known that late passage 
fibroblasts undergo replicative senescence, as the result of critically short telomeres that 
activate a local DDR (Bodnar et al. 1998). Here, I compared fibroblasts at population 
doubling 30-32 with fibroblasts at population doubling 62-66, that were in senescent state 
as indicated by senescence-associated β-galactosidase (β-gal) activity (Figure 40) and 
reduced 5-bromodeoxyuridine (BrdU) incorporation (Figure 41).  
 
 
 
 
 
 
Figure 40 - Quantification of β-gal positive cells. 
Early passage (PD 30-32) and late passage (PD 62-66) were compared with the β-gal assay (n=3). 
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Figure 41 - Quantification of BrdU-positive nuclei. 
Early passage (PD 30-32) and late passage (PD 62-66) were incubated for 6h with 5-bromodeoxyuridine, then 
fixed and stained for BrdU under DNA denaturation condition (Material and methods) (n=3). 
 
. 
As expected, most (~ 85%) of late passage BJ cells displayed DDR foci, with a mean of 5 
foci per nucleus as determined by immunofluorescent against 53BP1 and γH2AX (Figure 
42).  
 
 
 
 
 
 
 
 
 
 
 
 
Figure 42 - Immunofluorescence for DDR markers in replicative senescent cells. 
a. Immunofluorescence for the DDR markers 53BP1 and γH2AX in late passage BJ cells (PD62-66). DNA 
stained by DAPI. Quantifications in panels b-e (n=3). 
 
 
Then, on the same cells that I stained by IF, I performed PLA between 53BP1 and γH2AX. 
Here, consistently with IF results, I observed the accumulation of nuclear dots in about 65% 
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of nuclei of the senescent cells, with a mean of 5 dots per nucleus; instead, PLA signals could 
be detected only in a small fraction (20%) of early passage cells, with a mean of 2 dots per 
nucleus (Figure 43). 
Having quantitatively established the presence of persistent DDR activation in replicative 
senescent cells, in agreement with published data, I next tested for the presence of DSBs at 
the DDR foci by DI-PLA. Strikingly, DI-PLA between biotin and either 53BP1 or γH2AX, 
generated a 3-fold increase in average dots per nucleus upon senescence, increasing from 2 
in early passage cells to 6 (Figure 43). Overall, I observed that almost 60% of the senescent 
cells displayed DI-PLA signals, while I could detect nuclear dots in only 20% of the early 
passage cells (Figure 43). 
 
Figure 43 - Replicative senescent cells display unrepaired DSBs as detected by DI-PLA. 
a. PLA between ɣH2AX and 53BP1, and DI-PLA between 53BP1 and biotin or ɣH2AX and biotin in early 
passage (Early p.) and senescent (late passage – Late p.) BJ cells. DNA stained by DAPI. Scale bars: 10µm. 
Quantifications are shown in panels b,c (n≥3). 
 
 
Thus, the consistency of results between DI-PLA, PLA and IF experiments indicate that the 
persistent DDR foci that enforce cellular senescence correspond to physical DSBs. 
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4.3.1.2 Irradiation-induced senescent cells display persistent DSBs 
To strengthen my observations, I tested whether senescent cells obtained after exposure to a 
high dose of IR, also displayed persistent DSBs. As previously reported (Fumagalli et al. 
2012), BJ hTERT cells (that are immortalized, thus do not undergo telomere erosion and 
replicative senescence) showed all features of senescent cells 4 weeks after high-dose IR, 
including β-gal activity (Figure 44), reduced BrdU incorporation (Figure 45) and persistent 
DDR foci as visualized by IF for 53BP1 and γH2AX (Figure 46), differently from control 
cells that were not irradiated, but kept in culture for 28 days and underwent quiescence due 
to contact inhibition.  
 
 
 
 
 
 
Figure 44 - Quantification of β-gal positive cells. 
BJ hTERT cells that were kept in culture for 28 days (CTRL) were compared with BJ hTERT senescent 
irradiated cells (n=3). 
 
 
 
 
 
 
 
Figure 45 - Quantification of BrdU-positive nuclei. 
Quiescent cells do not show BrdU incorporation since they are unable to proliferate due to contact inhibition; 
however, once re-plated at a lower concentration they are able to restore growth, as indicated by BrdU 
incorporation. Differently, senescent cells are unable to proliferate, even after re-plating at a lower 
concentration, as shown by BrdU incorporation rates (n=3). 
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Figure 46 – Immunofluorescence for DDR markers in IR-induced senescent cells. 
a. immunofluorescence for the DDR markers 53BP1 and γH2AX in senescent irradiated BJ hTERT cells. DNA 
stained by DAPI. Quantifications in panels b-e (n=3). 
 
 
Under the same experimental conditions, I performed PLA between 53BP1 and γH2AX and 
observed that almost 60% of the senescent cells displayed PLA signals with a mean of 5 dots 
per nucleus, while only 25% of untreated cells were positive for PLA signals, with a mean 
of 2 dots per nucleus (Figure 47). I also observed similar results with DI-PLA between biotin 
and either γH2AX or 53BP1, with nearly 3 times more DI-PLA signals in senescent 
compared to quiescent cells, consistently with the results obtained with the other techniques 
(Figure 46). 
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Figure 47 - DI-PLA detects persistent DSBs in IR-induced senescent cells. 
a. PLA between ɣH2AX and 53BP1 or DI-PLA between 53BP1 and biotin or ɣH2AX and biotin, in Quiescent 
(Quie) or IR-induced senescent (Sen) BJ hTERT fibroblasts. DNA stained by DAPI. Scale bars: 10µm. 
Quantifications are shown in panels b,c (n≥3). 
 
 
Altogether, these results, consistent for IF with individual DDR markers, PLA between the 
53BP1 and γH2AX and DI-PLA, in both types of senescent cells analyzed, strongly indicate 
that the persistent DDR foci correspond to physical DSBs. 
 
4.3.1.3 Tissues from aged animals accumulate persistent DSBs 
As discussed in the introduction (section 2.6), cellular senescence has also been strongly 
linked to in vivo ageing. Consistently with the observations generated in cell culture, also in 
vivo ageing tissues show accumulation of persistent DDR foci (Fumagalli et al. 2012, López-
Otín et al. 2013, White et al. 2015) 
Here, having already shown that senescent cells accumulate persistent DSBs, I asked 
whether the DDR signals that accumulate in aged tissues also correspond to physical DSBs. 
I first performed PLA between 53BP1 and γH2AX on frontal cortex brain tissue sections 
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from adult mice (12-14 months old) and old mice (22-24 months); in agreement with data 
previously reported in literature (Sedelnikova et al. 2004), in the cells of aged tissues I 
observed a mean of 2 dots per nucleus, with about 50% of the cells displaying at least 1 PLA 
signal (Figure 48). I did not perform any selection on the cell types used for analyses.  
 
Figure 48 - Aged mammalian tissues display unrepaired DSBs as detected by DI-PLA. 
a. PLA between ɣH2AX and 53BP1 or DI-PLA between ɣH2AX and biotin in brain sections from adult (12-
14 months) or old (22-24 months) mice (DNA stained by DAPI). Scale bars: 5µm. Quantifications are shown 
in panels b,c (n=3). 
 
 
Consistently, DI-PLA between biotin and γH2AX generated nearly 10 times more signals in 
frontal cortex sections from old mice (22-24 months) compared to adult mice (12-14 months 
old), with a mean of 2 DI-PLA dots per nucleus (Figure 48). 
To strengthen the results, I extended these analyses to liver sections of the same aged mice 
and, consistently with the aforementioned results, I measured a statistically significant 
increase with ageing in the number of signals generated either by PLA between γH2AX and 
53BP1 or DI-PLA between biotin and γH2AX, although the absolute numbers of dots per 
nucleus were overall lower than in the brain (Figure 49). 
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Figure 49 - Aged mice liver accumulate persistent DSBs, detectable by DI-PLA. 
a. PLA between ɣH2AX and 53BP1 or DI-PLA between ɣH2AX and biotin, in liver sections from adult (12-
14 months) or old (22-24 months) mice. DNA stained by DAPI. Scale bars: 5µm. Quantifications are shown 
in panels b,c (n=3). 
 
 
Overall, the consistent results between PLA and DI-PLA indicate that, in also aged 
mammalian tissues accumulate senescent cells displaying persistent DSBs. 
4.4 Genome-wide accumulation of persistent DSBs 
Having demonstrated that persistent DSBs accumulate in senescent cells and tissues, I 
planned to investigate whether there is any preferential genomic location for the 
accumulation of DNA damage. It has been proven that telomeric sequences accumulate 
DNA damage in senescent cells (Fumagalli et al. 2012, Hewitt et al. 2012); however, in the 
same reports, other regions accumulating γH2AX in senescent cells were observed. Most 
importantly, the recently developed genome-wide DSBs mapping techniques have never 
been applied to senescent cells, so I felt that further investigation might reveal new genomic 
regions accumulating DSBs. 
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I therefore exposed BJ hTERT cells to a high dose of IR (20Gy). I fixed cells at five different 
time points after IR: immediately after IR (also called 0 minutes), 60 minutes, 24 hours, 7 
days, and 28 days. The last time point was the same at which I validated the presence of 
persistent DSBs by DI-PLA. As control, I used quiescent BJ hTERT cells that were not 
irradiated but were kept in culture for 28 days in parallel with the irradiated cells. After cell 
fixation, I performed BLISS followed by NGS. With this strategy, I aimed to discriminate 
regions that are repaired quickly after IR and regions that instead accumulate hard-to-repair 
DSBs till later time points. 
In collaboration with our bioinformatician Dr. Iannelli, we, unexpectedly, observed a wide-
spread background BLISS signal in not irradiated cells, which represented a problem when 
trying to infer IR-induced DSBs. Differently from the applications of BLISS that I described 
in previous paragraphs, here we had to call DSBs de novo or, in other words, without a priori 
knowledge of the genomic region where we expected DSB to form. Thus, in order to analyze 
BLISS data in this particular setting, we set up a collaboration between our group and the 
one of Prof. Pattini at Politecnico di Milano. I was involved in the development of an 
algorithm able to identify DSBs in genomic regions of user-defined length (2kbp windows 
in our analysis) on a genome-wide scale, by processing and analyzing the sequencing output 
data obtained with BLISS. With this algorithm (see methods, section 3.22), we obtained, for 
each time point, a list of peaks having significant p-values, representing genomic windows 
more enriched for reads in the irradiated sample than in the normalized not irradiated control, 
that we called DSBs. We detected a decreasing number of DSBs at later time points after 
irradiation (Figure 50a), and we were able to identify 67 DSB sites (defined as 2kbp 
window), shared between all the time points, excluding repetitive sequences (Figure 50b). 
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Figure 50 - Genome-wide DSBs accumulation in IR exposed cells, detected by BLISS. 
a. DSBs detected by BLISS in BJ hTERT cells exposed to 20Gy IR and fixed at the indicated time point: 0 
minutes (immediately after irradiation), 60 minutes, 24 hours, 7 days, 28 days. b. Shared DSBs among different 
time points. “Hard to Repair” DSBs are shared among all time points. c. Representation of the genomic location 
of the “Hard to Repair” DSBs, indicated in green. 
 
 
To validate these results, I performed a biological replicate followed by BLISS-qPCR on a 
selected number of sites, comparing quiescent cells with irradiation-induced senescent cells. 
As shown in Figure 51, I could only observe a partial reproducibility of the expected “hard 
to repair” sites. In particular, I observed inconsistencies between 2 primer couples matching 
different sub-regions of the 2kb window detected by our pipeline.  
 
 
 
 
 
 
 
 
 
Figure 51 - BLISS-qPCR in IR-induced cells at selected “Hard to repair” sites. 
BLISS-qPCR on BJ hTERT cells Quiescent or irradiation-induced senescent (Sen) at different “Hard to repair” 
sites: .1 or .2 indicate different primer couples in the same 2kb window detected by BLISS sequencing. Bars 
represent the normalized ratio of % of input for each site in the Induced sample over the Uninduced one. Error 
bars represent the s.e.m. of 2 replicates. 
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The inconsistency between BLISS sequencing analysis and BLISS-qPCR could be due to 
several reasons. First and foremost, it is likely that I was not able to saturate the genome with 
DSBs when exposing cells to 20 Gy: as further discussed in the Discussion section 5.6, this 
could result in potentially “hard to repair” regions to never be damaged or damaged in a 
fraction of cells too low to become detectable by BLISS when cells are pooled. This would 
also explain the inconsistency of detection between biological replicates. Of course, we 
cannot rule out the possibility that the pipeline used to analyze BLISS results, is immune 
from false positive results. In fact, differently from other cases, where we just focused our 
analysis on selected small regions, and we could simply measure their coverage, in this case 
we had to develop a pipeline ad hoc to identify DSBs (peaks) de novo on the whole genome. 
In particular, as a proof of principle we tested this pipeline on the AsiSI induced DSBs and 
we found that the results did not completely overlap (data not shown).  Another possibility 
is that, except for telomers, there are no conserved genomic regions for the accumulation of 
persistent DSBs in irradiation-induced senescent cells. Before further investigations, I will 
carry out another round of BLISS followed by NGS on a biological replicate of the first 
experiment.  
 
4.4.1.1 DSBs accumulate at telomeres in senescent cells 
When we performed BLISS analyses, we excluded repetitive sequences, including 
telomeres, since it would have been impossible to precisely align BLISS reads in those 
regions, thus our normalization pipeline that counts the number of reads in each 2kb window 
would not work properly. Moreover, due to their long stretches of repeated sequences, 
telomeres are prone to sequencing errors. However, it was already known, from data reported 
in literature by our group and others (Fumagalli et al. 2012, Hewitt et al. 2012) that senescent 
cells accumulate persistent DDR foci at telomeres (see introduction section 2.6.1), thus I 
expected to capture telomeric sequences by BLISS in senescent cells. Applying BLISS-
qPCR to detect telomeres was also challenging, due to do primer dimers formation or 
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artefactual amplifications generated when using primers matching the telomeric repeats. 
However, Cawthon and colleagues (Cawthon 2009) described a strategy to generate fixed 
length amplicons with telomeric primers containing mismatches, that allow telomere 
quantification by qPCR. Thus, I used these telomeric primers, to perform BLISS-qPCR on 
quiescent and senescent cells (BJ hTERT fixed 28 days after IR). Although Cawthon and 
colleagues developed this strategy to quantify telomere length, here I performed the qPCR 
on fragmented DNA (where each sample has the same fragment size distribution), so any 
difference measured by qPCR will be due to a different copy number in telomeres captured 
by BLISS. Importantly, though, I normalized the BLISS enriched material on the input using 
different primers, matching a unique genomic locus (in the actin gene body, in this case), 
since if I used telomeric primers also on the input, the qPCR readout would be dependent 
not only on the starting material, but also on the telomere length in each sample. 
In agreement with data reported in the literature, I observed an increase in captured telomeric 
regions in senescent cells, compared to quiescent (Figure 52). This value and the background 
signal obtained in quiescent cells was consistent with the observations reported by Crosetto 
and colleagues who detected telomeric reads when performing BLESS and BLISS (Crosetto 
et al. 2013b, Yan et al. 2017). 
 
 
 
 
 
 
 
Figure 52 - BLISS-qPCR on Quiescent or irradiation-induced senescent BJ hTERT after 28 day. 
BLISS-qPCR was performed on BJ cells either quiescent (Quie) or fixed IR-induced (Sen) after irradiation. 
Bars represent the % of input for the telomeric primers in each sample (n=2). 
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To further confirm this result, I performed DI-PLA on the same cells, using an antibody 
against biotin and a partner antibody against the shelterin protein TRF2, that was observed 
to be retained at damaged telomeres in IR-induced senescent cells (Fumagalli et al. 2012) 
(Figure 53). 
 
Figure 53 - DI-PLA detects DSBs at telomere in IR-induced senescent cells. 
a. DI-PLA between TRF2 and biotin on quiescent or irradiation-induced senescent BJ hTERT. Quantifications 
are shown in panel b (n=2). 
 
I could clearly observe an increased number of signals in senescent cells compared to 
quiescent, with almost 6-times more positive cells compared to quiescent cells. 
The observation that both by DI-PLA and BLISS, I could observe a lower signal in control 
cells with intact telomeres, compared to irradiated cells is particularly interesting. In fact, it 
suggests that ligation of the biotinylated linkers is inefficient when telomeres are protected 
by shelterin proteins. Thus, I thought to exploit this feature to use DI-PLA and BLESS as 
assays for the telomeric state. 
 
4.4.2  DI-PLA and BLESS can detect dysfunctional telomeres 
4.4.2.1 DI-PLA detect uncapped telomeres 
Having observed that linkers are not efficiently ligated at functional telomeres, I thought to 
test the feasibility of using DI-PLA as an assay to probe for telomeres state. I already 
demonstrated by DI-PLA between TRF2 and biotin that I could detect whether a telomeric 
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sequence carries a DSB (Figure 53). However, I was interested to test whether I could also 
use DI-PLA to discriminate between a telomere with a functional shelterin cap and a 
dysfunctional telomere that has lost the shelterin proteins and its capped state. Although T-
loops were first observed in vitro almost 20 years ago (Griffith et al. 1999), their detection 
in situ has not been possible until recently (Doksani et al. 2013). However, even if possible, 
T-loop detection in situ requires super-resolution microscopy, thus an assay based on a more 
accessible technique, would prove valuable for many research laboratories. 
To test the feasibility of a DI-PLA based assay to detect uncapped telomeres, I took 
advantage of Trf2 conditional knockout mouse embryonic fibroblasts (Trf2F/F MEFs) 
carrying a Cre-recombinase (Rosa26-CreERT2) inducible by 4OHT and constitutively 
expressing the fusion protein TRF1-GFP (Rossiello et al. 2017). Recombination by Cre 
robustly induced telomere deprotection and DDR activation at telomeres in the Trf2F/F cell 
line (Okamoto et al. 2013). Thus, in this cell line, telomeres are detectable by GFP imaging, 
and telomere uncapping can be induced by adding 4-OHT in cell culture medium.  
I performed PLA between γH2AX and GFP (labeling the telomeres) and DI-PLA between 
biotin and GFP, on uninduced and induced MEFs Trf2F/F TRF1-GFP (Figure 54). As 
expected, by performing PLA between γH2AX and GFP, I observed an increased number of 
signals in induced cells, due to DDR activation at uncapped telomeres. Strikingly, I could 
observe the same trend with DI-PLA between biotin and GFP, indicating that the uncapped 
telomeres are efficiently labeled by the biotinylated linkers, differently from the protected 
telomeres. 
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Figure 54 - DI-PLA specifically detects only uncapped telomeres. 
a. PLA between ɣH2AX and GFP and b. DI-PLA between GFP and biotin MEF Trf2F/F either uninduced or 
induced. TRF1-GFP in green. DNA stained by DAPI. Quantifications are shown in panels c (n=3). 
 
This intriguing result shows that DI-PLA can be adapted to detect dysfunctional telomeres: 
either damaged or intact and uncapped. 
 
4.4.2.2 BLESS distinguishes between capped, uncapped and broken telomeres 
Based on the observations generated with DI-PLA, I thought to extend the assay to BLESS. 
Since the technique is based on the same DSB labeling approach by DI-PLA, I expected to 
measure by BLESS-qPCR an enrichment for telomeric sequences also in the presence of 
uncapped telomeres. 
To first test this hypothesis, I performed BLESS-qPCR with the same telomeric primers used 
to generate Figure 52, under several conditions: MEFs TRF Trf2F/F either uninduced, as 
control, or induced with 4OHT for 48h, leading to the telomere uncapping; as positive 
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control I also used MEFs transfected with a vector coding for the fusion protein TRF1-FokI 
(Doksani & de Lange 2016) to induce DSBs at telomeres, which I compared with MEF 
transfected with the same vector coding for the nuclease-dead version of the fusion protein 
TRF1-FokID405A, to exclude any effect of TRF1 overexpression on telomere detection. As 
expected, I could observe γH2AX foci by immunofluorescence in induced Trf2F/F MEF and 
in MEF transfected with TRF1-FokI, but not in uninduced cells or in MEFs transfected with 
the nuclease-dead version of FokI (Figure 55). 
 
 
 
 
 
Figure 55 - Induction of telomere uncapping or DSB at telomeres induces DDR activation. 
a. Quantification of immunofluorescence for γH2AX in TRF2F/F MEFs either uninduced or induced with 4-
OHT for 48h. b. Quantification of immunofluorescence for γH2AX in MEFs either transfected with a vector 
coding for TRF1-FokI or the nuclease-dead version TRF1-FokI D405A (n=3). 
 
 
Once I validated the experimental conditions, I performed BLESS-qPCR in the same setup 
described above. To detect telomeres in BLESS captured material, I performed qPCR with 
the telomeric primers used to generate Figure 52. As shown in Figure 56, I could observe a 
higher telomeric content in samples containing either uncapped or DSB bearing telomeres, 
compared to samples with functional telomeres.  
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Figure 56 - BLESS-qPCR on MEFs with dysfunctional telomeres. 
MEFs TRF2F/F either uninduced or induced with 4-OHT for 48h to induced uncapping, and MEFs transfected 
with a vector coding for TRF1-FokI or the nuclease dead version TRF1-FokI D405A were fixed and analyzed 
by BLESS-qPCR using primers matching the telomeric sequences as in Figure 52. Bars represent the 
normalized ratio of % of input for each site in the Induced sample over the uninduced (n=1). 
 
 
The higher enrichment of telomeric repeats observed in the FokI transfected cells, compared 
to the sample with uncapped telomeres, is not completely surprising, because the 
endonuclease FokI induces several breaks at each telomere, thus providing multiple DNA 
ends to be captured by BLESS, compared to telomeres uncapped which only have one end 
to be ligated. 
 
With this strategy qPCR strategy, while being able to discriminate dysfunctional telomeres 
from intact and functional telomeres, it is not possible to distinguish between DSB bearing 
telomeres and uncapped telomeres. However, I reasoned that using strand specific primers 
it could be possible to make this distinction. In particular, using one primer matching the 
linker sequence and either one primer for the G-rich telomeric repeats or the C-rich telomeric 
repeats, I could discriminate among intact capped telomeres (that would not be detected by 
neither of the two primer couples), telomeres containing DSBs (that would be amplified both 
with G-rich and C-rich primers) and uncapped telomeres that do not bear DSBs (that would 
only be amplified with a G-rich primer) as depicted in Figure 57. 
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Figure 57 - Scheme of the primers used for telomeric strand-specific BLESS-qPCR. 
a. Capped telomeres are folded in a T-loop structure that prevents efficient linker ligation. b. Uncapped 
telomeres have a G-rich 3’ end (blue) that can be ligated to the linker (black); PCR amplification with a primer 
matching the G-rich telomeric sequence (blue arrow) and a primer matching the linker (black arrow) yields 
detectable amplicons. c. DSB bearing telomeres have both a 3’ G-rich end (blue) and a 3’ C-rich end (red) that 
can be ligated to the linker (black). PCR amplification with a primer matching the linker (black arrow) and 
either with a primer matching the G-rich telomeric sequence (blue arrow) or with a primer matching the C-rich 
telomeric sequence yields detectable amplicons. 
 
 
Thus, I performed qPCR with strand-specific primer couples on the same samples that I 
already used to generate Figure 56. The mismatches in the G/C-rich telomeric primers still 
allowed the specific accumulation of the amplicons generated after the first PCR cycle; 
however, when used in combination with the primer matching the linker, different amplicons 
could be generated during the first cycle. To partially prevent this problem, I shortened the 
amplification step in the qPCR program, to favour specific (short-sized) amplicons 
generation; indeed, I observed consistent melting temperatures among different samples, 
indicating the formation of comparable amplicons in all the reactions. 
 
 
 
 
 
3’ TTAGGG 
TTAGGG 
TTAGGG 
a 
b 
c 
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Figure 58 - BLESS-qPCR with strand specific telomeric primers. 
BLESS-qPCR on MEFs TRF2F/F either uninduced or induced with 4-OHT for 48h, and MEFs transfected 
with a vector coding for TRF1-FokI or the nuclease dead version TRF1-FokI D405A. Bars represent the 
normalized ratio of % of input for each site in the Induced sample over the uninduced (n=2). a. The G-rich 
primer used to generate Figure 56, was used in combination with the primer matching the linker sequence. b. 
The C-rich primer used to generate Figure 56, was used in combination with the primer matching the linker 
sequence. 
 
 
As shown in Figure 58, with G-rich primers in combination with the primer matching BLESS 
linker, I could specifically detect a signal both in uncapped telomeres and broken telomeres.  
Interestingly, I observed that, while the couple of telomeric primers produced a higher signal 
in DSB bearing telomeres compared to uncapped telomere (Figure 56), here, using strand-
specific qPCR, I detected more G-strand in uncapped telomeres than in broken telomeres. 
This suggests that the overall higher telomeric signal measured in FokI transfected cells, was 
due to the sum of G- and C-strand capture by BLESS. 
I also detected a higher signal in FokI transfected cells, compared to all other conditions, 
when using C-rich primers in combination with the primer matching BLESS linker, 
indicating that the approach is working as expected. However, I observed an increase over 
the uninduced also in the nuclease dead transfected cells and in cells with uncapped, possibly 
suggesting a low frequency accumulation of DSB due to the uncapping itself or due to the 
transfection reagents (as also suggested by γH2AX accumulation in about 20% of FokI 
D405A transfected cells – Figure 55). 
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In conclusion, these results show that DI-PLA and BLESS can be used as tools to detect 
uncapped telomeres, and BLESS followed by strand-specific qPCR can distinguish among 
3 different telomeric states: intact, uncapped and broken. 
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5 Discussion 
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5.1 BLESS-qPCR is a sensitive method to study DSB 
accumulation at specific loci 
The most used methods to map DNA damage accumulation and DNA repair, both at 
genome-wide level and in single cells are based on the use of antibodies that recognize DDR 
markers such as γH2AX. However, a growing body of evidence indicates that this indirect 
approach to detect DNA damage is not precise. Some groups have reported, or suggested, 
DDR marker accumulation in the absence of physical DSBs, such as in senescent cells 
(Rodier et al. 2011), in mitotic cells (Mcmanus & Hendzel 2005, Tu et al. 2013), and in 
replication stress-induced damage (Rybak et al. 2016b). On the contrary, DNA damage 
accumulation in the absence of DDR markers is also possible, and it has been reported in 
astrocytes (Schneider et al. 2012), and  in heterochromatic regions (Kim et al. 2007, Lafon-
Hughes et al. 2013). Moreover, DNA damage markers spread for several kilobases (up to 
1Mb) around the break, preventing precise localization of the DSB position on the genome.  
A few alternative approaches for direct detection of DNA damage genome-wide have been 
developed in the last years; they mainly rely on two different approaches, one detecting 
exposed DNA ends available in a population of cells at a given moment, and a second one 
tracking the repair of DSBs (see Introduction, section 2.5). Unfortunately, very little data is 
available in literature comparing the performance different methods, mostly due to the costs 
associated with reagents and high-throughput sequencing required to test these protocols. 
The work described in my thesis shows a simple and effective strategy to query by qPCR 
the DSBs captured by methods that rely on direct DSB labelling and enrichment, such as 
BLESS (Crosetto et al. 2013b), DSBCapture (Lensing et al. 2016) and BLISS (Yan et al. 
2017) (Figures 4-7, 15). The strategy, inspired by the ChIP-qPCR method, requires a primer 
couple to be designed next to the putative DSB site, then qPCR is performed on both the 
captured material and on the input (before DSB enrichment), in order to normalize the 
amount of DNA captured on the starting material, thus allowing comparisons among 
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different samples. I confirmed the effectiveness of this approach by detecting DSBs in 
conditions where DNA breaks accumulation was already reported in literature, such as at 
specific U2OS AsiSI-cleaved sites and in Hela cells transfected with the I-SceI endonuclease 
that cuts at a single locus in the genome. Further evidence that the approach works reliably 
came from validation of DSBs detected by NGS analysis of BLISS. 
Similar approaches have been described in literature for ligation-mediated PCR (Chailleux 
et al. 2014), although the recently published protocols developed to map DSBs have not 
included a qPCR validation step. However, a new protocol, recently published, based on 
digital droplet PCR, might provide the most sensitive quantification of DSBs accumulating 
at a specific locus in a population of cells available so far (Rose et al. 2017). 
 
5.2 BLISS performs better than other available methods 
to measure DSB genome-wide 
As mentioned above, very little data is available to compare how well different methods 
perform. In collaboration with our bioinformatician, Dr. Iannelli, we have compared one of 
the latest methods developed, BLISS, with two similar approaches (BLESS and 
DSBCapture) and γH2AX ChIP-seq, the most used technique used to map DNA damage. To 
have the cleanest experimental setup, I used U2OS cells expressing the AsiSI restriction 
enzyme, which can potentially cut about 1200 site in the human genome, although, being 
sensitive to chromatin state and methylation, it cleaves only 10-20% of the putative target 
loci. 
The data that we generated shows that BLISS outperforms both BLESS and DSBCapture, 
being able to detect the whole array of AsiSI target sites already validated in literature, 
differently from the other techniques (Figure 11), and it is able to detect a higher absolute 
number of DSBs. Moreover, target sites detected by BLISS significantly overlap with 
γH2AX enriched regions (Figure 13), and fall in transcriptionally active regions (Figure 14), 
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thus in regions where chromatin is open and DNA is likely accessible to the AsiSI enzyme, 
indicating that BLISS results are reliable. By BLISS, we also detected a number of AsiSI-
cleaved sites which were not detected neither by other DSB mapping techniques, nor 
significantly enriched in γH2AX ChIP-seq. This result suggests a higher sensitivity of BLISS 
compared to the other available methods, and, while I cannot completely exclude that these 
represent false positive signals, I could reproducibly detect a subset of these sites in a 
biological replicate by BLISS-qPCR (Figure 14). 
 
5.3 DSBs lead to transcription inhibition of genes in the 
surrounding regions 
By intersecting the map of DSBs generated by AsiSI induction in U2OS cells with a 
multilayered expression profiling (including data from RNA-seq, Bru-seq, CAGE and RNA 
POL II ChIP-seq) we could observe transcription inhibition around the DSB sites (Figure 
16, Iannelli et al., 2017). This result shows at unprecedented resolution and at genome-wide 
level the impact of DSBs in endogenous regions on transcription. Transcription repression 
following DSB generation is in line with several reports in the literature that show the 
activation of different mechanisms to prevent aberrant transcript production in the presence 
of DNA damage, including RNA POL II degradation, chromatin condensation and the 
recruitment of transcription repressors such as PRC1 (Adam & Polo 2014, Bregman et al. 
1996, Shanbhag et al. 2010, Svejstrup 2010). However, there is an apparently contrasting 
report showing that expression of the I-PpoI endonuclease in mice only induces 
transcriptional silencing of the genes bearing the damage and not in the surrounding genes 
(Kim et al. 2016). This discrepancy, could be partially due to the fact that I-PpoI target sites 
are mainly within ribosomal DNA repeats, while AsiSI targets are in non-repetitive 
sequences: thus, the different genomic sequences might trigger different mechanisms. Most 
importantly though, Kim and colleagues, have not validated which subset of I-PpoI sites are 
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actually cleaved, thus they have probably made an underestimation of DSBs impact on 
transcription: assuming that I-PpoI cuts only 20% of its putative target sites similarly to 
AsiSI, the transcription alterations that they observed were masked by 80% of the I-PpoI 
sites that were not cleaved, thus not associated with any transcriptional perturbation. We 
observed that the strongest transcription inhibition effect happens in proximity to the DSB, 
while the repression progressively weaken spreading away from the break site (Iannelli et 
al. 2017); thus it is likely that Kim and colleagues did not detect transcription inhibition at 
10kb or more from the break, just because they did not have enough sensitivity in their 
analysis. 
 
5.4 Transient DSB formation is involved in LPS-induced 
enhancer activation 
Despite having demonstrated that DSBs induce transcriptional repression, several reports 
show that transient DSB formation is a mechanism involved in stimuli-specific transcription 
activation (as discussed in the introduction – section 2.4.3). In agreement with this 
physiological role for DNA damage, in collaboration with Dr. Vitelli, we probed for the 
presence of DSBs at the enhancers activated after by LPS stimulation in macrophages and, 
strikingly, we found that, 5 minutes after exposure of cells to LPS, there is a transient wave 
of induction of DSBs that are rapidly repaired and disappear after 60 minutes (Figures 17-
19). This preliminary observation will be followed by other experiments to understand 
whether DSBs formation and/or repair is needed for transcription activation and what 
mechanism leads to the DSB induction in response to LPS recognition (Vitelli, Galbiati et 
al., in preparation). To prove that DSBs need to be repaired to allow transcription activation 
we will perform experiments in the absence of Ligase IV; moreover, as proof of concept we 
will design a guide for an inducible CRISPR-Cas9 to activate transcription in a specific 
enhancer. Certainly, it will be very interesting to check how the DSB is generated in response 
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to LPS. At the moment we can speculate that DSBs might be generated by a specific nuclease 
that is translocated at the enhancer together with factors involved in enhancer activation such 
as PU1 (Kaikkonen et al. 2014), although experiments will be necessary to prove this 
hypothesis. 
 
5.5 DI-PLA is a sensitive method to detect DSBs in single-
cells 
The new method that I have developed and described here, DI-PLA, is a tool to detect by 
imaging, physical DSBs in proximity of a DDR marker or a chromatin bound factor localized 
next to the DSB, in single-cells. It allows detection of DSBs induced by several sources, 
including restriction enzymes, IR and NCS (Figure 24, 26, 28). Although it is difficult to 
quantitate DI-PLA efficiency in detecting DSBs, the similar results obtained by PLA 
between two DDR markers and by DI-PLA show that DNA ends generated by different 
sources are generally available for blunting and ligation reactions. This is also in agreement 
with several reports using a similar DSB labelling strategy, but followed by NGS (such as 
BLESS, BLISS, DSBCapture and more), to detect DSB generated by several sources, 
including restriction enzymes, topoisomerase inhibitors or replication stress (Baranello et al. 
2014, Crosetto et al. 2013b, Yan et al. 2016). 
I have demonstrated that DI-PLA signals are dependent on the presence of the biotinylated 
linker (Figure 29), and that the partner antibody used in combination with the anti-biotin one 
needs to recognize a protein in proximity of a DSB to generate a detectable signal by DI-
PLA (Figure 31-32). Interestingly, the partner antibody does not necessarily recognize a 
DDR marker, opening up the possibility to use DI-PLA to detect DSB at specific loci that 
are marked by a set of proteins, such as centromeres or telomeres. 
Moreover, I have showed that DI-PLA signals are dependent on the number of DSBs present 
in the cell (Figure 34), they disappear if DSBs are in vitro re-ligated (Figure 35), and DI-
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PLA dotted signals co-localize with DSBs positions in the nucleus (Figure 36), strongly 
supporting the specificity of the assay.  
Although most of the DI-PLA validations were performed on adherent cells, I have data 
showing that DI-PLA can be applied to fixed tissues (Figure 38), albeit I found that section 
thickness is critical, because I occasionally observed unequal staining efficiency in the 
sections. 
 
5.6 Senescent cells accumulate persistent DSBs both in 
vitro and in vivo 
One of the hallmark of cellular senescence is the presence of DDR activation which plays a 
role both in the initiation and in the maintenance of the senescent state, through activation 
of the p53/p21 pathway (Munoz-Espin & Serrano 2014). Moreover, following DNA damage 
induction by several events, including replication stress or exogenous damage, in some cell 
types, also p16, the other main regulator of senescence, is activated (Mirzayans et al. 2012). 
Although a DDR-independent mechanism for senescence induction, dependent on the stress-
inducible kinase p38MAPK, has been reported, several experiments showed that inactivation 
of DDR components such as ATM, ATR or CHK2, leads to escape from OIS, replicative 
senescence and SIPS (Bartkova et al. 2006, Beauséjour et al. 2003, Di Micco et al. 2006, 
d'adda di Fagagna et al. 2003). However, it has been hypothesized that senescent cells do 
not retain physical DNA damage, rather stable chromatin alterations resulting from the 
damage, but without the underlying lesion, which are necessary to reinforce senescence, 
termed DNA-SCARS (Rodier et al. 2011). Here, by DI-PLA I have showed that both 
replicative senescent cells (Figure 43) and IR-induced senescent cells (Figure 47) 
accumulate persistent physical DSBs that are associated with the well-characterized 
persistent DDR foci. This observation is in agreement with data in the literature showing a 
preferential accumulation of DDR foci at telomeres (Fumagalli et al. 2012, Hewitt et al. 
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2012), where DSB repair is physiologically inhibited to prevent chromosome fusions. 
Interestingly, a recent report showed that DNA repair at telomeres is possible in human 
proliferating cells, but not in senescent cells (Mao et al. 2016), further supporting the model 
of persistent physical DSBs fuelling the senescent state. 
Cellular senescence associated with DDR activation has also been reported in vivo, where it 
plays a role in the ageing phenotype (as discussed in the introduction – section 2.5.3). Here, 
I showed that tissues (brain and liver) from aged mice, accumulate persistent DSBs (Figure 
48-49). This result is consistent with a recent report showing that chronic DNA damage 
induction in vivo, induces an ageing-like phenotype after only 1 month of treatment, 
including ageing pathologies, markers of senescence, fused mitochondria and alterations in 
gene expression profile (White et al. 2015). 
 
It has been well characterized by our group and others that persistent DDR activation in 
senescent cells is preferentially localized at telomeres (Fumagalli et al. 2012, Hewitt et al. 
2012), however we had previously observed that also non-telomeric regions accumulate 
DNA damage in IR-induced senescent cells. Thus, I applied for the first time a genome-wide 
single-nucleotide DSB mapping technology, BLISS, to study DNA damage accumulation 
and repair, over time, following cells exposure to a high dose of IR and during establishment 
of senescence. However, this is a very challenging experimental setup for several reasons. 
Firstly, in an ideal setup, the experiment should start by inducing DNA damage at each 
nucleotide in the genome in all cells. Luckily, since in BLISS analysis we divided the 
genome in 2kb windows, I only needed to generate 1 DSB every 2kb; this still results in 
about 1.5milion DSBs. Considering that 2Gy induce roughly 100 DSB per cell (personal 
observation based on DI-PLA between γH2AX and biotin), 20Gy should induce about 1.000 
DSBs per cell, which, in the population of 50.000 cells used for the experiments, exceeds by 
30-fold the minimum amount of DSBs (1.5M) that needs to be induced in the ideal 
experimental setup. While mathematically correct, I cannot exclude that some regions might 
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be more resistant than others to IR damage, thus resulting in a biased IR-induced damage. 
Secondly, we unexpectedly found a high background signal in quiescent cells, that led us to 
use a normalization pipeline (see materials and methods 3.22, and result section 4.4.1.1), 
that might have masked low-frequency DSB signals; the high-background that we observed 
in untreated cells might be due to the fact that we kept them in culture for 28 days, thus they 
have likely been exposed to oxidation stress. Thirdly, de novo DSBs detection by BLISS is 
more challenging than detecting DSBs in specific regions: as reference, the BLISS pipeline 
that we developed in collaboration with prof. Pattini, detected less than 50% of the U2OS 
AsiSI-induced DSBs that we detected using a different pipeline that only focuses around 
AsiSI cleavage sites (Figure 12). For all these reasons, it is likely that we underestimated the 
number of DSBs generated in this experiment.  
As shown if Figure 50, we were able to identify 67 genomic loci that accumulated DSBs at 
all the time points analysed (but not in the control), that I named “hard to repair”. Although 
some of these sites are falling in pericentromeric or subtelomeric regions, after a preliminary 
qualitative analysis, I could not observe any shared striking feature among these sites. Most 
importantly, I was not able to determine whether these sites are biologically relevant, since 
in a biological replicate analysed by BLISS-qPCR, I did not consistently detect all of them 
(Figure 51). This inconsistency, might be either due to any of the challenges in the 
experimental setup and analysis mentioned above, or to an actual lack of conserved genomic 
regions for DNA damage accumulation in senescent cells, except for telomeric regions. For 
example, it has been suggested that, in SIPS, non-telomeric DNA damage is short-lived and 
induced by highly reactive ROS, thus resulting in very low-frequency DSBs that are very 
hard to detect by BLISS (Hewitt et al. 2012, Passos et al. 2010).  
In any case, another round of BLISS followed by NGS will be needed to draw further 
conclusions. 
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On the other hand, I was able to detect DSBs accumulating at telomeres both by DI-PLA 
and by BLISS-qPCR using telomeric primers, exploiting the strategy described by Cawthon 
and colleagues (Cawthon 2009), thus confirming data available in literature (Figure 52-53). 
 
5.7 DI-PLA and BLESS can be used to study the telomere 
state 
The possibility to detect DSBs accumulation at telomeres in senescence cells by DI-PLA 
and BLESS (Figures 52-53) led me to think that these two tools could be used to specifically 
detect dysfunctional telomeres. As proof of concepts experiments I used a cell line where I 
could induce telomere uncapping, with the addition of tamoxifen to cell culture medium and, 
indeed, I observed an increase in telomeric signal both by DI-PLA and BLESS (Figures 54-
56). Thus, this result suggests the possibility to use these two tools to discriminate between 
functional and dysfunctional telomeres. 
For most of the experiments, however, using DDR markers to check for the presence of 
damaged or uncapped telomeres is more practical and just as sensitive (if not more, given 
the low induction measured by BLESS-qPCR at uncapped telomeres, Figure 56) than DI-
PLA and BLESS. However, the only way to distinguish between DSBs accumulation at 
telomeres and T-loop disruption, is by super-resolution imaging (Doksani et al. 2013) or 
electron microscopy (Griffith et al. 1999). Here, I was able, by using strand specific primers 
(either C- or G- rich) in combination with a primer matching BLESS linker sequence, to 
discriminate between three different telomeric states: intact, uncapped and broken (Figure 
57-58).  
Interestingly, I measured higher enrichments over untreated sample with the C-strand, than 
with the G-strand, suggesting a higher background coming signal from the G-strand in 
capped, intact telomeres. This observation is in agreement with data in literature reporting 
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BLESS capture of telomeric sequences (Crosetto et al. 2013, Zhu et al. 2017). Further 
analyses will be required to understand why there is a background signal from a population 
of cells with intact capped telomeres. One possibility is that during S phase, replicating 
telomeres become available for DSB labelling by ligation with the linker, although this 
possibility could be ruled out by performing an experiment on quiescent cells. Another 
possibility is that during cell manipulation the T-loop structure is lost: interestingly very 
recent data reported by Zhu and colleagues (Zhu et al. 2017) showed that the BLESS 
crosslinking step and the short proteinase K step used to digest cell membrane prior DNA 
ends blunting and ligation, are critical for the number of telomeric reads retrieved when 
performing BLESS followed by NGS. In particular, performing BLESS without cells 
crosslinking and with a longer proteinase K incubation, yielded 10-fold more telomeric reads 
compared to the standard BLESS protocol. While this observation suggests that some 
optimization of the BLESS protocol might be needed to use it as a reliable assay for the 
telomeric state, it strongly supports the hypothesis that T-loop and shelterin proteins prevent 
telomere capture by BLESS. 
 
In conclusion, this set of results suggests that by applying BLESS followed by strand specific 
qPCR is be possible to discriminate between different telomeric states. This approach could 
be exploited to gain new insights into mechanisms of DDR activation and DNA repair at 
telomeres. 
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